Legend

Presentation Icons

CME

Non-CME

In Person

On Demand

Live Stream

Active Learning

Choose Rheum

Emerging Investigator Awardee

All times listed are Central Daylight Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.

Type here to filter the list

Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
ARP Posters II
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Cytokines & Cell Trafficking Poster
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Epidemiology & Public Health Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Health Services Research Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Imaging of Rheumatic Diseases Poster
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Measures & Measurement of Healthcare Quality Poster II
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Miscellaneous Rheumatic & Inflammatory Diseases Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Osteoarthritis & Joint Biology – Basic Science Poster
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Osteoarthritis – Clinical Poster II
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster II
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Pediatric Rheumatology – Basic Science Poster
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Pediatric Rheumatology – Clinical Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Professional Education Poster
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Reproductive Issues in Rheumatic Disorders
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Rheumatoid Arthritis – Treatment Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Sjögren’s Disease – Basic & Clinical Science Poster III: Treatment and Trial Outcome Measures
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Systemic Lupus Erythematosus – Treatment Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Systemic Sclerosis & Related Disorders – Basic Science Poster II
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Systemic Sclerosis & Related Disorders – Clinical Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
(TM57–TM80) Adult Thieves Market Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Vasculitis – ANCA-Associated Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
Vasculitis – Non-ANCA-Associated & Related Disorders Poster III
Location: Hall F1
CE: 0.00
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1780: Modeling Osteoarthritis Knee Joint in a Compartmentalized Microfluidic System using IPSC-derived Sensory Neurons and human Synovial Fibroblasts
Location: Hall F1
Abstract Poster Presenter: Abdelhak Belmadani, n/a (he/him/his) – Northwestern University Chicago
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1781: Specific gut microbiome remodeling occurs after induction of OA via DMM surgery compared to sham surgery
Location: Hall F1
Abstract Poster Presenter: Aleksander Szymczak, PhD – Oklahoma Medical Research Foundation
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1782: Mapping The Synovial Innervation Of The Human Knee Joint
Location: Hall F1
Abstract Poster Presenter: Alia Obeidat, PhD – Rush University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1783: Nerve Growth Factor Causes Sensitization, Nociceptor Sprouting, Synovitis, And Osteophyte Formation In Naïve Murine Joints
Location: Hall F1
Abstract Poster Presenter: Alia Obeidat, PhD – Rush University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1784: Multimodal Preclinical Screening Of Glucocorticoid-Induced Disruption Of Bone Remodeling In Rat
Location: Hall F1
Abstract Poster Presenter: Anik Tuladhar, PhD (he/him/his) – AbbVie
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1785: Soluble CD14 Amplifies Chondrocyte Inflammatory Responses to Lipopolysaccharide and Is Targetable by Anti-CD14 Therapy
Location: Hall F1
Abstract Poster Presenter: Anna Rapp, PhD – University of Pennsylvania
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1786: SEV-101, A Regenerative Exosome Therapeutic for the Treatment of Osteoarthritis
Location: Hall F1
Abstract Poster Presenter: Beth Lindborg, MS, MBA – Sarcio, Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1787: Spatial and Quantitative Semiautomated Image Analysis of Synovial Biopsies Studied Using a Novel High-Plex Immunofluorescence Platform
Location: Hall F1
Abstract Poster Presenter: Estefania Quesada-Masachs, MD, PhD – University of Miami
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1788: Manganese-associated Single-nucleotide Polymorphisms are Associated with Radiographic Knee Osteoarthritis: The Johnston County Osteoarthritis Project
Location: Hall F1
Abstract Poster Presenter: Griffin Sonaty, MD, MPH – University of North Carolina
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1789: Spatial Analysis of Advanced Osteoarthritis Synovial Tissue
Location: Hall F1
Abstract Poster Presenter: jacob Dickman, n/a – Medical College of Wisconsin
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1790: Targeted Ablation of Knee-innervating Nociceptors Attenuates Pain and Cartilage Degeneration in Experimental Osteoarthritis
Location: Hall F1
Abstract Poster Presenter: Lai Wang, MD;PhD – Rush University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1791: Determining the Effect of CD14 Deficiency on Osteoblastogenesis and Subchondral Bone Remodeling In Mice
Location: Hall F1
Abstract Poster Presenter: Lance Murphy, -None- – University of Pennsylvania Perelman School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1792: OA protection in African spiny (Acomys) mice is partially mediated by the gut microbiome and is transferrable to wild-type mice via microbiome transplantation
Location: Hall F1
Abstract Poster Presenter: Matlock Jeffries, MD, FACP, FACR – Oklahoma Medical Research Foundation
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1793: Sex-associated changes to synovial macrophages in the aging joint
Location: Hall F1
Abstract Poster Presenter: Matthew Dapas, PhD – Northwestern University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1794: OA-associated pain sensitivity is reduced in OA-protected MRL/MpJ mice, partially mediated by the gut microbiome, and transferable via microbiome transplantation
Location: Hall F1
Abstract Poster Presenter: Montana Barrett, BS – University of Oklahoma
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1795: Trends and Disparities in Osteoarthritis-Related Mortality in the United States: A 21-Year Analysis (1999-2020)
Location: Hall F1
Abstract Poster Presenter: muzamil Khan, MBBS – George Washington University School of Medicine and Health Sciences
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1796: Multi-Tissue Molecular and Histopathological Profiling of Facet Joints and Intervertebral Discs
Location: Hall F1
Abstract Poster Presenter: Nashrah Ahmad, PhD – Scripps Research
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1797: SEV 101 Exosomes Isolated from Induced Pluripotent Stem Cell Derived Hyaline Cartilage Tissue Characterization of Immunomodulatory and Chondroproliferative Effects In Vitro
Location: Hall F1
Abstract Poster Presenter: Parthasarathy Rangarajan, PhD – Medical School, UMN
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1798: Proteomic Profiling of Chondrogenic Gene Therapy in Human MSCs Reveals Distinct Regenerative Pathways for Articular Cartilage Repair
Location: Hall F1
Abstract Poster Presenter: Patricia Quaranta, PhD – INIBIC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1799: Validating the Gouty Arthritis Alleviating Effects of Cerevisterol through Integrated In Silico, In Vitro, and In Vivo Studies
Location: Hall F1
Abstract Poster Presenter: Qiang Xu, n/a – Guangzhou University of Traditional Chinese Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1800: The Role of Nociceptor-Expressed Piezo2 in Nervous System Immune Cell Infiltration in a Mouse Model of Osteoarthritis
Location: Hall F1
Abstract Poster Presenter: Rachel Miller, PhD, BS – Rush University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1801: Matrikine Activation of Synovial Fibroblasts Promotes Monocyte Migration and Stimulates an OA Chondrocyte Phenotype
Location: Hall F1
Abstract Poster Presenter: Richard F. Loeser, Jr, MD, MACR – University of North Carolina
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1802: Clearance Kinetics and Cartilage Retention of MM-II, a Dispersion of Large Empty Liposomes, in Rat Knees
Location: Hall F1
Abstract Poster Presenter: Roni Wechsler, PhD – Moebius Medical
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1803: Patching of Damaged Meniscus and Cartilage of Osteoarthritic Animals by MM-II, a Dispersion of Empty Large Multilamellar Liposomes
Location: Hall F1
Abstract Poster Presenter: Roni Wechsler, PhD – Moebius Medical
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1804: Pharmacology of LEVI-04, a novel treatment for OA
Location: Hall F1
Abstract Poster Presenter: Simon Westbrook, PhD – Levicept Ltd
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1805: Human meniscus histopathological and transcriptomic changes at early and advanced stages of knee osteoarthritis
Location: Hall F1
Abstract Poster Presenter: Takuya Sakamoto, MD, PhD – Scripps Research Institute
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1806: Sex differences in knee joint microbial DNA of C57BL/6 mice and the effect of cross-sex microbiome transplantation
Location: Hall F1
Abstract Poster Presenter: Veera Durga Vaishnavi Kurra, MD – University of Oklahoma Health Sciences Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1808: Lightsheet imaging with 3D analysis for wholistic assessment of synovial lymphatic vasculature within joints of murine models of arthritis
Location: Hall F1
Abstract Poster Presenter: Xi Lin, PhD – University of Rochester Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1830: Single-Cell and Spatial Profiling Reveal Proinflammatory and Profibrotic Fibroblast-Macrophage Niches in Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Chirag Raparia, PhD, MS, BS (he/him/his) – Donald and Barbara Zucker School of Medicine At Hofstra/Northwell
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1831: Distinct Proteomic Signature Predicts Post-MMF Withdrawal Flares in Systemic Lupus Erythematosus Patients
Location: Hall F1
Abstract Poster Presenter: Christian Wright, BS – University of Oklahoma Health Sciences Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1832: Time-to-Event Analysis of Statin Use and Thrombotic Risk in Patients with Systemic Lupus Erythematosus: A Single-Center Retrospective Study
Location: Hall F1
Abstract Poster Presenter: Christine Lenchur, DO – Icahn School of Medicine at Mount Sinai
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1833: DM618: A Novel Anti-IL12p35 Antibody Specifically Inhibiting IL-12 with Therapeutic Potential in a Set of Autoimmune Diseases
Location: Hall F1
Abstract Poster Presenter: DONG ZHANG, PhD (he/him/his) – D2M Biotherapeutics, Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1834: Integrative Bioinformatics Analysis Reveals Key Genes and Immune Profiles Associated with Preeclampsia in Lupus Pregnancy
Location: Hall F1
Abstract Poster Presenter: Eva Galindo Calvillo, MD (she/her/hers) – Hospital Universitario Dr. Jose Eleuterio Gonzalez
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1835: Serum Zonulin As A Biomarker Of Renal Involvement In Systemic Lupus Erythematosus: Shedding Light On The Gut-Kidney Axis
Location: Hall F1
Abstract Poster Presenter: Giulio Forte, n/a – Università della Campania Luigi Vanvitelli
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1836: Emerging Role of B Cell Subtype-Specific Intracytoplasmic Toll-Like Receptor Expression and Serum Eotaxin as Biomarkers in Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Jennifer Balderas Miranda, MD, PhD (she/her/hers) – Universidad Nacional Autónoma de México
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1837: Enhanced Mitochondrial Activity in B cells from Females Is Required to Drive Increased T-bet Induction by TLR7 in Lupus
Location: Hall F1
Abstract Poster Presenter: John D. Mountz, MD, PhD – University Alabama Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1838: Differential Expression Of Activation Markers On dsDNA-reactive B-cells Between Healthy Subjects And SLE Patients Reveals Unconventional Extrafollicular Activation In SLE
Location: Hall F1
Abstract Poster Presenter: Jolien Suurmond, PhD – Leiden University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1839: Transcriptional Profiling of Whole Blood and Kidney Biopsy Samples from Lupus Nephritis and IgA Nephropathy Patients Suggests Different Disease Pathways
Location: Hall F1
Abstract Poster Presenter: Loqmane seridi, PhD – J&J
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1840: Breathomics in Systemic Lupus Erythematosus: uncovering non-invasive markers of disease activity
Location: Hall F1
Abstract Poster Presenter: Lorenzo Beretta, MD – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di MIlano
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1841: Differential metabolomic signatures along lupus nephritis spectrum
Location: Hall F1
Abstract Poster Presenter: Mariana Jiménez Tirado, MD (she/her/hers) – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1842: Social Vulnerability Index, Type 2 Lupus Symptoms, and Select Dysregulated Immune Features Identify Stage 2 (Pre-classification) SLE in the Lupus Autoimmunity in Relatives (LAUREL) Follow-up Cohort
Location: Hall F1
Abstract Poster Presenter: Melissa Munroe, MD, PhD (she/her/hers) – Oklahoma Medical Research Foundation; Progentec Diagnostics, Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1843: Tissue Neutrophils in The Pathogenesis of Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Norio Hanata, M.D., Ph.D. – Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1844: Disease-Associated Macrophages Express an Injury-Associated Gene Program and Localize to Distinct Compartments in Proliferative and Mixed Histologic Classes of Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Paul Hoover, MD, PhD – Brigham and Women's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1845: Immune Cell Profiles and Transcriptomic Signatures of Atherosclerosis in Systemic Lupus Erythemathosus
Location: Hall F1
Abstract Poster Presenter: Rodolfo Martinez-Canales, MD (he/him/his) – Facultad de Medicina y Hospital Universitario UANL
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1846: Integrated spatial and single-cell profiling of treatment-naïve lupus nephritis biopsies
Location: Hall F1
Abstract Poster Presenter: Roopa Madhu, PhD – Brigham and Women's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1847: Spatial transcriptomics reveals a complex microanatomic patterning of complement mediated inflammation and fibrosis in Class III pediatric lupus nephritis associated with local histologic injury
Location: Hall F1
Abstract Poster Presenter: Sarah McCuaig, MD, PhD (she/her/hers) – Children's Hospital of Philadelphia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1848: DS-7011a, An Anti-TLR7 Antagonistic Monoclonal Antibody, Suppresses Human Immune Cells and Multiple Cytokines/Chemokines Related to the Pathogenesis of SLE
Location: Hall F1
Abstract Poster Presenter: Shigeko Uryu, MSc – Daiichisankyo Co.,Ltd.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1849: Time-course RNA sequencing analysis of longitudinal peripheral blood samples to elucidate the factors determining treatment resistance in systemic lupus erythematosus
Location: Hall F1
Abstract Poster Presenter: Shuji Sumitomo, MD, PhD (he/him/his) – Kobe City Medical Center General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1850: First American SLE patients demonstrate enhanced lipid metabolism and B cell activation by high-content proteomic analyses
Location: Hall F1
Abstract Poster Presenter: Tayte Stephens, BS – University of Oklahoma Health Science Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1851: Endotype Discovery in Systemic Lupus Erythematosus Using Multi-Omic Approaches: Toward Precision Insights into Cardiovascular and Renal Damage
Location: Hall F1
Abstract Poster Presenter: Tomás Cerdó, PhD – Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1852: Cellular Landscape of Cutaneous Lupus Erythematosus Revealed by Single-Cell RNA Sequencing and Spatial Transcriptomics in the Lupus Accelerating Medicine Partnership Cohort
Location: Hall F1
Abstract Poster Presenter: Victoria Werth, MD – University of Pennsylvania
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1853: SAP Expression in SLE T Cells is Associated with Differentiation Towards Pro-Inflammatory Effector Subsets.
Location: Hall F1
Abstract Poster Presenter: Yevgeniya Gartshteyn, MD, MS – Columbia University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1854: Resting-State Functional Magnetic Resonance Imaging Analysis Revealed Altered Functional Connectivity Associated with Fatigue in Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Yujie Song, MB – Hokkaido University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1877: Demographics and trends of Inflammatory Arthritis-Related Mortality in the United States, 1999–2019
Location: Hall F1
Abstract Poster Presenter: Aishwarya Sudheer, MD – Saint Vincent Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1878: Customized Therapy for SLE: How Disease Severity Influences the Use of Corticosteroids and Biologics in Patients with SLE in the Lupus Federated Data Network (LupusNet) and a US Claims Database
Location: Hall F1
Abstract Poster Presenter: Ashley Orillion, PhD,MS – Johnson & Johnson
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1879: Infections in Hospitalized Patients With and Without Psoriatic Arthritis (2016–2021): A National Inpatient Sample Study
Location: Hall F1
Abstract Poster Presenter: AYEMA HAQUE, MD, MBBS (she/her/hers) – Western Michigan University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1880: Rheumatoid Arthritis Mortality in the U.S. (1999–2020): A Decline in Rates, But Not in Disparities
Location: Hall F1
Abstract Poster Presenter: Aziz-ur-Rahman Khalid, DO – St. Joseph’s University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1881: Silent Impact: Two Decades of Sjögren’s Syndrome Mortality in the United States
Location: Hall F1
Abstract Poster Presenter: Aziz-ur-Rahman Khalid, DO – St. Joseph’s University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1882: Vessels Under Fire: National Mortality Trends in Systemic Vasculitides in the United States, 1999–2020
Location: Hall F1
Abstract Poster Presenter: Aziz-ur-Rahman Khalid, DO – St. Joseph’s University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1883: Temporal Patterns of Cardiometabolic Comorbidities Before and After Psoriatic Arthritis Diagnosis: A Nationwide Retrospective Study from Poland.
Location: Hall F1
Abstract Poster Presenter: Bogdan Batko, MD – UAFM
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1884: The Importance of Adherence to Dietary Recommendations for Rheumatoid Arthritis Risk May Be Greater in Younger Individuals – Results from a Nested Case-Control Study
Location: Hall F1
Abstract Poster Presenter: Carl Turesson, MD;PhD – Lund University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1885: Sex-specific Associations of Anthropometrics, Smoking and Eduction with the Risk of Rheumatoid Athritis: A Nested Case-Control Study
Location: Hall F1
Abstract Poster Presenter: Carl Turesson, MD;PhD – Lund University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1886: Thirty Percent of Older Adults with Rheumatic Disease Receive High-Risk Medication
Location: Hall F1
Abstract Poster Presenter: Christine Anastasiou, MD – Stanford University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1887: Incidence, Prevalence and Mortality of Systemic Lupus Erythematosus – A 20-year territory-wide analysis of electronic health records in Hong Kong
Location: Hall F1
Abstract Poster Presenter: Danting Zhang, MPH, PhD – The University of Hong Kong
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1888: Developing Machine Learning Algorithm in Electronic Health Record to Accurately Identify Psoriasis Patients
Location: Hall F1
Abstract Poster Presenter: Dilli Poudel, MD (he/him/his) – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1889: Navigating Diagnostic Challenges: Insights into the Patient Journey and Delays in Diagnosing Dermatomyositis from a Real-world Survey in the United States and Europe
Location: Hall F1
Abstract Poster Presenter: Esther Yi, MS, PharmD – Pfizer
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1890: Quantifying the Inflammatory Toll: Smoking-Attributable Rheumatoid Arthritis Burden Across the Globe, 1990–2021
Location: Hall F1
Abstract Poster Presenter: Eva Kalra, MBBS – Trident Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1891: Geographic Trends in the Burden of Gout in the United States from 1990 to 2021: A State-Level Analysis of Prevalence, Incidence, and Disability
Location: Hall F1
Abstract Poster Presenter: Eva Kalra, MBBS – Trident Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1892: Impact of Systemic Lupus Erythematosus on In-Hospital Outcomes Following Percutaneous Coronary Intervention: Insights from a 7 year Nationwide Analysis
Location: Hall F1
Abstract Poster Presenter: Freya Shah, MD (she/her/hers) – NYMC/Landmark Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1893: Increased Atrial Fibrillation Risk in Rheumatoid Arthritis: Greater in Seropositive Than Seronegative Patients
Location: Hall F1
Abstract Poster Presenter: Hyungjin Kim, MD;PhD – Samsung Medical Center, Sungkyunkwan University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1894: Opioid Use Disorder Among Patients with Rheumatic Conditions in the All of Us Research Program: A Descriptive Analysis
Location: Hall F1
Abstract Poster Presenter: Jacob Riegler, MD, MS, MBA (he/him/his) – Cambridge Health Alliance
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1895: Assessing the Validity of Self-reported Medication Data Through Metabolite Analysis: Data from the Osteoarthritis Initiative
Location: Hall F1
Abstract Poster Presenter: Jeffrey Driban, PhD – UMass Chan Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1896: Electronic Cigarette Use in Association with Risks of Developing Rheumatoid Arthritis or Systemic Lupus Erythematosus in the All of Us Research Program
Location: Hall F1
Abstract Poster Presenter: Jeong Yee, PhD,PharmD – Sungkyunkwan University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1897: Changes in SLE Mortality During and After the COVID-19 Pandemic
Location: Hall F1
Abstract Poster Presenter: Laura Hernandez, BS – University of California, Los Angeles
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1898: Assessing Representation in a Nation-wide Psoriasis Registry: A Single-institution Comparison
Location: Hall F1
Abstract Poster Presenter: Mackenzie Kilton, BS – University of Nebraska Medical Center College of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1899: Regional Variability in SLE Damage Accumulation by Disease Activity Across the Lupus Federated Data Network (LupusNet)
Location: Hall F1
Abstract Poster Presenter: Manuel Ugarte-Gil, MD, PhD, MSc – Universidad Cientifica del Sur
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1900: Capturing Patient Cohorts: A Temporal Arteritis Classifier
Location: Hall F1
Abstract Poster Presenter: Megan Sullivan, MD, RhMSUS – Mayo Clinic Arizona
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1901: Epidemiology of Adult-Onset Still’s Disease in South Korea: A Nationwide Study Using Health Insurance Claims Data
Location: Hall F1
Abstract Poster Presenter: Mihye Kwon, MD, PhD (she/her/hers) – Konyang University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1902: Investigating Factors Associated With Respiratory Syncytial Virus Vaccination and Breakthrough Infection Among Patients With Systemic Autoimmune Rheumatic Diseases
Location: Hall F1
Abstract Poster Presenter: Natalie Davis, MSc – Brigham and Women's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1903: Seasonal and Racial/Ethnic Variation in Achieving Target Uric Acid Levels in Gout Patients on Urate Lowering Therapy in US Veterans in Central California
Location: Hall F1
Abstract Poster Presenter: Nidaa Rasheed, MD – UCSF Fresno
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1904: Mapping CTD-ILD in a Spanish Cohort – the NIRRVANA Registry
Location: Hall F1
Abstract Poster Presenter: Paula García-Escudero, MD – Hospital Universitario Álava
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1905: Exploring the Association Between Environmental Quality Index and Rheumatoid Arthritis Mortality in the United States
Location: Hall F1
Abstract Poster Presenter: Rohan Sharma, Medical Student – UCLA
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1906: The incidence and mortality of connective tissue diseases in England: a population-level cohort study from 2012 to 2023
Location: Hall F1
Abstract Poster Presenter: Samir Patel, MBBS – King's College London
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1907: Twenty-Year Trends in the U.S. Burden of Gout: A State-Level Analysis of Disability and Prevalence from 2001 to 2021
Location: Hall F1
Abstract Poster Presenter: Shiza Sarfraz, MD – Brody School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1908: Clinical and Imaging Features of Haemochromatosis Arthropathy - a Systematic Literature Review and Meta- Analysis
Location: Hall F1
Abstract Poster Presenter: Stephanie Finzel, MD (she/her/hers) – University Medical Center Freiburg
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1909: Trends of venous thromboembolism after total joint replacement in the United Kingdom after the introduction of NICE guidelines.
Location: Hall F1
Abstract Poster Presenter: Subhashisa Swain, PT, PhD, MPH – University of Oxford
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1910: Clinical profile and healthcare resource utilization of patients diagnosed with giant cell arteritis or polymyalgia rheumatica in the US: a real-world cohort study using a large database of administrative health claims
Location: Hall F1
Abstract Poster Presenter: Valeria Jordan M., MD – Novartis
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1911: Characterizing Psoriasis Patients at Risk for Transition to Psoriatic Arthritis: Early Insights from the STOP PsA At-Risk Cohort
Location: Hall F1
Abstract Poster Presenter: Victoria Konzett, MD – Medical University of Vienna
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1912: Cutaneous manifestations of vasculitis: A cross-sectional analysis from an international cohort
Location: Hall F1
Abstract Poster Presenter: William Song, MD – Pennsylvania Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1913: Do We Screen For and Do We Miss Antimalarial-Induced Cardiomyopathy (AMIC)? Risk Profiles according to Hydroxychloroquine Exposure Duration
Location: Hall F1
Abstract Poster Presenter: Youngmin Kim, MD – Brigham and Women's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1915: Innovative Clinical Trial Recruitment Approaches in Lupus Research: LuCIN Site Perspectives on Use of Social Media and Artificial Intelligence
Location: Hall F1
Abstract Poster Presenter: Brandon Jackson, MPH – Lupus Therapeutics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1916: Adherence to Cervical Cancer Screening Programs in Women with Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Carmen Lasa Teja, n/a – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1917: Characterizing the Frequency and Timing of Changes in Patient-Reported Social Risk Factors among Rheumatology Outpatients
Location: Hall F1
Abstract Poster Presenter: Daphne Lew, PhD,MPH – Washington University in St. Louis School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1918: Vigorous Physical Activity in Patients with SLE Was Not Associated with Disease Activity or Socioeconomic and Social Factors
Location: Hall F1
Abstract Poster Presenter: Heather Gold, PhD, MA – NYU Grossman School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1919: Financial insecurity and discrimination are associated with patient-reported quality of life in patients with SLE
Location: Hall F1
Abstract Poster Presenter: Heather Gold, PhD, MA – NYU Grossman School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1920: Lung Cancer Screening with Rheumatoid Arthritis: A Retrospective Claims Analysis
Location: Hall F1
Abstract Poster Presenter: Huifang Lu, MD;PhD – UT MD Anderson Cancer Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1922: Exploration of patient and clinician perspectives on rehabilitation in contemporary rheumatology care for rheumatoid arthritis: A qualitative study
Location: Hall F1
Abstract Poster Presenter: Joel Thompson – University of North Carolina at Chapel Hill
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1923: A Real-World Survey on Physicians Perspectives of Uncontrolled Gout and Gout Management Practices
Location: Hall F1
Abstract Poster Presenter: John Botson, MD – Orthopedic Physicians Alaska
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1924: Real-World Treatment Patterns of Patients with Systemic Autoimmune Rheumatic Disease-associated Interstitial Lung Disease After Progression in The United States
Location: Hall F1
Abstract Poster Presenter: Joseph Yang, PharmD – Boehringer Ingelheim
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1925: Associations Between representation And quality in Clinical Trials for Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Joshua Skydel, MD – Yale-New Haven Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1927: Development of the PREVAIL model of care: Optimizing feasibility and acceptability for trial implementation
Location: Hall F1
Abstract Poster Presenter: Louise Thoma, PhD, DPT – University of North Carolina
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1928: Oral Health in Patients with Rheumatic Diseases: A Pilot Quality Improvement Program
Location: Hall F1
Abstract Poster Presenter: Margarita Isabel Alarcón Jarquin, MD (she/her/hers) – Hospital universitario Dr. José Eleuterio González
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1929: Economic Burden of Macrophage Activation Syndrome (MAS) in Patients with Still's Disease (Systemic Juvenile Idiopathic Arthritis (sJIA) and Adult-onset Still’s Disease (AOSD)): Analysis of a US National Administrative Claims Database
Location: Hall F1
Abstract Poster Presenter: Michael Marrone, PhD, MPH – Sobi Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1930: Can a Multinational Awareness Campaign Improve Referral Rates and Reduce Diagnostic Delays in Patients with Chronic Inflammatory Rheumatic Diseases? The Impact of a Prospective Interventional Study
Location: Hall F1
Abstract Poster Presenter: Nelly Ziade, MD, PhD, FRCP – Saint-Joseph University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1931: COSMOS Prevalence of aTTP in SLE
Location: Hall F1
Abstract Poster Presenter: Nisha Sapkota, MD – One Brooklyn Health- Interfaith Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1932: Evaluating a Potential Cause of Excess Lung Cancer Mortality in RA: An Analysis of Chest CT Imaging Frequency in RA
Location: Hall F1
Abstract Poster Presenter: Rebecca Brooks, MD (she/her/hers) – Mayo Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1933: Specialist Wound Care Services Provision and Sharp Debridement Practices for Digital Ulcers (DU) Management in Systemic Sclerosis (SSc): An International Survey
Location: Hall F1
Abstract Poster Presenter: Rúben Duarte Fernandes, MSc, RN – LIRMM, University of Leeds
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1934: Analysis of the Determinants of Vaccine Acceptance and Hesitancy in Germany: A Mixed-methods Approach Incorporating Health Insurance Data and Qualitative Interviews with Patients and Physicians
Location: Hall F1
Abstract Poster Presenter: Uta Kiltz, MD – Rheumazentrum Ruhrgebiet
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1935: Sex-associated disparities in industry payments to US authors in high-impact rheumatology journals correlate with author impact
Location: Hall F1
Abstract Poster Presenter: William Stohl, MD, PhD – University of Southern California
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1936: A Fully Automated Method for Measuring Minimum Tibiofemoral Joint Space Width in Knee Osteoarthritis Assessment: Data from the FNIH Cohort
Location: Hall F1
Abstract Poster Presenter: Ahmad Almhdie, PhD – University Hospital Center of Orleans
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1937: Does Combining Standard MRI-Based Scores with Radiographic Trabecular Bone Texture Biomarkers Improve Predictive Performance for Radiographic Knee Osteoarthritis Progression?
Location: Hall F1
Abstract Poster Presenter: Ahmad Almhdie, PhD – University Hospital Center of Orleans
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1938: Optimizing Patient Outcomes: The Experience of a Multidisciplinary Rheumatology and Hand Surgery Clinic with Point-of-Care Musculoskeletal Ultrasound Integration
Location: Hall F1
Abstract Poster Presenter: Aidan Pye, MD, BSc (he/him/his) – University of British Columbia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1939: Salivary Gland Ultrasounds Can Be Read by General Radiologists: A Review Of 4 Years of Reports from an Urban Academic Radiology Department
Location: Hall F1
Abstract Poster Presenter: Ali Dhanaliwala, MD, PhD – University of Pennsylvania
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1940: Correlation of Hand and Lymphatic Function Post Exercise Intervention in Rheumatoid Arthritis
Location: Hall F1
Abstract Poster Presenter: Allen Anandarajah, MD, MS – University of Rochester Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1941: How Calculating Consensus Change Scores Can Go Wrong: Lessons from Multi-reader Imaging Assessments in Axial Spondyloarthritis
Location: Hall F1
Abstract Poster Presenter: Ana Bento da Silva, MD – Leiden University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1942: An Agnostic Evaluation of Serum Proteins Discriminates the Severity of Ultrasound Arthritis in SLE Patients
Location: Hall F1
Abstract Poster Presenter: Anca Askanase, MD, MPH – Columbia University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1943: Searching for subclinical synovitis and erosions in seropositive palindromic rheumatism: the added value of the ultrasonographic study of feet
Location: Hall F1
Abstract Poster Presenter: Andrés Ponce Fernández, MD (he/him/his) – Hospital Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1944: Musculoskeletal Ultrasound Clinic Referral Patterns and Joint Findings in a Tertiary Care Center amongst Patients with Elevated BMI and Inflammatory Arthritis
Location: Hall F1
Abstract Poster Presenter: Anna Lichtiger, MD – Montefiore Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1945: Significance of Finger Joint Tenderness With or Without Swelling in Relation to MRI, Ultrasound, and X-Ray Findings in Psoriatic Arthritis_Final results
Location: Hall F1
Abstract Poster Presenter: Ari Polachek, MD – Beilinson Hospital, Petah Tikva, Israel
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1946: Quantitative Imaging Analysis of Chest Computed Tomography in Rheumatoid Arthritis-Associated Interstitial Lung Disease
Location: Hall F1
Abstract Poster Presenter: Emily Anthone, BS – University of Nebraska Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1947: Coronary computed tomography incidental findings in rheumatoid arthritis.
Location: Hall F1
Abstract Poster Presenter: Emmanuel Tapia López, MD (he/him/his) – Instituto Nacional de Cardiologia, Ignacio Chavez
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1948: Enhanced Prediction of Knee Osteoarthritis Progression through Deep Learning-Based Multimodal Data Fusion
Location: Hall F1
Abstract Poster Presenter: Eric Lespessailles, MD, PhD – CHU Orléans
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1949: Relapsing Polychondritis: Mimicking Asthma while Airways get Damaged
Location: Hall F1
Abstract Poster Presenter: Eric Robbins, MD (he/him/his) – University of Maryland Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1950: Pericoronary fat enhancement in rheumatoid arthritis differs from controls and associates with coronary atherosclerosis independently of epicardial fat volume
Location: Hall F1
Abstract Poster Presenter: Frederik Enevoldsen, MD – Aarhus University, Aarhus, Denmark
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1951: Quantitative HRCT Analysis in Sjögren’s Disease-associated ILD: CALIPER-Derived Imaging Biomarkers for Prognostic Assessment
Location: Hall F1
Abstract Poster Presenter: Gaetano La Rocca, MD – University of Pisa, Rheumatology Unit
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1952: Dermatoscopy Limitation and the Critical Role of Capillaroscopy in Systemic Sclerosis and Raynaud’s Phenomenon among African American Veterans
Location: Hall F1
Abstract Poster Presenter: Genessis Maldonado, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1953: Machine Learning-Based Classification of Raynaud’s Phenomenon and Autoimmune Diseases in Indeterminate Capillaroscopic Patterns
Location: Hall F1
Abstract Poster Presenter: Genessis Maldonado, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1954: Revolutionizing Microvascular Screening: AI-Powered Dermatoscopy for Efficient Nailfold Capillary Evaluation
Location: Hall F1
Abstract Poster Presenter: Genessis Maldonado, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1955: Regional variations in the relationship between pericoronary fat enhancement and atherosclerosis may reflect differences in local vascular inflammation in rheumatoid arthritis
Location: Hall F1
Abstract Poster Presenter: George Karpouzas, MD (he/him/his) – Harbor-UCLA Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1956: 68ga-fapi-04 and 18F-FDG PET/ CT in MDA5 Dermatomyositis-associated Interstitial Lung Disease: A Single-center, Pilot Study
Location: Hall F1
Abstract Poster Presenter: Jia Li, MD, PhD (she/her/hers) – Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1957: Correlates Between Cardiovascular Risk Scores with Coronary Microvascular Function and Plaque Burden in Rheumatoid Arthritis
Location: Hall F1
Abstract Poster Presenter: Katherine Liao, MD, MPH – Brigham and Women's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1958: Longitudinal analysis on imaging outcomes: should we use the individual scores from multiple readers or rather the consensus or average of readers?
Location: Hall F1
Abstract Poster Presenter: Liese de Bruin, MSc – Leiden University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1959: The development and validation of a Diagnostic Ultrasound Enthesitis Score (DUET) for Psoriatic Arthritis
Location: Hall F1
Abstract Poster Presenter: Lihi Eder, MD, PhD – University of Toronto
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1960: Item Response Theory to Develop an Ultrasound Composite Score for Knee Osteoarthritis Assessment
Location: Hall F1
Abstract Poster Presenter: Liubov Arbeeva, MSc – University of North Carolina, Chapel Hill
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1961: Clinical Utility and Patient Experience of Ultrasound-Guided Synovial Biopsy in Refractory Arthritis: A Case Series from a Secondary Care Center
Location: Hall F1
Abstract Poster Presenter: Maria Paredes Romero, MD (she/her/hers) – Infanta Sofía University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1962: Imaging findings in patients with enteropathic spondyloarthritis
Location: Hall F1
Abstract Poster Presenter: Marika Bodnárová, MD – Institute of Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1963: Efficacy of Apremilast in Patients With Psoriatic Arthritis and Pre-existing Dactylitis: Dynamic Contrast-Enhanced MRI Results From the Phase 4 MOSAIC Study
Location: Hall F1
Abstract Poster Presenter: Mikael Boesen, MD,PhD – Copenhagen University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1964: Performance of Artificial Intelligence-Based Salivary Gland Ultrasound in Sjögren Syndrome
Location: Hall F1
Abstract Poster Presenter: Otto Olivas, MD – Department of Rheumatology and Joint and Bone Research Unit. Fundación Jiménez Díaz University Hospital and Health Research Institute FJD-UAM, Madrid, Spain
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1965: Two-Year Outcomes of Microwave Ablation for Recurrent Monoarthritis with Synovial Hypertrophy Resistant to Medical Treatment: Expanded Cohort and Long-Term Follow-Up Results
Location: Hall F1
Abstract Poster Presenter: Rabia Deniz, MD;PhD (she/her/hers) – University of Health Sciences Basaksehir �am and Sakura City Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1966: Assessing the Impact of Cutaneous Melanin on Microvascular Oxygenation Measurement in Systemic Sclerosis Using Multispectral Imaging
Location: Hall F1
Abstract Poster Presenter: Rosie Barnes, BSc (she/her/hers) – Physics and Astronomy
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1967: Developing an Algorithm to Quantify Dermatomyositis-associated Calcinosis Using Infrared Imaging
Location: Hall F1
Abstract Poster Presenter: Saahil Sachdeva, BS (he/him/his) – National Institutes of Environmental Health Sciences
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1968: Relationship between ultrasonographic and elastographic findings of the median nerve and disease activity and hand function in patients with rheumatoid arthritis
Location: Hall F1
Abstract Poster Presenter: Şebnem Ataman, MD – Rheumatology Department, Ankara University,
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1969: Enhancing Objective Evaluation of Raynaud’s in Veterans with Scleroderma-related Hand Pain: Integrating Patient Reported Outcomes and Nailfold Capillaroscopy
Location: Hall F1
Abstract Poster Presenter: Sowmika Rao, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1970: Comparison of Optical Imaging with Musculoskeletal Ultrasound in Assessment of PIP Joints of Systemic Lupus Erythematosus Patients
Location: Hall F1
Abstract Poster Presenter: Wei Tang, MD – Westchester Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1971: Intracranial Arterial Stenosis in Antiphospholipid Syndrome: A Neglected Vascular Involvement?
Location: Hall F1
Abstract Poster Presenter: Yuying Fan, n/a – Department of Rheumatology and Immunology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2015: Clinical features of IgG4-related disease - a single centre experience
Location: Hall F1
Abstract Poster Presenter: Alojzija Hocevar, MD, PhD – University Medical Center Ljubljana
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2016: Effectiveness of Nintedanib combined with different DMARDs in joint and pulmonary domains of Rheumatoid Arthritis - Interstitial Lung Disease. National multicenter study of 74 patients
Location: Hall F1
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2017: Baseline and 2-year Follow-up of Pulmonary Function Among CTD-ILD Subtypes
Location: Hall F1
Abstract Poster Presenter: Anchal Sabharwal, MD – Northwell Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2018: Investigating Epidemiology, Clinical associations, and Outcomes of Uveitis: A Retrospective Cohort Study
Location: Hall F1
Abstract Poster Presenter: Archit Srivastava, MD, MBBS – Boston Medical Center-Brighton/South, Boston University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2019: Incidence of Coronavirus Disease 2019 in Participants with IgG4-Related Disease Treated with Inebilizumab in the MITIGATE Study
Location: Hall F1
Abstract Poster Presenter: Arezou Khosroshahi, MD – Emory University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2020: Inebilizumab Efficacy and Safety in Patients with Common, Urgent, and Fibrotic Organ Manifestations of IgG4-RD: Subgroup Analyses from the MITIGATE Trial
Location: Hall F1
Abstract Poster Presenter: Arezou Khosroshahi, MD – Emory University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2021: Can Colchicine Be a Therapeutic Option for Patients with Ankylosing Spondylitis?
Location: Hall F1
Abstract Poster Presenter: Bahaddin Ates, n/a – Cerrahpasa Faculty of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2022: Clinical Predictors of Macrophage Activation Syndrome and Treatment Outcomes in Adult-Onset Still’s Disease: A 24-Year Single-Center Experience
Location: Hall F1
Abstract Poster Presenter: Beste Acar, MD – Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2023: Isolated Anti-Ro52 Antibody Positivity Is Associated with Increased Cancer Risk and Distinct Malignancy Patterns: A Retrospective Cohort Study from a Single Tertiary Center
Location: Hall F1
Abstract Poster Presenter: CARMEN SECADA-GÓMEZ, MD – HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2024: Racial Disparities in Outcomes Among Patients With Neuromyelitis Optica: A Global Population-Based Study
Location: Hall F1
Abstract Poster Presenter: Chukwuemelie Okeke, MBBS – Maimonides Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2025: Spectrum of Autoantibodies in CNS Demyelinating Diseases: Clinical, Laboratory and Imaging Associations
Location: Hall F1
Abstract Poster Presenter: Clio Mavragani, MD – National and Kapodistrian University of Athens
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2026: Clinical Features and Treatment Outcomes in Aseptic Abscess Syndrome: A Systematic Review of 104 Cases
Location: Hall F1
Abstract Poster Presenter: Eleni Papachristodoulou, MD – Mount Auburn Hospital, Harvard Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2028: Behçet’s Syndrome Beyond Endemic Borders: A 24-Year Longitudinal Analysis of Mortality in a Diverse South American Cohort
Location: Hall F1
Abstract Poster Presenter: Fabio Specian, Sr, MD – Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP)
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2029: Characteristics of a Historical Cohort of Adult Patients with Juvenile Idiopathic Arthritis
Location: Hall F1
Abstract Poster Presenter: Francina Salabert Carreras, PhD – Hospital Germans Trias i Pujol
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2030: Krebs von den Lungen 6 levels (∆KL6) is a reliable marker of disease activity and response to therapy in CTD-ILD
Location: Hall F1
Abstract Poster Presenter: Fredeswinda Romero, MD (she/her/hers) – University Hospital Fundaci�n Jim�nez D�az\"\"
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2031: Management of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases: A Comparison of Rheumatologist and Pulmonologist Perspectives
Location: Hall F1
Abstract Poster Presenter: Genna Braverman, MD, MS – Hospital for Special Surgery
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2032: Validation of systemic Juvenile Arthritis Disease Activity Score 10 (sJADAS 10) in adult patients with Still’s Disease
Location: Hall F1
Abstract Poster Presenter: Georgia-Savina Moysidou, MD, PhD – AP-HP
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2033: Complement Fragments are Deposited in the Submandibular Glands in IgG4-Related Disease
Location: Hall F1
Abstract Poster Presenter: Guy Katz, MD – Massachusetts General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2034: Hidden Burden in Rheumatology: Cross-Sectional Study of Hearing Loss in Systemic Autoimmune Diseases
Location: Hall F1
Abstract Poster Presenter: Jairo Cajamarca, MD (he/him/his) – Fundacion universitaria de ciencia de la Salud
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2035: Interim Phase 1 Results for SPY002, a Novel Half-Life Extended Monoclonal Antibody Targeting TL1A, Suggest A Potential for Q3M or Q6M Maintenance Dosing for Rheumatologic Disease
Location: Hall F1
Abstract Poster Presenter: Joshua Friedman, MD, PhD – Spyre Therapeutics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2036: JAK1 selective inhibitors versus pan-JAK inhibitors: comparative real-world study of drug retention in chronic inflammatory arthritis
Location: Hall F1
Abstract Poster Presenter: Leticia Leon, PhD, MSc (she/her/hers) – Hospital Clinico San Carlos
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2037: The Largest International Cohort Study of HA20 Reveals Novel Genetic Architecture and Age-Dependent Phenotypic Evolution
Location: Hall F1
Abstract Poster Presenter: Manuel Carpio Tumba, MD – University of Pittsburgh
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2038: Real-World Use of Dual Targeted Therapy in Rheumatic Disease: A Single-Center Case Series
Location: Hall F1
Abstract Poster Presenter: Marta Aguilar Zamora, MD (she/her/hers) – Hospital de Sagunto
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2039: To Hold or Not to Hold: Variability in Management of DMARDs in the Setting of Acute Infections - A Survey of Rheumatologists
Location: Hall F1
Abstract Poster Presenter: Mollie Gellman, MD – Montefiore Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2040: Steroid Psychosis and Neuropsychiatric Symptoms induced by Corticosteroid Injection in Rheumatology Patients
Location: Hall F1
Abstract Poster Presenter: Morvarid Kavosh, MD – University of New Mexico
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2041: Evaluating Biologic Effectiveness in Co-Occurring Dermatologic and Rheumatic Disease: A Systematic Review
Location: Hall F1
Abstract Poster Presenter: Nashwah Memon, BS – Lake Erie College of Osteopathic Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2042: Safety and Effectiveness of the Use of Combined Therapy with bDMARDS and tsDMARDs in Immune-mediated Inflammatory Diseases
Location: Hall F1
Abstract Poster Presenter: Natalia López Juanes, MD – Hospital Universitario La Paz
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2043: Renal Outcomes of Long-term Canakinumab in Patients with Adult Familial Mediterranean Fever (FMF) and Biopsy-Confirmed AA Amyloidosis
Location: Hall F1
Abstract Poster Presenter: Omer Karadag, MD – Hacettepe University, Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2044: Infections and Associated Mortality in VEXAS Syndrome: A Systematic Review and Meta-Analysis
Location: Hall F1
Abstract Poster Presenter: Ozlem Arikan, MD – Istanbul Aydin University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2045: Malignancy in Behçet’s Syndrome: A 24-Year Cohort Study In a Non-Endemicand Multiethnic Country
Location: Hall F1
Abstract Poster Presenter: Pedro Araujo, MD – Universidade de Sao Paulo
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2046: Utilization of the All of Us Research Program to Study the Impact of Genetic Background on Autoinflammatory Diseases
Location: Hall F1
Abstract Poster Presenter: Qingping Yao, MD, PhD – Stony Brook University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2047: Trends in Lung Transplant Listing Outcomes in Connective Tissue Disease associated Interstitial Lung Disease (CTD-ILD) Across Two Decades
Location: Hall F1
Abstract Poster Presenter: Sambhawana Bhandari, MD – Washington University in St Louis
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2048: DDR2 auto-phosphorylation in patients with Warburg-Cinotti syndrome promotes differentiation of fibroblasts into myofibroblasts and expansion of immature B cells with antibody production.
Location: Hall F1
Abstract Poster Presenter: Sang Jin LEE, n/a – Kyungpook National University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2049: Descriptive Analysis of a Cohort of Neurosarcoidosis Mimics
Location: Hall F1
Abstract Poster Presenter: Shivani Rangaswamy, MD – Duke University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2050: Efficacy and Safety of Antifibrotic Therapy in Autoimmune–Associated Interstitial Lung Disease: A Meta-Analysis
Location: Hall F1
Abstract Poster Presenter: Sri Laxmi Priya Sunkara, MD (she/her/hers) – White river medical center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2051: Clinical Burden of Illness Among Patients with Immunoglobulin-G4-Related Disease in the United States
Location: Hall F1
Abstract Poster Presenter: Sushmitha Inguva, PhD – Amgen Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2052: Prevalence of anti-neutrophil extracellular trap antibodies and their relationship with the clinical characteristics of patients with idiopathic inflammatory myopathies.
Location: Hall F1
Abstract Poster Presenter: AGUSTIN HERNANDEZ LOPEZ, II, MD (he/him/his) – INCMNSZ
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2053: A Prospective Study Unveils Damage Accrual and Myositis Specific Antibodies as Key Risk Factors for Mortality in Myositis
Location: Hall F1
Abstract Poster Presenter: AGUSTIN HERNANDEZ LOPEZ, II, MD (he/him/his) – INCMNSZ
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2054: A Changing Paradigm: Reassessing the Role of Muscle Biopsy in Idiopathic Inflammatory Myopathies in a Single-center Cohort
Location: Hall F1
Abstract Poster Presenter: Ami Purohit, MD – University of Miami
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2055: Construct Validity of Total Improvement Score (TIS) as an Endpoint for Clinically Meaningful Improvement in Multiple Patient-Centered Outcome Measures in Dermatomyositis
Location: Hall F1
Abstract Poster Presenter: Anjana Chandrasekhara Pillai, MD – PPCP
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2056: Systematic Review: Nutritional Interventions in Muscle Diseases
Location: Hall F1
Abstract Poster Presenter: Deepanjali Vedantam, MD, MBBS – Shasta Regional Medical Centre/Prime West Consortium
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2057: Clinical Associations of Anti-Ro52 Antibodies in Idiopathic Inflammatory Myopathies: A Scoping Review
Location: Hall F1
Abstract Poster Presenter: Emily Sun, MD, MPH – Royal Melbourne Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2058: Organ-specific disease activity and serological patterns in idiopathic inflammatory myopathies: A descriptive study in a Hispanic cohort
Location: Hall F1
Abstract Poster Presenter: Emmanuel Dominguez-Chapa, MS (he/him/his) – Universidad Autonoma de Nuevo Leon
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2059: Autoantibody Patterns in Myositis Immunoblot Testing: A Retrospective Study inInflammatory Myopathies and Connective Tissue Diseases (2017–2023)
Location: Hall F1
Abstract Poster Presenter: Fabricio Benavides, MD – Hospital Universitario Marqués de Valdecilla
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2060: Treatment Patterns And Drug Use In Idiopathic Inflammatory Myopathies. Description Of The First Year After Diagnosis In A Swedish Myositis Cohort.
Location: Hall F1
Abstract Poster Presenter: Federico Zazzetti, MD – J&J Innovative Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2061: Tryptophan Metabolism Alteration Is Associated With Rapidly Progressive Interstitial Lung Disease Of Anti-MDA5+ Dermatomyositis
Location: Hall F1
Abstract Poster Presenter: Hongjiang Liu, n/a – West China Hospital, Sichuan University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2062: Immune Cell Signatures Associated with Disease Activity in Dermatomyositis Across Autoantibody Subtypes
Location: Hall F1
Abstract Poster Presenter: Jeffrey Sagun, BS – Stanford University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2063: Linking PROMIS scores to disease severity and treatment in dermatomyositis: a patient-centered evaluation
Location: Hall F1
Abstract Poster Presenter: Julie Paik, MD, MHS – Johns Hopkins University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2064: Kinematics Underlying IBM-induced Dysphagia
Location: Hall F1
Abstract Poster Presenter: Kevin Renz Ambrocio, MS – University of Pittsburgh
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2065: Pain in Idiopathic Inflammatory Myopathies: A Global Study of Patient Experience
Location: Hall F1
Abstract Poster Presenter: Lekshmi Minikumari Rahulan, MD, MBBS – Sanjay Gandhi Postgraduate Institute of Medical Sciences
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2066: Psychosocial Factors Strongly Influence Subjective Well-being in Patients with Idiopathic Inflammatory Myopathies
Location: Hall F1
Abstract Poster Presenter: Meera Shah, MD, MBBS – Topiwala National Medical College and Dr. B.Y.L Nair Charitable Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2067: Patterns of Comorbidity in Idiopathic Inflammatory Myopathies: A Cross-sectional Analysis of Disease Burden and Risk Factors
Location: Hall F1
Abstract Poster Presenter: Meera Shah, MD, MBBS – Topiwala National Medical College and Dr. B.Y.L Nair Charitable Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2068: Comparing characteristics, diagnostics, and treatment in people with different idiopathic inflammatory myopathies using a large representative cohort
Location: Hall F1
Abstract Poster Presenter: Michael George, MD, MSc – University of Pennsylvania
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2069: Concordance of low titer positive myositis-specific autoantibodies and myositis-associated autoantibodies on subsequent myositis panel testing.
Location: Hall F1
Abstract Poster Presenter: Nikola Wilk, MD, FRCPC (he/him/his) – University of Ottawa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2070: Characterization of Hospitalization, Patient Demographics and Impact of Idiopathic Inflammatory Myopathies on Hospitalization Outcomes in Adult Fracture Patients: A National Inpatient Sample Analysis.
Location: Hall F1
Abstract Poster Presenter: Pranathi Bandarupalli, MD (she/her/hers) – Mercy St Vincent Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2071: Impact of Diagnostic Delay on Disease Activity and Cumulative Damage in Patients with Idiopathic Inflammatory Myopathies in a Third-level Hospital in Mexico
Location: Hall F1
Abstract Poster Presenter: Rebeca Polina-Lugo, MD (she/her/hers) – Division of Rheumatology, Hospital Universitario, UANL
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2072: Results of an Integrated Program for Early Cancer Detection in Idiopathic Inflammatory Myopathies
Location: Hall F1
Abstract Poster Presenter: Rebeca Polina-Lugo, MD (she/her/hers) – Division of Rheumatology, Hospital Universitario, UANL
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2073: Cell-free DNA as a Potential Marker of Muscle Involvement and Treatment Response in Myositis
Location: Hall F1
Abstract Poster Presenter: Sabína Oreská, MD, PhD (she/her/hers) – Institute of Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2074: Increased Mortality in Hispanic Males with Lymphopenia: A Descriptive and Statistical Analysis of Anti-Melanoma Differentiation-Associated Protein 5 (MDA-5) Antibody Positive Patients
Location: Hall F1
Abstract Poster Presenter: Sergio M. Maldonado Chaar, MD (he/him/his) – University of Miami/Jackson Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2075: Ferritin trends differentiate anti-MDA5 Dermatomyositis from anti-Jo1 Antisynthetase Syndrome
Location: Hall F1
Abstract Poster Presenter: Silvia Grazzini, MD – University of Siena
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2076: Nutritional Discourse in Online Myositis Communities: A Reddit Analysis of Patient-led Discussions
Location: Hall F1
Abstract Poster Presenter: Taanya Talreja, MBBS – Seth GS Medical College and KEM Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2077: Statin-Associated Immune-Mediated Necrotizing Myopathy in Native Americans
Location: Hall F1
Abstract Poster Presenter: Tam Dinh, MD – University of New Mexico Internal Medicine Program
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2078: Neutrophil Extracellular Traps from Patients with Idiopathic Inflammatory Myopathies Induce Interferogenic Responses in Macrophages and Myeloid Dendritic Cells
Location: Hall F1
Abstract Poster Presenter: Yatzil Reyna-Juárez, MD – Instituto Polit�cnico Nacional
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2079: Association Between Symptomatic Knee Osteoarthritis and Health-related Quality of Life in Individuals with Type 2 Diabetes: A Cross-sectional Study
Location: Hall F1
Abstract Poster Presenter: Abdalmohsen Almodahka, MD – University of Toronto
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2080: Foot laterality does not modify outcome of knee and/or hip osteoarthritis
Location: Hall F1
Abstract Poster Presenter: Alain SARAUX, MD, PhD (he/him/his) – CHU Brest
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2081: Radiologic surveillance in the Phase II RCT of LEVI-04, a novel neurotrophin-3 inhibitor, in people with knee osteoarthritis: exclusions at screening
Location: Hall F1
Abstract Poster Presenter: Ali Guermazi, MD, PhD, MSc – Boston University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2082: Pharmacokinetic Profile of MM-II Following a Single Intra-Articular Injection in Patients with Knee Osteoarthritis in a Phase 2b Randomized, Controlled, Dose-Ranging Trial
Location: Hall F1
Abstract Poster Presenter: Ballari Brahmachari, MD – Sun Pharmaceuticals Industries Ltd.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2083: Evaluation of a Parent-Trial as a Run-In Period: Efficacy and Safety of Repeat Injections of Lorecivivint over Three Years
Location: Hall F1
Abstract Poster Presenter: Christopher Swearingen, PhD – Biosplice Therapeutics, Inc
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2084: Predictors of Change in Physical Activity Level Among Veterans with Knee Osteoarthritis in a Behaviorally Designed Incentive Program
Location: Hall F1
Abstract Poster Presenter: Criswell Lavery, MPH (she/her/hers) – Department of Veteran's Affairs
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2085: Estimating the Association between Effusion-synovitis and Knee Pain in a Subset of Participants with Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative (OAI)
Location: Hall F1
Abstract Poster Presenter: Dagoberto Robles, MPH – University of Arizona
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2086: WOMAC Physical Function and 3D MRI Bone Shape: Advancing a “Virtual” Total Knee Replacement Endpoint for Knee Osteoarthritis Clinical Trials
Location: Hall F1
Abstract Poster Presenter: Dawn McGuire, MD (she/her/hers) – OrthoTrophix
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2087: Does Carbamazepine Impact Risk of Developing Osteoarthritis? Results of a Real-World Data Analysis
Location: Hall F1
Abstract Poster Presenter: Erfan Afshar, MD – Northwell Health- SIUH
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2088: Aging Unevenly: National Trends and Inequities in Osteoarthritis Mortality, 1999–2020
Location: Hall F1
Abstract Poster Presenter: Ghassan Makhoul, MD – St. Joseph's University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2089: Traction Therapy May Improve Hand Function in Those with Distal Interphalangeal Osteoarthritis
Location: Hall F1
Abstract Poster Presenter: Grace Lo, MD, MSc – Baylor College of Medicine / MEDVAMC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2091: Multiplanar MRI Quantification of Effusion-Synovitis: Reliability and Potential Investigative Utility for Inflammation-Mediated Knee Conditions
Location: Hall F1
Abstract Poster Presenter: Greg Gilles, BS – The University of Arizona Arthritis Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2092: Associations Among Biomarkers, Cytokines, and Ultrasound Features of Knee Osteoarthritis: A Cross-sectional Analysis in the Johnston County Health Study
Location: Hall F1
Abstract Poster Presenter: Jasmine Kimber, BS – University of North Carolina School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2093: Association of Acetaminophen Use with Clinical Outcomes in Older Adults with Osteoarthritis: A Global Propensity-matched Retrospective Cohort Analysis
Location: Hall F1
Abstract Poster Presenter: Justin Riley Lam, MD – Jefferson Einstein Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2094: Evaluating the Accuracy of Knee Acoustic Emissions Classification of Varus Thrust
Location: Hall F1
Abstract Poster Presenter: Kari Falaas, MD – University of Minnesota
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2096: Gamification and Social Incentivization to Promote Physical Activity in Adults with Knee Osteoarthritis: Results from a Multi-site Randomized Trial
Location: Hall F1
Abstract Poster Presenter: Kimberly Hayes, BA;MA – Teachers College, Columbia University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2097: Trajectories of psychological symptoms during an 18-month Diet + Exercise intervention in overweight or obese adults with osteoarthritis
Location: Hall F1
Abstract Poster Presenter: Lily Alomari, B.S – Kansas City University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2098: Responder Phenotype Analysis for Intra-Articular Injections: Secondary Analysis from a Large Multi-Site Crossover Clinical Trial
Location: Hall F1
Abstract Poster Presenter: Natalie Keller, BS, BA – Corporal Michael J. Crescenz VA Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2100: Trabecular Bone Texture is Associated with Structural and Pain Progression in Later Stages of Knee Osteoarthritis: Longitudinal Data from the FNIH OAI Cohort
Location: Hall F1
Abstract Poster Presenter: Pawel Podsiadlo, PhD – Curtin University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2101: LEVI-04, a Novel Neurotrophin-3 Inhibitor, Demonstrates Clinically Meaningful Improvements in Pain and Physical Function across a Range of OA Outcomes, Including the Staircase-Evoked Pain Procedure (StEPP)
Location: Hall F1
Abstract Poster Presenter: Philip Conaghan, MD,PhD – University of Leeds
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2102: Construct Validity of the Six-Minute Walk Test in Knee Osteoarthritis
Location: Hall F1
Abstract Poster Presenter: Sivakami Mylvaganam, MD – Department of Medicine, University of Toronto
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2103: PCRX-201 High-Capacity Adenovirus Serotype 5 Gene Therapy Demonstrates Sustained Clinical Efficacy and Safety in Patients With Knee Osteoarthritis
Location: Hall F1
Abstract Poster Presenter: Stanley Cohen, MD – Metroplex Clinical Research Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2104: Pain 0-10 visual analog scale (VAS) and RAPID3 (routine assessment of patient index data) in OA and RA are similar in 2024 to 1979 and 1989
Location: Hall F1
Abstract Poster Presenter: Theodore Pincus, MD, FACR, MACR – Rush University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2105: Stratification for elevated urate identifies a pro-inflammatory synovial fluid proteome in knee osteoarthritis: a pilot study
Location: Hall F1
Abstract Poster Presenter: Tuhina Neogi, MD, PhD – Boston University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2106: Prevalence and Characteristics of Morphometric Vertebral Fractures in the Spanish Population: Data from the OsteoSER Study
Location: Hall F1
Abstract Poster Presenter: Carmen Gomez Vaquero, MD – Hospital Universitari de Bellvitge
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2107: Experience of a Fragility Fracture Coordination Unit Integrated Across Two Hospitals: An Innovative Multidisciplinary Model for Optimizing the Management of Geriatric and Non-Geriatric Patients Beyond Surgery After an Osteoporotic Bone Fragility Fracture
Location: Hall F1
Abstract Poster Presenter: César Antonio Egües Dubuc, MD,MSc (he/him/his) – Hospital Universitario Donostia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2108: Multidisciplinary Fragility Fracture Management Across Two Coordinated Hospitals: Evaluating Risk Factors, Treatment Approaches, and Long-Term Patient Outcomes in Those With and Without Prior Fractures
Location: Hall F1
Abstract Poster Presenter: César Antonio Egües Dubuc, MD,MSc (he/him/his) – Hospital Universitario Donostia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2109: Comparative Effects of IL-6 inhibition, Methotrexate, and Glucocorticoid Monotherapy on Bone Mineral Density, 3D-DXA femoral structure and Bone Turnover Markers in GCA and PMR
Location: Hall F1
Abstract Poster Presenter: Edgar Wiebe, MD – Charité University Medicine Berlin
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2110: Effect of Proton-Pump-Inhibitors on Bone Mineral Density and Microarchitecture in Patients with Inflammatory Rheumatic and Musculoskeletal Diseases
Location: Hall F1
Abstract Poster Presenter: Edgar Wiebe, MD – Charité University Medicine Berlin
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2111: Cost-effectiveness Analysis of Biosimilar Denosumab for the Treatment of Women with Post-menopausal Osteoporosis in the United States: A Risk Based Analysis
Location: Hall F1
Abstract Poster Presenter: Edward Li, PharmD, MPH (he/him/his) – Sandoz Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2112: Which drugs are associated with the development of osteonecrosis of the jaw? clinical and epidemiological analysis of a cohort of patients diagnosed with osteonecrosis of the jaw.
Location: Hall F1
Abstract Poster Presenter: Esther Monleon Acosta, -None- – Hospital Santa Lucia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2113: Mortality rate in patients with hip fracture: is it recommendable to establish fracture units?
Location: Hall F1
Abstract Poster Presenter: Esther Monleon Acosta, -None- – Hospital Santa Lucia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2114: Development of a Fracture Prediction Model for Patients Aging with HIV
Location: Hall F1
Abstract Poster Presenter: Evelyn Hsieh, MD, PhD (she/her/hers) – Yale School of Medicine/VA Connecticut Healthcare Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2115: METHOFRACT, a methotrexate osteopathy multicentric binational cohort study.
Location: Hall F1
Abstract Poster Presenter: François ROBIN, MD, PhD (he/him/his) – Rennes University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2116: Romosozumab in Multiple Myeloma Patients at High Risk of Fracture
Location: Hall F1
Abstract Poster Presenter: Giovanni Adami, MD – University of Verona, Italy
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2117: Denosumab Discontinuation and Switching in Glucocorticoid-Induced Osteoporosis: A Multi-site Randomized Clinical Trial
Location: Hall F1
Abstract Poster Presenter: Giovanni Adami, MD – University of Verona, Italy
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2118: Risks of Fracture in Current and Previous Anticonvulsant Users, An Observational Study
Location: Hall F1
Abstract Poster Presenter: Grace Hyeyeon Lee, MBBS – Newcastle University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2119: Fracture rates in 6475 individuals with osteogenesis imperfecta stratified by age, sex and clinical severity
Location: Hall F1
Abstract Poster Presenter: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2120: Analyzing Gender and Racial Disparities in Paget’s Disease of Bone: A Large-scale Observational Study
Location: Hall F1
Abstract Poster Presenter: Kinga Grzybowski, MD – Jefferson Einstein Montgomery Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2121: Prevention of Bone Mass Loss Associated With Aromatase Inhibitors in Breast Cancer. A Study in Real-World Clinical Practice.
Location: Hall F1
Abstract Poster Presenter: Lucia Paz Liñeira, -None- – Hospital General Universitario Gregorio Marañón
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2122: Safety and Efficacy of Romosozumab in the Treatment of Patients with High-Risk Fracture Osteoporosis in Clinical Practice: Experience from a Tertiary University Hospital in Spain
Location: Hall F1
Abstract Poster Presenter: Maryia Nikitsina, DM (she/her/hers) – University Hospital la Princesa, Madrid
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2123: Sclerostin in Aging Bone and Muscle: A Comparative Study of Osteoporosis, Sarcopenia, and Osteosarcopenia
Location: Hall F1
Abstract Poster Presenter: Mohamed Tharwat Hegazy, MD, PhD, FACR (he/him/his) – Faculty of Medicine, Cairo University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2124: Reliability and Validation of the Physician's Global Assessment of Lung Disease (PGALD) in Systemic Juvenile Idiopathic Arthritis -Associated Lung Disease (SJIA-LD)
Location: Hall F1
Abstract Poster Presenter: Eileen Rife, MD – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2125: Development and Validation of Minimal Clinically Important Difference for Children with Chronic Nonbacterial Osteomyelitis Using a Consensus and Data-Driven Approach
Location: Hall F1
Abstract Poster Presenter: Farzana Nuruzzaman, MD – Stony Brook Children's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2126: Preliminary Results of a Large, Global Registry Characterizing Childhood-Onset Takayasu Arteritis
Location: Hall F1
Abstract Poster Presenter: James Bistolarides, MD – Medical College of Wisconsin
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2127: Chronic Non-Bacterial Osteomyelitis of the Petrous Bone: A Case Series
Location: Hall F1
Abstract Poster Presenter: Jeanine McColl, MD – University of Calgary
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2128: Prevalence of Risks and Complications in a Longitudinal International Cohort of Children with Chronic Nonbacterial Osteomyelitis (CNO)
Location: Hall F1
Abstract Poster Presenter: Jessica Kent, MBA (she/her/hers) – Medical College of Wisconsin
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2129: Distinct endotypes of SURF associated with clinical phenotypes, inflammatory cytokines, and treatment responses
Location: Hall F1
Abstract Poster Presenter: Marci Macaraeg, MD, MSc – University of Arizona/Banner
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2130: Systemic juvenile idiopathic arthritis- Fifteen-year experience from a tertiary centre at Bristol, United Kingdom
Location: Hall F1
Abstract Poster Presenter: Ashwini Batchu Prithvi, MBBS, MD, MRCP – Bristol Royal Hospital for Children
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2131: Transition from Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype
Location: Hall F1
Abstract Poster Presenter: austen grooms, DO (he/him/his) – Beaumont Royal Oak
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2132: The Bridge to Adult Care from Childhood for Young Adults with Rheumatic Disease (BACC YARD) Program, a Pediatric-To-Adult Rheumatology Transition Program, Reduces Median Time between Final Pediatric, First Adult, and Second Adult Visits
Location: Hall F1
Abstract Poster Presenter: Ayah Eltoum, MD, MPH – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2133: Examination of HLA-DRB1*15-linked Candidate Antigens in Still’s Disease with and without Lung Disease and Features of Drug Hypersensitivity
Location: Hall F1
Abstract Poster Presenter: Dale Kobrin, MD – NIAMS, NIH
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2134: Krebs von den Lungen-6 (KL-6) as a Potential Diagnostic Biomarker of Lung Disease in Pediatric Systemic Juvenile Idiopathic Arthritis: Preliminary Findings from a Multisite US Cohort
Location: Hall F1
Abstract Poster Presenter: Eileen Rife, MD – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2135: Medication Use and Disease Activity in Systemic Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry
Location: Hall F1
Abstract Poster Presenter: Ginger Janow, MD, MPH – Joseph M. Sanzari Children's Hospital at Hackensack Meridian Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2136: Confirming The Validity Of The New EULAR/ACR Classification Criteria For Pediatric Chronic Nonbacterial Osteomyelitis
Location: Hall F1
Abstract Poster Presenter: Greta Mastrangelo, MD (she/her/hers) – The Hospital for Sick Children
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2137: Therapeutic Strategies in Newly Diagnosed Still’s Disease: Real-Life Clinicians’ Choices from the METAPHOR Project Worldwide Survey
Location: Hall F1
Abstract Poster Presenter: Greta Rogani, MD – University Medical Center Utrecht
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2138: Factors driving therapeutic decision-making in Still’s Disease: When to Start and When to Stop? Data from the METAPHOR Project Worldwide Survey
Location: Hall F1
Abstract Poster Presenter: Greta Rogani, MD – University Medical Center Utrecht
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2139: Real-Life Treatment Strategies for Refractory Still’s Disease: Results from a Worldwide Survey, the METAPHOR Project
Location: Hall F1
Abstract Poster Presenter: Greta Rogani, MD – University Medical Center Utrecht
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2140: Identification of immune phenotypes in systemic juvenile idiopathic arthritis associated lung disease (SJIA-LD) using high parameter flow cytometry
Location: Hall F1
Abstract Poster Presenter: Haeja Kessler, MD (she/her/hers) – Cincinnati Children's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2141: Treatment of Refractory Still’s/Systemic Juvenile Idiopathic Arthritis Lung Disease with the bi-specific IL-1Beta/IL-18 neutralizing antibody MAS825
Location: Hall F1
Abstract Poster Presenter: Hallie Carol, MD (she/her/hers) – Children’s Hospital of Philadelphia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2142: Multidisciplinary Rheumatology Transition Clinic for Young Adults Shows Improved Experience, Utilization, and Health Maintenance: A Mixed-Methods Evaluation
Location: Hall F1
Abstract Poster Presenter: Hannah Concannon, BS – Duke University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2143: Ruxolitinib for Refractory sJIA/AOSD: A Single Center Case Series
Location: Hall F1
Abstract Poster Presenter: Janna Shim, DO – Kaiser Permanente San Jose
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2144: The Association Between Age at Diagnosis and Health-Related Quality of Life in ANCA-Associated Vasculitis
Location: Hall F1
Abstract Poster Presenter: Jessica Bloom, MD, MS – University of Colorado
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2145: EOS® Imaging System Is a Novel, Rapid, Safe, and Effective Technique To Detect And Assess Calcinosis In JDM
Location: Hall F1
Abstract Poster Presenter: Philip Kahn – Hassenfeld Children's Hospital at NYU Langone
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2146: Impact of a Clinical Pathway on Medication Use and Outcomes in Kawasaki Disease
Location: Hall F1
Abstract Poster Presenter: Jonathan Yu, MD – Children's Hospital of Philadelphia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2147: Elevated fMET and GDF-15 Circulating Levels in Pediatric CNO Patients with Psoriasis Define a Distinct Mitochondrial-Inflammatory Signature
Location: Hall F1
Abstract Poster Presenter: Jorge Gonzalez Chapa, MD, PhD – University of Washington
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2148: Initial MRI Findings as Predictors of Disease Phenotype in Juvenile Dermatomyositis: A Comparative Study of Myositis Specific Antibodies NXP2-Positive and Myositis Specific Antibody-Negative Patients in a Large Tertiary Hospital
Location: Hall F1
Abstract Poster Presenter: Juan Torres Sanchez, MD (he/him/his) – Baylor College of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2149: Rheumatology Transitions of Care: Patient Stability and Follow-Up at a Single Center
Location: Hall F1
Abstract Poster Presenter: Julia Witowska, MD – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2150: Rheum to Grow:An Approach Towards Human Centered Design through a Qualitative Analysis on the Transition from Pediatric to Adult Rheumatology
Location: Hall F1
Abstract Poster Presenter: Lillian Chang, MD – Geisinger Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2151: Real-World Experience with IL-1 Blockade in Children with Undifferentiated Systemic Autoinflammatory Diseases (uSAIDs)
Location: Hall F1
Abstract Poster Presenter: Maryam Ashoor, MBBCH;BAO – Division of Immunology, Boston Children’s Hospital, Harvard Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2152: Blau Syndrome: features beyond the classic triad and proposal for clinical criteria
Location: Hall F1
Abstract Poster Presenter: Narendra Bagri, MD (he/him/his) – All India Institute of Medical Sciences(AIIMS)
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2153: Giant Coronaries in Children with Kawasaki Disease: A Single Centre Experience
Location: Hall F1
Abstract Poster Presenter: Pavneet Kaur, MBBS, MD – All India Institute of Medical Sciences, New Delhi
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2154: Whole-Body MRI Findings in a Cohort of Children with Chronic Nonbacterial Osteomyelitis
Location: Hall F1
Abstract Poster Presenter: Sampath Prahalad, MD, MSc – Emory + Children's Pediatric Institute
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2155: A Novel TNFAIP3 Mutation Associated with Large Vessel Vasculitis: Expanding the Phenotypic Spectrum of A20 Haploinsufficiency
Location: Hall F1
Abstract Poster Presenter: Sirada Panupattanapong, MD, RhMSUS – Cleveland Clinic Foundation
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2156: Bridging the Gap: Juvenile Spondyloarthritis (JSpA) vs. Chronic Non-bacterial Osteomyelitis (CNO)
Location: Hall F1
Abstract Poster Presenter: Sophia Elfrink, BA – Grinnell College
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2157: Optimizing the Diagnosis and Treatment of Kawasaki Disease-Associated Macrophage Activation Syndrome: A Clinical Cohort and Literature Analysis
Location: Hall F1
Abstract Poster Presenter: Xi Yang, MD – Department of Rheumatology & Immunology, Children’s Hospital of Chongqing Medical University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2158: Evaluating Nailfold Capillary Changes as Indicators of Disease Activity in Juvenile Dermatomyositis
Location: Hall F1
Abstract Poster Presenter: Zilan Zheng, BS, CCRP – University of California, San Francisco
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2159: Teaching Musculoskeletal Ultrasound Improves Knowledge and Confidence in the Knee Exam: A Pilot Session with Internal Medicine Trainees
Location: Hall F1
Abstract Poster Presenter: Ann Cameron Barr, MD, RhMSUS – Duke University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2160: RadRheum: Improving Resident and Medical Student Musculoskeletal Radiology Interpretation Skills Utilizing an Interactive Module
Location: Hall F1
Abstract Poster Presenter: Elizabeth Konon, MD – University of Colorado Internal Medicine Residency Program
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2161: Perceptions of the Importance of Pediatric Rheumatology Education in Pediatric Residency: A Needs Assessment
Location: Hall F1
Abstract Poster Presenter: Katherine Nowicki, MD (she/her/hers) – University of Colorado
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2162: An Updated Needs Assessment for the Virtual Rheumatology Program for Fellows in Training (V-FIT)
Location: Hall F1
Abstract Poster Presenter: Laura Arneson, MD (she/her/hers) – Northwestern University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2163: Enhancing Post-Conference Engagement Through Expert Q&A: A Pilot Collaboration Between ACR Convergence & theMednet.org
Location: Hall F1
Abstract Poster Presenter: Nina Couette, DO, RhMSUS – The Ohio State University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2164: East Meets West: A Novel Tofu-Pasta-Cardstock Phantom Model for Teaching Ultrasound-Guided Procedures
Location: Hall F1
Abstract Poster Presenter: Philip Chu, MD, RhMSUS – Duke University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2165: Targeted Needs Assessment of Provider Medical Knowledge of Juvenile Scleroderma, a Mixed Methods Study
Location: Hall F1
Abstract Poster Presenter: Rachel Guess, MD – Washington University in St Louis
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2166: Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis: A Clinical Educational Workshop
Location: Hall F1
Abstract Poster Presenter: Rubia Ahmed, DO – Hospital of the University of Pennsylvania
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2167: Rheum4Games: A Game-Based Rheumatology Board Review for Internal Medicine Residents
Location: Hall F1
Abstract Poster Presenter: Sonam Kiwalkar, MD – The Vancouver Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2168: Training Objective Structured Clinical Examinations in a Clinical Immunology department: Expectations and Perceptions of Medical students at Graduating Level
Location: Hall F1
Abstract Poster Presenter: Aïcha Kante, MD, MSc – Université Paris Cité
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2169: Bridging the Gap: A National Needs Assessment of Rheumatology Fellowship Training in Adolescent and Young Adult Care
Location: Hall F1
Abstract Poster Presenter: Amanda Moyer, MD – Oklahoma University (OU) Health & the Oklahoma Medical Research Foundation (OMRF)
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2170: I Know It When I See It! Improving Visual Diagnosis Education in Rheumatology Fellowship Training
Location: Hall F1
Abstract Poster Presenter: Amarjyot Randhawa, MBBS – University of Colorado Anschutz Medical Campus
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2171: Knowledge of Fertility and Infertility Treatments Among Physicians Treating Women with Rheumatic Diseases: FIT-KS Survey
Location: Hall F1
Abstract Poster Presenter: Andres Manuel Ortiz-Rios, Sr, BS (he/him/his) – Facultad de Medicina, Universidad Autonoma de Nuevo Leon
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2172: Automating the Curation and Summarization of Rheumatology Fellowship Applications using Generative AI Agents and Transformer Models
Location: Hall F1
Abstract Poster Presenter: Andrew Trotter, n/a – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2173: Developing Musculoskeletal Ultrasound Clinical Electives: Bridging the Basic Sciences and Clinical Application in Undergraduate Medical Education
Location: Hall F1
Abstract Poster Presenter: Beth Scholz, MD, RhMSUS, FACP – Scott & White Healthcare
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2174: Using Natural Language Processing to Identify Character Strengths in Rheumatology Fellowship Candidate Applications: A Feasibility Study
Location: Hall F1
Abstract Poster Presenter: Bharat Kumar, MD, RhMSUS, MMed – University of Iowa Hospitals and Clinics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2175: Skin Manifestations of Rheumatic Diseases: Educating Providers to Improve Diagnostic Skills
Location: Hall F1
Abstract Poster Presenter: Brittany Ashe, MD (she/her/hers) – UPMC Children's Hospital of Pittsburgh
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2176: Addressing Hesitancy in JAK Inhibitor Use: Outcomes from Continuing Medical Education Reveal Confidence-knowledge Gaps Among Community Rheumatologists
Location: Hall F1
Abstract Poster Presenter: Carole Drexel, PhD (she/her/hers) – MedliveCME, LLC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2177: A Rheumatologic Ultrasound (RhUS) Educational Framework: Expert Consensus on Rhus Skills for Adult Rheumatology Fellows in the United States
Location: Hall F1
Abstract Poster Presenter: Christine Parsons, MD (she/her/hers) – Columbia University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2178: Online Education Significantly Improved Rheumatologists’ Knowledge of the Diagnosis and Management of Sjögren's Disease
Location: Hall F1
Abstract Poster Presenter: Elaine Bell, PhD – Medscape Global Education
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2179: Educational online webinars of European Reference Network (ERN) on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ReCONNET) for patients, caregivers and healthcare professionals: six years’ experience
Location: Hall F1
Abstract Poster Presenter: Emanuele Gotelli, MD, PhD – Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2180: Helping Hands: Curriculum using Simulators to Teach the Hand Exam and Assessment of Small Joint Swelling in Inflammatory Arthritis
Location: Hall F1
Abstract Poster Presenter: Ibtissam Gad, MD – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2181: A Pilot High-fidelity Simulation for Pediatric Rheumatology Learners
Location: Hall F1
Abstract Poster Presenter: John Bridges, MD, MS – University of Alabama at Birmingham/Children's of Alabama
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2182: Rheum for Improvement: A Needs Assessment Survey for an Internal Medicine Resident Curriculum
Location: Hall F1
Abstract Poster Presenter: Kailey Singh, MD – Northwell Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2183: Bridging the Musculoskeletal Ultrasound Training Gap: Analysis of Confidence, Competency, and Clinical Readiness
Location: Hall F1
Abstract Poster Presenter: Kamini Shah, MD, RhMSUS (she/her/hers) – Northwell Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2184: Diagnosing the Deficit: Addressing Gaps in Rheumatology Training for Internal Medicine Residents
Location: Hall F1
Abstract Poster Presenter: Kristen Young, DO – Mayo Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2185: The Evolving Digital Landscape of Social Media among Rheumatology Professionals: A Global Analysis by the EULAR SoMeR Study Group
Location: Hall F1
Abstract Poster Presenter: Latika Gupta, MD, DM, MRCP – University of Birmingham & Royal Wolverhampton NHS Trust
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2186: Developing Rheumatology Specific Anki Electronic Flashcards for Teaching Preclinical Students United States Medical Licensing Examination Board Relevant Topics 
Location: Hall F1
Abstract Poster Presenter: Madison Bellamy, MD – University of Iowa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2187: Transforming MSUS Access in Mexico: A Comparative Study of National Trends and a Hybrid Training Cohort
Location: Hall F1
Abstract Poster Presenter: Mario Garcia-Pompermayer, MD – Hospital San Jose Tecnologico de Monterrey
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2188: Enhancing Pediatric Rheumatology Education Through Case-Based Learning: Impact on Knowledge, Confidence, and Elective Interest
Location: Hall F1
Abstract Poster Presenter: Nayimisha Balmuri, MD – Johns Hopkins Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2189: Physician Practices and Perspectives in the Diagnosis and Management of Fibromyalgia: A US Chart Review Study
Location: Hall F1
Abstract Poster Presenter: Parul Houston, PhD – Axsome Therapeutics, Inc
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2190: Successful Implementation of an Innovative Rheumatology Curriculum for Internal Medicine Residents: Fellow-Initiated Rheumatology EDUcation Project (FIRED UP)
Location: Hall F1
Abstract Poster Presenter: Raeann Bowman, MD – University of Alabama Birmingham / UT Southwestern
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2191: Development, Validation and Performance of a Questionnaire for Assessing the Knowledge Base of Primary Care Physicians About Management of Rheumatoid Arthritis and Impact of an Information Course
Location: Hall F1
Abstract Poster Presenter: Ranjan Gupta, MD, DM (he/him/his) – All India Institute of Medical Sciences
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2192: Survey of Healthcare Providers’ Knowledge and Attitudes Toward the Management of Uncontrolled Gout
Location: Hall F1
Abstract Poster Presenter: Shilpa Sharan, PhD, MS – The HWP Group
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2193: Inpatient Rheumatology Consultations at a Tertiary Academic Medical Center: A Retrospective Cohort Study
Location: Hall F1
Abstract Poster Presenter: Shivang Chaudhary, MD – Saint Louis University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2194: Utilizing Case-Based Learning to Teach the Teacher and Improve Health Insurance Literacy
Location: Hall F1
Abstract Poster Presenter: Tyler Reese, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2227: The Paraoxonase-1 Q192R Polymorphism is Associated with Increased Risk of Incident Clinical Rheumatoid Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population
Location: Hall F1
Abstract Poster Presenter: Amir Razmjou, MD, MSc – UCLA / GLA-VA
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2239: Increased Cardiovascular Morbidity in Patients with Rheumatoid Arthritis and Type 2 Diabetes: A Large-Scale Electronic Health Record Analysis
Location: Hall F1
Abstract Poster Presenter: Gurjot Singh, MD – Trihealth Good Samaritan Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2240: Diabetes Significantly Amplifies Risk of Cardiac Arrhythmias in Rheumatoid Arthritis Patients: Results from a Multi-Center Electronic Health Record Study
Location: Hall F1
Abstract Poster Presenter: Gurjot Singh, MD – Trihealth Good Samaritan Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2251: Dual Diagnoses, Diminished Survival: Association between rheumatoid arthritis and survival among older adults with lung cancer
Location: Hall F1
Abstract Poster Presenter: Michelle Nguyen, MD – University of Washington
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2253: Wrist-worn Wearable Device Data Can Be a New Digital Biomarker For Disease Activity In Rheumatoid Arthritis: a Multicenter Single-arm Prospective Study
Location: Hall F1
Abstract Poster Presenter: Misako Higashida-Konishi, MD – NHO Tokyo Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2265: Progressive Interstitial Lung Disease associated to Rheumatoid Arthritis despite Abatacept therapy. Data from a large national multicenter cohort of 526 patients
Location: Hall F1
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2266: Impact of Rheumatoid Arthritis Therapeutic Classes on Risk of All-Cause Mortality and All-Cause Cancer: A Population-Based Cohort Study
Location: Hall F1
Abstract Poster Presenter: Bindee Kuriya, MD, MS – University of Toronto - Toronto
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2267: Impact of Baseline Cardiovascular Risk Factors Comorbidities on an Adalimumab Biosimilar Efficacy, Quality of Life and Safety In Patients with Patients with Moderately to Severely Active Rheumatoid Arthritis: Results from the AURIEL-RA study
Location: Hall F1
Abstract Poster Presenter: Christopher Edwards, MD;FRCP – University Hospital Southampton
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2268: Differential Impact of Certolizumab Pegol, Etanercept, and Adalimumab on Rheumatoid Factor Reduction and Seroconversion in Rheumatoid Arthritis: A Propensity Score–Matched Study
Location: Hall F1
Abstract Poster Presenter: Clementina Lopez-Medina, MD, PhD (she/her/hers) – Reina Sofia University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2269: Key factors in optimizing the dose of Baricitinib in rheumatoid arthritis: a study based on routine clinical practice and its therapeutic implications
Location: Hall F1
Abstract Poster Presenter: Daniel Campos-Martin, n/a (he/him/his) – Rheumatology Department, Donostia University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2270: ACKR1 and Leukopenia in Patients with Rheumatoid Arthritis Treated with Disease Modifying Antirheumatic Drugs
Location: Hall F1
Abstract Poster Presenter: Daniela Chavez de Paz Solis, BS (she/her/hers) – National Institutes of Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2271: Assessing the Real-world Impact of Earlier Initiation of Adalimumab vs. Conventional Synthetic Dmards on Healthcare Resource Utilization in Patients with Rheumatoid Arthritis in Europe
Location: Hall F1
Abstract Poster Presenter: Dr. Carmen Bremer, PhD – Sandoz International GmbH
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2272: Combination Therapy with TNF Inhibitors and JAK Inhibitors in Multi-Drug-Resistant Rheumatoid Arthritis: A Case Series from the RA UCLouvain Brussels Cohort
Location: Hall F1
Abstract Poster Presenter: Francesco Natalucci, MD, PhD – UCLouvain University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2273: Impact of Upadacitinib on Glucocorticoid Reduction in Patients with Moderate-to-Severe RA Who Achieved and Maintained Clinical Remission in the 2-Year UPHOLD Study
Location: Hall F1
Abstract Poster Presenter: FRANK BUTTGEREIT, MD – Charité University Medicine Berlin
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2274: Importance Of Fc Region On Therapeutic Survival In Rheumatoid Arthritis Patients With Anti-TNF Therapy
Location: Hall F1
Abstract Poster Presenter: Iago Alcántara Álvarez, MD – Hospital Universitari i Politènic La Fe
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2275: Agreement Between Two Rheumatoid Arthritis Response Measures Across Bts DMARD Treatment Classes in a Large, Prospective Observational Study Supporting the Development and Clinical Validation of a Novel Blood based Precision Medicine Test
Location: Hall F1
Abstract Poster Presenter: Jason Carlson, MPH – Aqtual Inc
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2276: Long-Term Cardiovascular Risk Following Tnfi vs Triple Therapy: A Post-hoc Analysis Integrating Randomized Clinical Trial and Electronic Health Record Data
Location: Hall F1
Abstract Poster Presenter: Jennifer Hanberg, MD – Brigham and Women's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2277: Immunophenotyping of peripheral blood mononuclear cells reveals potential cellular biomarkers of disease in rheumatoid arthritis
Location: Hall F1
Abstract Poster Presenter: John Bui, BSc – Sonoma Biotherapeutics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2278: Neuroimmune modulation for the Treatment of Rheumatoid Arthritis: Results at 12 months from a Randomized, Sham-Controlled, Double-Blind Study
Location: Hall F1
Abstract Poster Presenter: John Tesser, MD, FACP, MACR – Arizona Arthritis & Rheumatology Associates
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2279: Long-Term Prevention of RA in high-risk individuals after a 6-Month Placebo-Controlled Intervention with Abatacept -The ARIAA Trial
Location: Hall F1
Abstract Poster Presenter: Koray Tascilar, MD – Friedrich Alexander University of Erlangen Nuremberg, Universitätsklinikum Erlangen Department of Medicine-3 Rheumatology and Immunology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2280: Changes of B Cell Subsets During Treatment with Abatacept in Patients with Rheumatoid Arthritis
Location: Hall F1
Abstract Poster Presenter: Lazaros Sakkas, MD, PhD, DM, FRCP – IASO General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2281: Effectiveness of Upadacitinib in Patients with Rheumatoid Arthritis in Canadian Real-World Practice: Final Results from the CLOSE-UP Post-Marketing Observational Study
Location: Hall F1
Abstract Poster Presenter: Louis Bessette, MD, MSc – Centre de l'Ostéoporose et de Rhumatologie de Québec
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2282: Effect of Online Continuing Education on Advancing Care for Rheumatoid Arthritis: A Real-World Outcome Analysis
Location: Hall F1
Abstract Poster Presenter: Nimish Mehta, PhD,MBA – Medscape
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2283: Arrhythmia Risk in Diabetic Rheumatoid Arthritis Patients: Comparative Analysis of IL-6 Inhibitors versus TNF-α Inhibitors
Location: Hall F1
Abstract Poster Presenter: Sila Mateo Faxas, MD (she/her/hers) – Good Samaritan Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2284: Cardiovascular Outcomes in Diabetic Rheumatoid Arthritis Patients: TNF-α Inhibitors versus IL-6 Inhibitors
Location: Hall F1
Abstract Poster Presenter: Sila Mateo Faxas, MD (she/her/hers) – Good Samaritan Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2285: Synovium-on-a-chip – Development of a Humanized Rheumatoid Arthritis Model that Mimics Disease and Patient Biological Heterogeneity
Location: Hall F1
Abstract Poster Presenter: Theresa Wampler Muskardin, MD – Hospital for Special Surgery, Weill Cornell Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2286: Association of Semaglutide Prescription with Improved Joint Outcomes in Rheumatoid Arthritis Patients
Location: Hall F1
Abstract Poster Presenter: Yazin Hindosh, BS (he/him/his) – University of Arizona College of Medicine Tucson
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2287: Interpretable Ensemble Machine Learning Explaining Nonadherence and the Risk of Nonpersistence of Targeted Disease-Modifying Antirheumatic Agents in Older Adults with Rheumatoid Arthritis
Location: Hall F1
Abstract Poster Presenter: Yinan Huang, PhD, MS – Department of Pharmacy Administration, University of Mississippi
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2288: Efficacy of Ivarmacitinib in Patients with Moderate-to-severe Rheumatoid Arthritis Stratified by Baseline Characteristics: A Post-hoc Study of a Phase III Clinical Trial
Location: Hall F1
Abstract Poster Presenter: Yuan Xue, MD – Zhongshan Hospital Xiamen University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2289: Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Disease Activity in Patients with Rheumatoid Arthritis: A Pilot Study
Location: Hall F1
Abstract Poster Presenter: Yuichiro Fujieda, MD,PhD – Hokkaido University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2290: Patterns and Predictors of Clinical Improvement in Patients with Sjögren’s Disease: A Longitudinal Analysis of ESSDAI and ESSPRI Improvements
Location: Hall F1
Abstract Poster Presenter: Alejandro Gómez Gómez, PhD – Hospital Universitari Vall d'Hebron
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2291: Correlation and Concordance Between the Oxford Grading Scale, Ocular Staining Score, and van BijsterveldScore in the diagnosis of Sjögren's Disease
Location: Hall F1
Abstract Poster Presenter: Alejandro Gómez Gómez, PhD – Hospital Universitari Vall d'Hebron
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2292: Safety and Humoral Response to Recombinant Herpes Zoster Vaccine in immunosuppressed Sjögren's Disease Patients: Results From a Double-Blinded Placebo-Controlled Study
Location: Hall F1
Abstract Poster Presenter: Ana Medeiros-Ribeiro, MD, PhD (she/her/hers) – Hospital das Clinicas da Faculdade de Medicina da USP
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2296: Evaluation of the Dual Mode of Action of Ianalumab (VAY736) in the Circulation and Salivary Gland Tissue of Patients With Sjögren’s Disease: Results From a Phase 2 Mechanistic Study
Location: Hall F1
Abstract Poster Presenter: Divi Cornec, MD PhD (he/him/his) – LBAI, UMR1227, University of Brest, CHU Brest, Brest, France
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2300: Evaluation of the Ianalumab Treatment Effects on Major Salivary Glands of Patients With Sjögren’s Disease by Multimodal Ultrasound: Results From a Phase 2 Mechanistic Study
Location: Hall F1
Abstract Poster Presenter: sandrine jousse joulin, MD – cavale blanche hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2302: Clustering by ESSPRI and PROMIS domain measures defines distinct subtypes and facilitates longitudinal assessment of patients with Sjogren’s disease
Location: Hall F1
Abstract Poster Presenter: Thomas Grader-Beck, MD – Johns Hopkins
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2305: Predictors of Hospitalization and Emergency Department Visits Among Patients with Psoriatic Disease: Insights from the Forward Psoriasis Registry
Location: Hall F1
Abstract Poster Presenter: Alexis Ogdie, MD – University of Pennsylvania
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2306: Prevalence and Clinical Significance of the Gastrointestinal Fat Halo Sign in Patients with Psoriatic Arthritis: A Cross-Sectional Study
Location: Hall F1
Abstract Poster Presenter: Amir Haddad, MD – Carmel Medical Centre
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2309: Lifestyle behaviours and disease activity in patients with psoriatic arthritis: the Dutch south west psoriatic arthritis study
Location: Hall F1
Abstract Poster Presenter: Batoul Hojeij, n/a (she/her/hers) – Erasmus MC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2310: Neuropeptide influence in nociception and inflammation through immune system modulation in SPA patients
Location: Hall F1
Abstract Poster Presenter: ELENA GRAU GARCIA, PhD – HUP La Fe
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2311: Obstructive Sleep Apnea Syndrome in Patients with Psoriatic Arthritis and Its Relationship with Disease Activity and Comorbidities
Location: Hall F1
Abstract Poster Presenter: Esther Toledano, MD, PhD – Hospital Universitario Clínico San Carlos
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2313: From Plaque to Plaque: Bridging Oral and Systemic Inflammation in Psoriasis and PsA
Location: Hall F1
Abstract Poster Presenter: Guru Vijay Chagalakondu, DM – Employee State Insurance Corporation (ESIC)
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2314: Radiographic and Ultrasonographic Assessments of Sesamoid Index in Patients with Psoriatic Arthritis
Location: Hall F1
Abstract Poster Presenter: Hung Vo, MD;RhMSUS (he/him/his) – Boston Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2316: Sexual Dysfunction in Women with Axial Spondyloarthritis: A Meta-Analysis of FSFI Total and Domain Scores
Location: Hall F1
Abstract Poster Presenter: Jose Fernando Verztman, MD – Hospital Federal dos Servidores do Estado do Rio de Janeiro
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2317: Cardiovascular Risk and Psoriatic Arthritis Features: Dactylitis may Predict Cardiovascular Events
Location: Hall F1
Abstract Poster Presenter: Katherine K. Benson, MD, BA – University of California, San Diego
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2318: Practice Patterns and Barriers in the Referral, Management and Monitoring of Axial Spondyloarthritis: Insights from an Online Survey of Rheumatologists
Location: Hall F1
Abstract Poster Presenter: Khalid Al Naqbi, MD, MSc, CCD, FRCPC, FACP, FACR (he/him/his) – Sheikh Tahnoon Medical City
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2319: Reducing selection bias while maintaining precision through an integrated analysis: 2-year longitudinal analysis of imaging outcomes in the SPondyloArthritis Caught Early cohort
Location: Hall F1
Abstract Poster Presenter: Liese de Bruin, MSc – Leiden University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2320: Sleep Disturbance in Psoriatic Arthritis: Prevalence by Minimal Disease Activity Status and Associated Clinical Factors
Location: Hall F1
Abstract Poster Presenter: Lourdes Perez Chada, MD,MMSc – Harvard Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2321: Uncovering Clinical Phenotypes of Sexual Dysfunction in Spondyloarthritis: A Multidimensional Analysis
Location: Hall F1
Abstract Poster Presenter: Martín Valdez-López, MD – Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubiran
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2322: Gender-related Differences in Peripheral and Axial Spondyloarthritis
Location: Hall F1
Abstract Poster Presenter: Tuncay Duruoz, MD, -None- – Marmara University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2323: Short-term predictive factors for the development of psoriatic arthritis in patients with psoriasis: findings from a joint consultation between Rheumatology and Dermatology
Location: Hall F1
Abstract Poster Presenter: Mitndbaim Parra Moreno, MD – Reina Sofia University Hospital, Cordoba
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2324: Early Prediction of Complex Forms of Spondyloarthritis Using Artificial Intelligence: A Modeling Study Based on Routine Clinical Data
Location: Hall F1
Abstract Poster Presenter: MOHAMMED KHALIL JNYAH, MD (he/him/his) – University Hospital Center Hassan II of Fez, Faculty of Medicine, Dentistry and pharmacy Sidi Mohamed Ben Abdellah of Fez, Morocco
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2325: Association of galectin-3 and Myocardial Dysfunction in Patients with Psoriatic Arthritis
Location: Hall F1
Abstract Poster Presenter: Natalia Guajardo-Jauregui, MD – Hospital Universitario "Dr. Jose E. Gonzalez", Monterrey, Mexico
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2326: Impact of Regular Exercise, Mobility Impairment, and Obesity on Quality of Life in Patients with Axial Spondyloarthritis: A Cross-Sectional Analysis from the Brazilian Registry of Spondyloarthritis
Location: Hall F1
Abstract Poster Presenter: Rafael Bassara Macedo, MD – Rheumatology Division - University of São Paulo
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2327: Persistent Pain in PsA: A Distinct Phenotype of Depression, Fatigue, And Catastrophizing
Location: Hall F1
Abstract Poster Presenter: Rebecca Haberman, MD – NYU Langone Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2328: Increased Risk of Stroke In Patients With Psoriasis: A Systematic Review And Meta-Analysis
Location: Hall F1
Abstract Poster Presenter: Rubab Rizwan, MD – VBMC,Nuvance Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2329: Increased Risk of Atrial Fibrillation In Patients With Psoriasis: A Systematic Review And Meta-Analysis
Location: Hall F1
Abstract Poster Presenter: Sehneet Grewal, MBBS (she/her/hers) – Nuvance Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2330: Correlation of Comorbidities with Psoriatic Arthritis Duration in Elderly Veterans - A Retrospective Cohort Study
Location: Hall F1
Abstract Poster Presenter: Siba Raychaudhuri, MD – UC Davis, School of Medicine/ VA Medical Center, Sacramento
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2331: Coping with Rheumatic Stressors in Axial Spondyloarthritis: Association with Patient Characteristics and Disease Phenotypes and Changes Over Time
Location: Hall F1
Abstract Poster Presenter: Sofia Ramiro, MD, PhD – Leiden University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2333: Validation of a Corrected Axial Spondyoarthritis Metrology Index in 9 Randomized Clinical Trials
Location: Hall F1
Abstract Poster Presenter: Sofia Ramiro, MD, PhD – Leiden University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2334: Development and validation analysis of a Corrected Axial Spondyloarthritis Metrology Index
Location: Hall F1
Abstract Poster Presenter: Sofia Ramiro, MD, PhD – Leiden University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2336: Early Axial Spondyloarthritis in Latin America: Prevalence and Regional Differences from the "ESPALDA" Multinational Registry
Location: Hall F1
Abstract Poster Presenter: Wilson Bautista-Molano, Sr, MD, PhD – University Hospital Fundación Santa Fe de Bogotá
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2337: A Mediation Analysis of Tofacitinib's Effects on SF-36: The Roles of Fatigue, Pain, Stiffness, and Mobility in Ankylosing Spondylitis
Location: Hall F1
Abstract Poster Presenter: Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2338: Real-World Outcomes of Combined Tofacitinib and TNF Inhibitor Therapy in Refractory Inflammatory Arthritis: A Tertiary Care Experience from India
Location: Hall F1
Abstract Poster Presenter: Aashish Agrawal, MD, MBBS – Hinduja Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2339: Joint Groups Involved in Early Oligoarticular Psoriatic Arthritis and the Impact of Apremilast Treatment: Data From FOREMOST
Location: Hall F1
Abstract Poster Presenter: Alen Zabotti, MD, MSc – Azienda Sanitaria Universitaria del Friuli Centrale
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2340: Lighten the Load: Artificial Intelligence Reveals Body Mass Index Outranks Treatment in One-Year Psoriatic Arthritis Outcomes—Findings from the SPEED Trial
Location: Hall F1
Abstract Poster Presenter: Alexander Garaiman, n/a – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2341: Bimekizumab Treatment Resulted in Long-Term Sustained Reductions in Disease Impact Assessed by the Psoriatic Arthritis Impact of Disease (PsAID)-12 Questionnaire in Patients with Active Psoriatic Arthritis: Up to 3-Year Results from Two Phase 3 Studies
Location: Hall F1
Abstract Poster Presenter: Ana-Maria Orbai, MD, MHS – Johns Hopkins University School of Medicine, Division of Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2342: Real-World Effectiveness and Satisfaction in Biologic-Naïve Patients With Psoriatic Arthritis and Limited Joint Involvement Treated With Risankizumab in the United States and Europe
Location: Hall F1
Abstract Poster Presenter: Andrew Ostor, MD – Australian National University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2343: Risk of Arrhythmias Following IL-17 Inhibitor Use; A Pharmacosurvellience Study of FDA Adverse Event Reporting System (FAERS)
Location: Hall F1
Abstract Poster Presenter: Asim Khanfar, MD – Rochester General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2344: Impact of Bimekizumab Use in Spondyloarthritis and Psoriatic Arthritis: Persistence Study in Routine Clinical Practice in Spain (BIMPACT study)
Location: Hall F1
Abstract Poster Presenter: Cristina Valero, MD – Hospital de la Princesa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2345: Biological Sex-Related Differences in Radiographic Progression and Relationship with Early Clinical Response: Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo‑Controlled Study in Biologic-Naive Participants with Active Psoriatic Arthritis Treated with Guselkumab
Location: Hall F1
Abstract Poster Presenter: Dafna Gladman, MD, FRCPC, FACR, MACR – University of Toronto, Toronto Western Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2346: Back in Action: Six Months of Biological Therapy Improve Sexual Function in Men with Ankylosing Spondylitis
Location: Hall F1
Abstract Poster Presenter: Daniel Zavada, MD – Charles University, Third Faculty of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2347: Bimekizumab Treatment Resulted in Patients with Axial Spondyloarthritis Maintaining Their Clinical Responses Over 3 Years: Results from Two Phase 3 Studies and Their Open-Label Extension
Location: Hall F1
Abstract Poster Presenter: Fabian Proft, MD – Charité Universityhospital Berlin
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2348: Efficacy and safety of dual biological therapy in the treatment of rheumatic diseases: experience from a single highly specialized center.
Location: Hall F1
Abstract Poster Presenter: Francesco Fulvio Bizzarri, MD – Complejo Hospitalario de Jaen
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2349: Classification of "Difficult-to-Manage Axial Spondyloarthritis": A Real-World Cohort Study Evaluating the ASAS 2024 Criteria Over Time
Location: Hall F1
Abstract Poster Presenter: Gözde Kart Bayram, MD – Hacettepe University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2350: Multicenter study on the use of Upadacitinib: sex specific results in Spondyloarthritis
Location: Hall F1
Abstract Poster Presenter: Guillermo Gonzalez Mozo de Rosales, MD – Basurto University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2351: Modulation of Tyrosine Kinase 2- and Disease-Related Biomarkers by Zasocitinib (TAK-279), an Oral, Allosteric, Highly Selective and Potent Tyrosine Kinase 2 Inhibitor, Is Associated With Clinical Response in Patients with Active Psoriatic Arthritis
Location: Hall F1
Abstract Poster Presenter: Iain McInnes, PhD, FRCP – University of Glasgow
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2352: Long-Term Uveitis Rates with Bimekizumab Treatment Across Pooled Phase 2b and Phase 3 Studies in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: 3-Year Update
Location: Hall F1
Abstract Poster Presenter: Irene van der Horst-Bruinsma, MD, PhD – Radboud umc
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2353: Efficacy of Vunakizumab in Reducing Pain in Ankylosing Spondylitis: A Post-Hoc Analysis of a Phase 2/3 Clinical Trial
Location: Hall F1
Abstract Poster Presenter: Xu Jian, PhD – First Affiliated Hospital of Kunming Medical University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2354: ChatGPT or SPSS? A comparison between AI-based and Traditional Statistical Analysis of Longitudinal Inflammatory Marker Data in Spondyloarthritis
Location: Hall F1
Abstract Poster Presenter: José Miguel Sequí-Sabater, Jr, MD,MSc (he/him/his) – La Ribera University Hospital, Rheumatology Department
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2355: Ixekizumab Provided Rapid Improvement in Key Patient Subgroups with Psoriatic Arthritis: Findings from a Prospective Observational Study in the United States of Patients Initiating Ixekizumab or Interleukin-23 Inhibitors
Location: Hall F1
Abstract Poster Presenter: KURT OELKE, MD – rheumatic disease center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2356: Clinical Efficacy in Male and Female Patients With Active Psoriatic Arthritis Treated With Deucravacitinib: A Pooled Analysis of Pivotal Phase 3 Studies
Location: Hall F1
Abstract Poster Presenter: Lihi Eder, MD, PhD – University of Toronto
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2357: Impact of Sonelokimab, a Novel IL-17A- and IL-17F-Inhibiting Nanobody, in Active Psoriatic Arthritis: Key Subgroup Analyses in the Randomized, Double-Blind, Placebo-Controlled Phase 2 ARGO Trial
Location: Hall F1
Abstract Poster Presenter: Lihi Eder, MD, PhD – University of Toronto
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2358: Bimekizumab Demonstrated Early and Sustained Efficacy Regardless of Baseline Characteristics in Patients with Active Psoriatic Arthritis: Pooled Post Hoc Results up to 1-Year from Two Phase 3 Studies
Location: Hall F1
Abstract Poster Presenter: Lihi Eder, MD, PhD – University of Toronto
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2359: Combination Of TNF Inhibitors And NSAIDs Versus TNF Inhibitors Alone On The Progression Of Structural Damage In The Spine And Hip: a Retrospective Study In 262 Patients With Radiographic Axial Spondyloarthritis
Location: Hall F1
Abstract Poster Presenter: MARIA KONSTA, MD, PhD (she/her/hers) – Sismanoglion Hospital, Athens, Greece
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2360: Treatment adherence in ankylosing spondylitis: A comparison of TNFi, IL-17i, and JAKi using real-world data
Location: Hall F1
Abstract Poster Presenter: Marina Magrey, MD – Case Western Reserve University School of Medicine/University Hospitals Cleveland
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2361: Secondary Outcomes from a Series of N-of-1 NSAID Trials in Axial Spondyloarthritis: Functional, Quality-of-Life, and Safety Results from a Bayesian Analysis
Location: Hall F1
Abstract Poster Presenter: Mark Hwang, MD,MS – UTHealth Houston
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2362: Long-Term Efficacy and Safety of Risankizumab for csDMARD-IR Patients With Active Psoriatic Arthritis: 244-Week Results From the KEEPsAKE 1 Trial
Location: Hall F1
Abstract Poster Presenter: Mauro Keiserman, MD – Rheumatology Section, Pontifical Catholic University, School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2363: Impact of Biologic Therapies on Cardiovascular and Venous Thromboembolic Events in Psoriatic Arthritis: Real-World Evidence
Location: Hall F1
Abstract Poster Presenter: Milad Heydari-Kamjani, DO – University Hospitals Cleveland Medical Center/ Case Western Reserve University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2364: Real-World Characteristics and Treatment Patterns of Difficult-to-Treat Psoriatic Arthritis
Location: Hall F1
Abstract Poster Presenter: Milad Heydari-Kamjani, DO – University Hospitals Cleveland Medical Center/ Case Western Reserve University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2365: Sustained Efficacy up to 3 Years with Bimekizumab Treatment Across GRAPPA Core Domains in Patients with Psoriatic Arthritis: Long-Term Results from Two Phase 3 Trials
Location: Hall F1
Abstract Poster Presenter: Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2366: Association Between Skin and Joint Symptom Control and Patient-reported Pain and Health Status Among Patients with Psoriatic Arthritis in the Corevitas Psoriatic Arthritis/spondyloarthritis Registry Initiating Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drugs
Location: Hall F1
Abstract Poster Presenter: Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2367: Real-World Effectiveness of Risankizumab on Axial Symptoms in Biologic-Naïve Patients With Psoriatic Arthritis in the United States and Europe
Location: Hall F1
Abstract Poster Presenter: Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2368: Inhibition of Structural Damage Progression with Guselkumab, a Selective IL-23i, in Participants with Active PsA: Results Through Week 24 of the Phase 3b, Randomized, Double-Blind, Placebo-Controlled APEX Study
Location: Hall F1
Abstract Poster Presenter: Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2369: Real-World On-Label Treatment Persistence Through 24 Months in Biologic-Naïve and Biologic-Experienced Patients with Psoriatic Arthritis: Comparison of Guselkumab versus Subcutaneous Interleukin-17A Inhibitors
Location: Hall F1
Abstract Poster Presenter: Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2370: Comparative Efficacy and Safety of IL-17 Inhibitors Versus Adalimumab in Biologic-Naive Psoriatic Arthritis Patients: A Meta-Analysis of Randomized Controlled Trials
Location: Hall F1
Abstract Poster Presenter: Punith Chirumamilla, MD (he/him/his) – Baptist Memorial Hospital North Mississippi
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2371: A Predictive Model Combining Clinical and Laboratory Parameters to Predict Anti-tnf Response in Patients with Psoriatic Arthritis
Location: Hall F1
Abstract Poster Presenter: Raquel Granados, MD – Hospital Universitario Reina Sofia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2372: Treatment Outcome and Persistence of IL-23 Inhibitors in Real World Cohort of PsA Patients- A Retrospective Study
Location: Hall F1
Abstract Poster Presenter: Reut Tzemach, MD (she/her/hers) – Sourasky Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2373: Effectiveness and Tolerability of Guselkumab or TNF inhibitors as Second-Line Treatment After Receiving a TNF inhibitor as First-Line Therapy to Treat Active Psoriatic Arthritis: 52-Week Interim Data from the Manhattan Study
Location: Hall F1
Abstract Poster Presenter: Rocio Gonzalez Molina, PhD – Hospital Reina Sofía
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2374: Bimekizumab Efficacy And Safety Through 5 Years In Patients With Moderate To Severe Plaque Psoriasis In The US And Canada
Location: Hall F1
Abstract Poster Presenter: Saakshi Khattri, MD, MBBS – Mount Sinai Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2375: Ixekizumab Provided Rapid Improvements in Quality of Life and Disease Activity in Patients with Psoriatic Arthritis: Findings from a Real-World Study in the United States of Patients Initiating Ixekizumab or Interleukin-23 Inhibitors
Location: Hall F1
Abstract Poster Presenter: Shikha Singla, MD – MCW
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2376: Efficacy And Safety of Vunakizumab in Patients with Active Ankylosing Spondylitis Stratified by Disease Course: A Post-hoc Analysis of a Randomized, Double-Blind, Phase 2/3 Trial
Location: Hall F1
Abstract Poster Presenter: Xiaofei Shi, MD – The First Affiliated Hospital of Henan University of Science and Technology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2377: Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Patients with Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Aakash Patel, MD – Massachusetts General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2378: Factors Associated With Fatigue In Systemic Lupus Erythematosus: Data From The Almenara Lupus Cohort
Location: Hall F1
Abstract Poster Presenter: Alvaro Oyarce-Calderón, Sr, MD (he/him/his) – Hospital Nacional Guillermo Almenara Irigoyen
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2379: Predicting Type 1 and Type 2 SLE Activity Using the LupusPRO
Location: Hall F1
Abstract Poster Presenter: Amanda Eudy, PhD – Duke University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2380: Factors Influencing Time to Diagnosis in Systemic Lupus Erythematosus: A Real-World Retrospective Analysis
Location: Hall F1
Abstract Poster Presenter: April Barnado, MD, MSc – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2381: Renal Tubular Complement C9 Deposition is Linked to Tubulointerstitial Fibrosis and Progression to Chronic Kidney Disease in Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Angela Lu, BS – Albert Einstein College of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2382: Autoimmune Hemolytic Anemia in SLE: A Real-World National Cohort Study
Location: Hall F1
Abstract Poster Presenter: Ansaam Daoud, MD – Case Western Reserve University/University Hospitals
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2383: The Age-Adjusted Charlson Comorbidity Index (CCI) Predicts All-Cause Mortality in Systemic Lupus Erythematosus (SLE) Patients: Data from the Almenara Lupus Cohort
Location: Hall F1
Abstract Poster Presenter: Benny Rashuamán-Conche, MD (he/him/his) – Hospital Guillermo Almenara Irigoyen.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2384: Patient-Reported Quality of Life in SLE: Association with Biomarker-Derived Disease Activity Index (L-DAI) and hSLEDAI in a Prospective Cohort
Location: Hall F1
Abstract Poster Presenter: Bernie Rubin – Progentec Diagnostics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2385: The Presence of Avascular Necrosis in Patients with Systemic Lupus Erythematosus Undergoing Total Knee Arthroplasty is Not Associated with Worse Outcomes
Location: Hall F1
Abstract Poster Presenter: Billy Kim, MD – Hospital for Special Surgery
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2386: anti-trim72 Auto-antibodies in Systemic Lupus Erythematosus Patients and a Lupus Mouse Model with Myocarditis Compromise Membrane Repair in Mouse & Human Cardiomyocytes
Location: Hall F1
Abstract Poster Presenter: Braden Zeno, BS – Ohio State University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2387: Lupus Damage Index Revision – Item Generation and Reduction Phases
Location: Hall F1
Abstract Poster Presenter: Burak Kundakci, PhD, MSc – University of Manchester
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2388: Correlation between Activity Index, Organ Damage Index, and HAQ in Systemic Lupus Erythematosus: a single-center study
Location: Hall F1
Abstract Poster Presenter: Carmen Lasa Teja, n/a – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2389: A Comparison of Patients with Older Onset vs. Younger Onset SLE: A Retrospective Cohort Study
Location: Hall F1
Abstract Poster Presenter: Chelsea Guan, MD – University Hospitals Cleveland Medical Center/Case Western Reserve University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2390: SLE Genetic Risk Loci in the Context of Environmental Exposure: A Gene-Based Classification and Clinical Insight
Location: Hall F1
Abstract Poster Presenter: Dag Leonard, MD, PhD – Uppsala University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2391: Antinuclear Antibody Positivity in Patients with Psoriasis and Psoriatic Arthritis and the Risk of Developing Clinical Symptoms of SLE Following TNF Inhibitor Therapy
Location: Hall F1
Abstract Poster Presenter: Damira Sereda, MD – Stamford
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2392: Does Obesity Influence Disease Activity and Biomarkers in Systemic Lupus Erythematosus Patients?: A Retrospective Study
Location: Hall F1
Abstract Poster Presenter: Daniyal Nadeem, MD – Louisiana state university health shreveport
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2393: Improving Clinical Outcomes In SLE Arthritis Trials: Post-Hoc Analysis Of A Prospective Intervention Study
Location: Hall F1
Abstract Poster Presenter: Ed Vital, MD – University of Leeds
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2394: Impact of Immunosuppressive Regimens on Major Cardiac Events in Patients with Systemic Lupus Erythematosus (SLE): A Survival Analysis
Location: Hall F1
Abstract Poster Presenter: Emily Cosentino, MD – Icahn School of Medicine at Mount Sinai
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2395: Analysis of Histopathological Changes in the Placenta of Patients with Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Evandro Klumb, n/a (he/him/his) – UERJ - Universidade do Estado do Rio de Janeiro
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2396: A Machine Learning Algorithm Based on a 15-autoantibody Profile by a Novel Fully Automated Multiplexed Microarray Immunoassay for the Diagnosis of Autoimmune Connective Tissue Diseases
Location: Hall F1
Abstract Poster Presenter: Gerber Gomez, MD, MSc (he/him/his) – AliveDx Suisse SA
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2397: Analytical Performance of a Fully Automated Multiplexed Microarray Immunoassay for the Simultaneous Detection of Fifteen Autoantibodies Associated with Connective Tissue Diseases in a Reference Laboratory in Southern France
Location: Hall F1
Abstract Poster Presenter: Gerber Gomez, MD, MSc (he/him/his) – AliveDx Suisse SA
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2398: Analytical Performance of the hep-2 Substrate Diagnostic Kit for ANA as an Initial Step in the Evaluation of a Novel Fully Automated IFA Analyzer in a Laboratory in England
Location: Hall F1
Abstract Poster Presenter: Gerber Gomez, MD, MSc (he/him/his) – AliveDx Suisse SA
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2399: Identification of an LN endotype linked to intestinal expansion of Pathogenic Strains of a Pathobiont Bacterium that induces Systemic Thrombo-inflammatory Pathways directly measurable in Urine
Location: Hall F1
Abstract Poster Presenter: Gregg Silverman, MD – NYU Grossman School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2400: Prevalence and Predictors of Types and Subtypes of Pulmonary Diseases in Systemic Lupus Erythematosus: A Population-Based Cross-Sectional Study Using High-Resolution Computed Tomography Scan and Pulmonary Function Testing
Location: Hall F1
Abstract Poster Presenter: Henrik Zachar Langkilde, MD (he/him/his) – Department of Rheumatology, Odense University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2401: Associations Between Serum Levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Activity and Chronicity Features in Diagnostic and Per-protocol Repeat Kidney Biopsies in Patients with Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Ioannis Parodis, MD, PhD – Karolinska Institutet and Karolinska University Hospital, Department of Medicine Solna, Division of Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2402: High-Resolution Proteomic Profiling Validates BAFF Pathway Modulation and Reveals Novel Biomarker Signatures in Belimumab Treatment
Location: Hall F1
Abstract Poster Presenter: Ioannis Parodis, MD, PhD – Karolinska Institutet and Karolinska University Hospital, Department of Medicine Solna, Division of Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2403: Differential Risk of Inpatient Admissions Among SLE Subgroups: A Population-Based Analysis
Location: Hall F1
Abstract Poster Presenter: Jaime Flores Gouyonnet, MD – Mayo Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2404: Clinical features of Elderly-onset Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Jessica Dai, BS – New York University Grossman School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2405: Machine Learning in SLE Diagnosis: Performance of the SLE Risk Probability Index Questionnaire in a Multicenter Cohort of Patients with Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Joan Manuel Dapeña, Sr, MD (he/him/his) – Sanatorio Dr. Julio Mendez
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2406: Machine Learning-Based Artificial Intelligence in Systemic Lupus Erythematosus: A Systematic Review of Outcome Prediction and Patient Stratification
Location: Hall F1
Abstract Poster Presenter: Jorge Juan Fragio Gil, MD;PhD (he/him/his) – Hospital General Universitario
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2407: Mapping Neurological Involvement, Regional Disparities, and Moderators of the Central Nervous System in Adult-Onset Systemic Lupus Erythematosus: A Global Systematic Review and Meta-Analysis
Location: Hall F1
Abstract Poster Presenter: Jorge Juan Fragio Gil, MD;PhD (he/him/his) – Hospital General Universitario
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2408: Direct Medical Cost Burden of Cutaneous Lupus Erythematosus (CLE): A Comparison with Psoriasis, Atopic Dermatitis, and a General Population
Location: Hall F1
Abstract Poster Presenter: Joseph Merola, MD, MSc, FACR, FAAD – UT Southwestern Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2409: Cutaneous Lupus Activity Investigator’s Global Assessment―Revised (CLA-IGA-R) Content Validity: Cutaneous Lupus Erythematosus (CLE) Patient Qualitative Study
Location: Hall F1
Abstract Poster Presenter: Joseph Merola, MD, MSc, FACR, FAAD – UT Southwestern Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2410: Immune Cell/Pathway-Specific Polygenic Risk Scores Reveal Immune Pathway Associations in Childhood-Onset Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Liyoung Kim, MD (she/her/hers) – Boston Children's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2411: The 2019 EULAR/ACR and 2012 SLICC Classification Criteria for SLE Should Be Applied with Caution as Diagnostic Criteria
Location: Hall F1
Abstract Poster Presenter: Luca Mazzoleni, -None- – University of Brescia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2412: Evolving Trends in Pulmonary Arterial Hypertension among Systemic Lupus Erythematosus Patients: A Nationwide Analysis
Location: Hall F1
Abstract Poster Presenter: Maria Emilia Romero Noboa, MD – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2413: Hydroxychloroquine and Adverse Cardiovascular Outcomes in Pregnant Patients with Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Mariana Gonzalez-Trevino, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2414: Autoantibody Clusters and SIGLEC1 are Predictive of Systemic Lupus Erythematosus Development
Location: Hall F1
Abstract Poster Presenter: May Choi, MD, FRCPC, MPH – University of Calgary
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2415: Evaluating the Readability and Comprehension of Patient Education Materials for Systemic Lupus Erythematosus (SLE) Available Online
Location: Hall F1
Abstract Poster Presenter: Meenakshi Jolly, MD – Rush University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2416: Direct and Indirect Costs Associated with Damage Accrual: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Location: Hall F1
Abstract Poster Presenter: Megan Barber, MD, PhD – University of Calgary
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2417: Anti-dense Fine Speckled 70 Antibodies in Undefined Disease, Systemic Autoimmune Rheumatic Diseases and Controls
Location: Hall F1
Abstract Poster Presenter: Meghna Gavali, MBBS, MD (she/her/hers) – Nizam's institute of medical sciences ,Hyderabad
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2418: ORF1p Expression Correlates with STING Activation and IFN Signatures in SLE Nonlesional Skin
Location: Hall F1
Abstract Poster Presenter: Mehrnaz Gharaee-Kermani, DVM, MPH, PhD – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2419: Dried Blood Spots for Remote ANA and Autoantibody Screening
Location: Hall F1
Abstract Poster Presenter: Feng Yun Li, MD – University of Calgary
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2420: In-patient Outcomes of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome in SLE: US National Inpatient Database (2021-2022)
Location: Hall F1
Abstract Poster Presenter: Nattanicha Chaisrimaneepan, MD – Texas Tech University Health Sciences Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2421: Whole Blood Immune Phenotyping Reveals Cytometric Differences in B Cell Clusters Between Lupus Nephritis and Non-Lupus Nephritis SLE Patients with Minimal Proteinuria
Location: Hall F1
Abstract Poster Presenter: Nicholas Bauer, BS – Oklahoma Medical Research Foundation
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2422: Cluster Analysis of Autoantibodies in Patients with Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Oihane Ibarguengoitia-Barrena, MD – Galdakao-Usansolo University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2423: Clinical and Sociodemographic Factors Associated with Diagnostic Delays in Pediatric Lupus Patients
Location: Hall F1
Abstract Poster Presenter: Rebecca Hetrick, MD, MS – Indiana University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2425: Neutrophil Transcriptomics in SLE: Exploring Intrinsic, Ex Vivo Adaptation, and CAR-T Cell Therapy-Induced Changes
Location: Hall F1
Abstract Poster Presenter: Roberto Caricchio, MD – University of Massachusetts Chan Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2426: Physical Activity Patterns and Health-Related Quality of Life in Middle-Aged and Older Adults with Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Sarah Lieber, MD, MS – Hospital for Special Surgery
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2427: Kidney-Specific Four-Protein Index Outperforms Conventional Measures for Detecting Early Kidney Damage in Lupus Nephritis and Diabetic Kidney Disease
Location: Hall F1
Abstract Poster Presenter: Sepehr Taghavi, MSc – Exagen Inc
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2428: Differences in Dyspigmentation and Scarring Across Cutaneous Lupus Erythematosus Categories and Subtypes
Location: Hall F1
Abstract Poster Presenter: Shae Chambers, BA – University of Pennsylvania
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2429: mHealth-enabled Peer Coaching for Fatigue in Systemic Lupus Erythematosus (SLE): Preliminary Results from the Restore Energy, Activity Can Help (REACH) Pilot Randomized Controlled Trial
Location: Hall F1
Abstract Poster Presenter: Shanthini Kasturi, MD;MS (she/her/hers) – Tufts Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2430: Disease Activity Independently Correlates with Cognitive Impairment in Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Steven Bieser, MD – Northwestern University Feinberg School of Medicine, NMH hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2431: Bone marrow- activity on 18F-FDG PET/CT as a Predictor of Hematologic Manifestations in Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Sungwon Ko, MD – ASAN MEDICAL CENTER
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2432: Duffy Null Genotype and Autoantibodies Synergistically Contribute to Severe Leukopenia in Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Valerie Lewis, Ph.D. (she/her/hers) – Oklahoma Medical Research Foundation
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2433: The Clinical Utility of a Multianalyte Lupus Risk Score Incorporating Cell-bound Complement Activation Products: A Systematic Evaluation
Location: Hall F1
Abstract Poster Presenter: Vasileios Kyttaris, MD, PhD – BIDMC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2434: Specificity of Cell-bound T Cell Biomarkers (TC4d, TIgG, TIgM) in Differentiating SLE from ANA-Associated Rheumatic Diseases
Location: Hall F1
Abstract Poster Presenter: Vasileios Kyttaris, MD, PhD – BIDMC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2436: Preload deficiency as a treatable cause of fatigue and exercise intolerance in SLE
Location: Hall F1
Abstract Poster Presenter: Yoo Jin Kim, MD, MS – Duke University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2437: Bupropion for Lupus-Induced Fatigue Treatment (B-LIFT): A Retrospective Analysis
Location: Hall F1
Abstract Poster Presenter: Aaron Smith, MD, MS – University of North Carolina
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2438: SGLT2 Inhibitors in SLE: Impact on Pulmonary Hypertension, Mortality, and Renal Outcomes
Location: Hall F1
Abstract Poster Presenter: Ahmad Alomari, MD – UCF / North Florida Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2439: Belimumab Versus Mycophenolate Mofetil in Lupus Nephritis: A Real-World Comparative Analysis
Location: Hall F1
Abstract Poster Presenter: Ahmad Alomari, MD – UCF / North Florida Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2440: Effect of Cenerimod on Four Main Clinical Items of SLEDAI-2K Score in SLE Patients in a Phase 2b Study
Location: Hall F1
Abstract Poster Presenter: Bruno Flamion, MD, PhD (he/him/his) – Viatris Innovation GmbH
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2441: Dapirolizumab Pegol Demonstrated Improvement in Quality of Life of Patients with Systemic Lupus Erythematosus: LupusQoL Results from a Phase 3 Trial
Location: Hall F1
Abstract Poster Presenter: Cynthia Aranow, MD – Feinstein Institutes for Medical Research
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2442: Reduction in Extrafollicular B Cell Responses in SLE Patients after CAR T Cell Therapy
Location: Hall F1
Abstract Poster Presenter: Danae-Mona Nöthling, MD – University Clinic Erlangen, Germany
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2443: WITHDRAWN
Location: Hall F1
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2444: Hydroxychloroquine-Induced Retinopathy in Systemic Lupus Erythematosus: Predictors of Progression Following Drug Discontinuation
Location: Hall F1
Abstract Poster Presenter: Emily Gutowski, MD – NYU
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2445: Achievement of Treat to Target Measures with Upadacitinib in Patients with Systemic Lupus Erythematosus: Phase 2 Randomized Sleek Clinical Trial Results
Location: Hall F1
Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2446: Use of Voclosporin in Pediatric Patients: A Summary of Available Data from Post-marketing Reports
Location: Hall F1
Abstract Poster Presenter: Eugenia Chock, MD – Yale School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2447: Longitudinal Disease Activity Trajectories in Patients with Systemic Lupus Erythematosus Treated with Belimumab
Location: Hall F1
Abstract Poster Presenter: Fumin Qi, n/a – Tianjin Medical University General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2448: Rituximab as the first line treatment in newly diagnosed systemic lupus erythematosus
Location: Hall F1
Abstract Poster Presenter: Haiting Wang, MD, PhD (she/her/hers) – Renji Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2449: Patient Characteristics, Treatment and Prognosis in Patients with Neuromyelitis OpticaSpectrum Disorder Coexisting with Systemic Lupus Erythematosus or Sjögren's Syndrome: An Analysis Using Japanese Inpatient Database
Location: Hall F1
Abstract Poster Presenter: Hiroshi Shiba, MD – Suwa central hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2450: Spanish Real-World Ambispective Multicenter Registry of Anifrolumab in Systemic Lupus Erythematosus: Efficacy and Safety at 3- and 6-Month Follow-Up (ANIFRO-Reu Study)
Location: Hall F1
Abstract Poster Presenter: Irene Carrión-Barberà, MD, PhD – University of Washington
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2451: Tofacitinib Lowers Markers of Photosensitivity in Patients with Cutaneous Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: J. Michelle Kahlenberg, MD, PhD – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2452: Preliminary Safety, Efficacy, and Cellular Kinetics of CTA311, a CD19 Targeted Universal CAR-T Therapy, for Active Autoimmune Diseases
Location: Hall F1
Abstract Poster Presenter: Jan Davidson-Moncada, PhD, MBBS – Bioheng
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2453: Belimumab Is Associated with Lower Risk of Progression to LN Compared with Standard of Care in Patients with SLE
Location: Hall F1
Abstract Poster Presenter: Jeff Ellis, PharmD, MS – GSK
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2454: Longitudinal Analysis of B cell Remodeling in Systemic Lupus Erythematosus Following iPSC-Derived CAR T-cell Therapy
Location: Hall F1
Abstract Poster Presenter: Trever Greene, PhD – Fate Therapeutics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2455: Lupus Intervention Fatigue Trial: Preliminary Analysis of Baseline Data
Location: Hall F1
Abstract Poster Presenter: Justin Arnold, BA (he/him/his) – Northwestern Feinberg School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2456: Predictors of Real-World Remission in Patients with SLE Initiating Belimumab in the USA
Location: Hall F1
Abstract Poster Presenter: Karen Worley, PhD, MS – GSK, Global Real-World Evidence & Health Outcomes Research
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2457: Maternal, Embryo-Fetal And Neonatal Outcomes Following Belimumab Exposure During Pregnancy In Patients With Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Kenza EL OUAZZANI ECH CHAHDI, BS – Bordeaux University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2458: Obecabtagene autoleucel (obe-cel), a CD19-targeting Autologous Chimeric Antigen Receptor T-cell Therapy (CAR T) with a fast off-rate binding domain, in Patients (pts) with Severe, Refractory Systemic Lupus Erythematosus (srSLE): Preliminary Results from the Phase I CARLYSLE Study
Location: Hall F1
Abstract Poster Presenter: Maria Leandro, MD,PhD,FRCP – UCL/UCLH
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2459: Hydroxychloroquine Discontinuation in Systemic Lupus Erythematosus: A Retrospective Cohort Study with 3-Year Follow-Up
Location: Hall F1
Abstract Poster Presenter: Milena Delai, MD – Beth Israel Deaconess Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2460: Comparative Efficacy of Belimumab, Anifrolumab, and Rituximab in SLE: A Retrospective Analysis of Serological and Clinical Outcomes
Location: Hall F1
Abstract Poster Presenter: Pablo Martinez Calabuig, Sr, MD – HOSPITAL GENERAL UNIVERSITARIO VALENCIA SPAIN/ Escuela de doctoradoUniversidad Católica de Valencia San Vicente Mártir, Valencia, Spain
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2461: Targeting treatment-resistant Systemic Lupus Erythematosus through transcriptome-informed drug repurposing
Location: Hall F1
Abstract Poster Presenter: Panagiotis Garantziotis, MD – Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2462: Precision Dosing is Needed to Establish Predictable Exposure to the Active Metabolite of Mycophenolate Mofetil (MMF) in Pediatric Lupus Nephritis (LN)
Location: Hall F1
Abstract Poster Presenter: Pooja Patel, DO – Ann and Robert H. Lurie Children's Hospital of Chicago
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2463: Allogenic Anti- CD19 CAR-T Cells Induce Remission in Refractory Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Qian Tan, MD, PhD – BRL Medicine Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2464: IMC-002 (IMM0306), a First-in-Class Bi-specific Fusion Protein, Demonstrates Improvements in Systemic Lupus Erythematosus (SLE) Disease Activity Measures and Biomarkers in Patients with Moderate to Severe Active SLE in the Open-label Phase 1b/2 Study
Location: Hall F1
Abstract Poster Presenter: Qian Zheng, PhD – ImmuneCare Biopharmaceuticals(Shanghai) Co., LTD
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2465: CD19/BCMA Dual-Targeting FasTCAR-T Cells GC012F (AZD0120) in patients with refractory Systemic Lupus Erythematosusm: an open-label, single-center Phase I study
Location: Hall F1
Abstract Poster Presenter: Qiong Fu, MD (she/her/hers) – Renji Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2466: Efficacy and Safety Results of Zetomipzomib from the PALIZADE Phase 2b Clinical Trial in Patients with Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Richard Furie, MD – Northwell
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2467: Complete Renal Responses and Safety for Belimumab Versus Placebo in a Post Hoc Mycophenolate Mofetil Subgroup with Active Proliferative Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Richard Furie, MD – Northwell
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2468: RESET-SLE: Clinical Trial Evaluating Rese-cel (Resecabtagene Autoleucel), a Fully Human, Autologous 4-1BB CD19-CAR T Cell Therapy in Non-Renal SLE and Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Saira Sheikh, MD – University of North Carolina at Chapel Hill
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2469: Development of Consensus Statements on Glucocorticoid Use in Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Wen-Nan Huang, MD, PhD. (he/him/his) – Taichung Veterans General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2470: Impaired Myocardial Flow Reserve on 82-Rubidium Positron Emission Tomography in Patients with Systemic Sclerosis
Location: Hall F1
Abstract Poster Presenter: Attila Feher, MD, PhD – Yale University School of Medicine - New Haven, CT
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2471: Automated Feedback and Quality Control in Nailfold Capillaroscopy: A Tool for Clinical and Educational Use
Location: Hall F1
Abstract Poster Presenter: Borja Gracia, MD, PhD – Hospital Clínico Universitario Lozano Blesa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2472: Digesting the data: tracking gastro-intestinal manifestations in systemic sclerosis over time
Location: Hall F1
Abstract Poster Presenter: Carina Mihai, MD, PhD – University Hospital Zurich, University of Zurich
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2473: Nailfold Capillaroscopy Improves Cardiovascular Risk Stratification in Systemic Sclerosis: An Adjustment to the SCORE2 Algorithm
Location: Hall F1
Abstract Poster Presenter: Carlos Valera Ribera, MD – Hospital Universitario Doctor Peset
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2474: Unveiling the clinical spectrum of ACA-positive SSc-ILD: not as benign as expected
Location: Hall F1
Abstract Poster Presenter: Carlos Valera Ribera, MD – Hospital Universitario Doctor Peset
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2475: GERD Severity, Proton Pump Inhibitor Use, and Longitudinal Forced Vital Capacity in the CONQUER Registry
Location: Hall F1
Abstract Poster Presenter: Carrie Richardson, MD, MHS – Northwestern University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2476: Blinatumomab in rapid progressive systemic sclerosis
Location: Hall F1
Abstract Poster Presenter: Christina Gebhardt, MD – LMU Klinikum
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2477: Current treatment Strategies in Systemic Sclerosis- Interstitial Lung Disease Patients: Real-World Insights from the EUSTAR Cohort (CP138)
Location: Hall F1
Abstract Poster Presenter: Corrado Campochiaro, MD – IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2478: Endothelial Cell Biomarker Expression Suggests Increased Cell Adhesion in Juvenile SSc, Increased Cytokine Expression in JDM, and an Intermediate Phenotype in Overlap Syndrome Patients
Location: Hall F1
Abstract Poster Presenter: Daniel Barnett, PhD, DO – UPMC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2479: REMS technology 5-y Imminent Fracture Risk in Systemic Sclerosis.
Location: Hall F1
Abstract Poster Presenter: Edmund MacLaughlin, MD – Rheumatology Associates of Delmarva
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2480: Respiratory Muscle Weakness in a Systemic Sclerosis Cohort
Location: Hall F1
Abstract Poster Presenter: Fabian Mendoza, MD – Thomas Jefferson University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2481: Prevalence and Trends of Suicidal Ideation Among Hospitalized Adults with Systemic Lupus Erythematosus (SLE): A National Inpatient Sample Analysis (2016–2020)
Location: Hall F1
Abstract Poster Presenter: Fatima Khdeir, MD – ECU Health Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2482: Characterizing Gastrointestinal Involvement in Systemic Sclerosis: Insights from the National Systemic sclerosis Progression INvestiGation (SPRING) Registry of the Italian Society of Rheumatology
Location: Hall F1
Abstract Poster Presenter: Francesco Bonomi, MD – University Hospital Careggi, Florence
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2483: Is There a Seasonal Variation in Raynaud’s Phenomenon Severity in Patients with Systemic Sclerosis?
Location: Hall F1
Abstract Poster Presenter: Gulsen Ozen, MD – University of Iowa Carver College of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2484: Phenotype of systemic sclerosis patients with positive anti–NOR-90 antibodies
Location: Hall F1
Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2485: Prevalence of progressive pulmonary fibrosis in systemic sclerosis-associated interstitial lung disease
Location: Hall F1
Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2486: In Vitro Antifibrotic Effects of Nerandomilast on Cell Types Relevant to Intestinal Remodeling and Fibrosis in Systemic Sclerosis
Location: Hall F1
Abstract Poster Presenter: Jochen SCHMITZ, n/a – Immunology & Respiratory Disease Research, Boehringer Ingelheim Pharmaceuticals, Inc
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2487: Cardiovascular and venous thromboembolic events in systemic sclerosis: Epidemiological analysis of the Clinical Practice Research Datalink
Location: Hall F1
Abstract Poster Presenter: John Pauling, PhD, BSc, FRCP, MBBCH – North Bristol NHS Trust & University of Bristol Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2488: Efficacy and Safety of Rituximab for Skin Involvement in Systemic Sclerosis: A Single-Center Study
Location: Hall F1
Abstract Poster Presenter: Kanako Chujo, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2489: Unraveling IPAF, VEDOSS and connective tissue diseases classifications through the mixed connective tissue disease spectrum
Location: Hall F1
Abstract Poster Presenter: Kevin Chevalier – Université Paris Cité
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2490: Unmasking Mortality Risk: The Impact of Systemic Sclerosis in Stress-Induced Cardiomyopathy
Location: Hall F1
Abstract Poster Presenter: Laura Rojo Grajales, MD – Nassau University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2491: High Prevalence of Autoimmunity and Cancer in Anti-NOR90-positive Patients: A Multicenter Observational Study
Location: Hall F1
Abstract Poster Presenter: Marina Dueñas Ochoa, MD (she/her/hers) – Hospital La Princesa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2492: Autoantibody Profiles and Disease Trajectories in Early Systemic Sclerosis: Insights from a Prospective Cohort
Location: Hall F1
Abstract Poster Presenter: Marzieh Jamali, MD (she/her/hers) – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2493: Investigating scoring systems to measure clinically relevant changes in systemic sclerosis-related finger acro-osteolysis over time, as assessed in serial hand radiographs
Location: Hall F1
Abstract Poster Presenter: Michael Hughes, PhD,MBBS,BSc,MSc,MRCP (he/him/his) – The University of Manchester
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2494: Abatacept Reduces CD319+ (SLAM-F7) Cytotoxic T Cells and Cytokine Production in Systemic Sclerosis
Location: Hall F1
Abstract Poster Presenter: Mikel Gurrea-Rubio, PhD – University of Michigan - Ann Arbor
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2495: IL-6/STAT3 Signaling is Central for Chemokine Production in E2-Induced Dermal Inflammation
Location: Hall F1
Abstract Poster Presenter: Nicolas Ancona, B.S. – MUSC Rheumatology & Immunology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2496: Comparing Long-term Outcome Across Systemic Sclerosis Subgroups Using a Multi-Organ Disease Progression Score
Location: Hall F1
Abstract Poster Presenter: Philip Yee, MD – UCL
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2497: Unraveling the Complexity of Interferon Responses in Peripheral Blood Mononuclear Cells in Systemic Sclerosis at Single-Cell Resolution
Location: Hall F1
Abstract Poster Presenter: Pietro Bearzi, MD – Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2498: Effect of autologous myeloablative hematopoietic stem cell transplantation on skin and peripheral blood mononuclear cells in systemic sclerosis patients with interstitial lung disease
Location: Hall F1
Abstract Poster Presenter: Poulami Dey, PhD – Michigan Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2499: Concomitant Anti-Ro/SSA Antibodies in Systemic Sclerosis Patients is Associated with Risks Beyond Dryness
Location: Hall F1
Abstract Poster Presenter: Rachael Gordon, MD, PhD – University of Pittsburgh
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2500: Greater Economic Burden and Healthcare Resource Utilization in Patients with Systemic Sclerosis With Versus Without Interstitial Lung Disease: Results from a Systematic Literature Review
Location: Hall F1
Abstract Poster Presenter: Roger Abramino Levy, MD, PhD – GSK, Rheumatology, Global Medical Affairs
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2501: Microvascular dysfunction contributes to hand bone deterioration in SSc patients
Location: Hall F1
Abstract Poster Presenter: Rosanna Campitiello, MD – University of Genoa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2502: Deciphering Systemic Sclerosis Phenotypes: A Novel Approach Using Clustering Algorithms and Proteomic Insights. Results from the PRECISESADS Study
Location: Hall F1
Abstract Poster Presenter: Santiago Dans Caballero, MD – H. U. Reina Sofía
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2503: Validation of a Composite Biomarker Score To Predict Modified Rodnan Skin Score: Insight From Autologous Stem Cell Transplantation International Scleroderma trial
Location: Hall F1
Abstract Poster Presenter: Stefano Rodolfi, MD – University College London
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2524: Rituximab in the Treatment of Susac Syndrome: Single Center Descriptive Study with a Large Susac Cohort
Location: Hall F1
Abstract Poster Presenter: Adam Brown, MD;BS – Cleveland Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2525: Point-of-Care Risk Factors for Systemic Disease in Patients Presenting with Small Vessel Vasculitis of the Skin
Location: Hall F1
Abstract Poster Presenter: Arjun Mahajan, MS – Harvard Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2526: Infection Risk Associated with Steroid-Sparing Therapies in GCA, PMR, and ANCA-Associated Vasculitis: A Systematic Review
Location: Hall F1
Abstract Poster Presenter: Divya Sudireddy, MBBS – Boston Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2527: Safety Profile and Impaired Humoral Response to the Recombinant Herpes Zoster Vaccine in Behçet’s Syndrome Patients under Immunosuppression: a Prospective, Randomized, Placebo-Controlled Trial
Location: Hall F1
Abstract Poster Presenter: Eduardo Borba, PhD – Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2528: Broad Screening of the Human Proteome Identifies a Cassette of Six Autoantigens that Distinguishes IgG4-Related Disease
Location: Hall F1
Abstract Poster Presenter: Federica Bonaso, MD – University of Brescia/MGH
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2529: IgG4-Related Disease Paravertebral and Ureteropelvic Mass Presentations are Linked to Specific Disease Features
Location: Hall F1
Abstract Poster Presenter: Federica Bonaso, MD – University of Brescia/MGH
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2530: Broad Screening of Inflammation-Associated Proteins Identifies Serum CCL19 and CCL2 as Versatile Biomarkers of Disease Activity in IgG4-Related Disease
Location: Hall F1
Abstract Poster Presenter: Federica Bonaso, MD – University of Brescia/MGH
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2531: Coronary periarteritis in IgG4-Related Disease
Location: Hall F1
Abstract Poster Presenter: Georges El Hasbani, MD – Mayo Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2532: Temporal arteritis revealing eosinophilic diseases: A multicenter retrospective study, literature review, and combined cluster analysis
Location: Hall F1
Abstract Poster Presenter: Julie Mérindol, MD (she/her/hers) – CHU de Nice
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2533: Patterns of skin lesion transcriptomics in different forms of vasculitis
Location: Hall F1
Abstract Poster Presenter: Karyssa Stonick, BS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2534: Frequency of Ocular and Gastrointestinal Lesions Is Increased in Japanese Behçet’s Disease Patients with HLA-B61
Location: Hall F1
Abstract Poster Presenter: Koichi Sugihara, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2535: Behçet’s syndrome: distinct features in 344 pediatric and adult patients in a non-endemic region
Location: Hall F1
Abstract Poster Presenter: Lucia Campos, MD, PhD (she/her/hers) – University of Sao Paulo Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2536: High Levels of Fatigue and Poor Sleep Quality in Behçet Disease: a Cross-sectional Study from a Non-endemic Area
Location: Hall F1
Abstract Poster Presenter: Mateus Nunes, MD – University of Campinas (UNICAMP)
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2537: Variation in Treatment Approaches in IgA-Vasculitis Among Pediatricians and Pediatric rheumatologists: A Cross-Sectional International Survey
Location: Hall F1
Abstract Poster Presenter: Merav Heshin Bekenstein, MD – Tel Aviv Medical Center Israel
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2538: Comparative Study of Two Classification Criteria Sets in Real Clinical Practice in Behçet’s Disease
Location: Hall F1
Abstract Poster Presenter: Rafael Gálvez Sánchez, Sr, MD – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2539: Patient-reported outcomes in patients with polymyalgia rheumatica under rheumatology care: baseline data from the ENRICH-PMR cohort
Location: Hall F1
Abstract Poster Presenter: Sebastian E. Sattui, MD, MS – University of Pittsburgh
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2540: Monocyte-to-High-Density Lipoprotein Cholesterol Ratio as a Clinical Marker of Gastrointestinal Involvement in Behçet Syndrome
Location: Hall F1
Abstract Poster Presenter: Seong Ryul Kwon, MD, PhD – Inha University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2541: Development of Severity Classification Criteria for Introduction of Infliximab for Chronic Pogressive Neuro-Behçet's Disease
Location: Hall F1
Abstract Poster Presenter: Shunsei Hirohata, MD – Nobuhara Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2542: A Rule Based NLP Pipeline for Glucocorticoid Exposure
Location: Hall F1
Abstract Poster Presenter: Simran Nimal, MBBS – Mayo Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2543: Severe Visual Impairment in Behçet Syndrome in Time: A Comparison of Four Time Periods
Location: Hall F1
Abstract Poster Presenter: Sinem Nihal Esatoglu, MD (she/her/hers) – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2544: Diagnostic value of vein wall thickness measurement for patients with suspected Behçet syndrome
Location: Hall F1
Abstract Poster Presenter: Sinem Nihal Esatoglu, MD (she/her/hers) – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2545: Prevalence, Clinical Correlations and Outcomes of Cryoglobulinemic Vasculitis: a Retrospective Monocentric Study (2013–2023)
Location: Hall F1
Abstract Poster Presenter: Valeria Manfrè, MD – Division of Rheumatology, Department of Medicine, University of Udine, Italy; Department of Medicine, Division of Rheumatology, University of Wisconsin - Madison, WI
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2546: Diagnostic Journey, Clinical Burden, And Quality Of Life Of Patients With IGg4-Related Disease: Results Of A Cross-Sectional Survey Of Patients And Physicians In The United States
Location: Hall F1
Abstract Poster Presenter: Yasmin Hernandez-Barco, MD – Massachusetts General Hospital, Harvard Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2547: Assessing the Reach of a Virtual Education Program: Lupus & You: Answers. Advocacy. Action
Location: Hall F1
Abstract Poster Presenter: Ashley Holden, BS, MEd (she/her/hers) – Lupus Foundation of America
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2548: Management of Uncontrolled Gout Among Rheumatologists: Findings from a Medical Chart Audit
Location: Hall F1
Abstract Poster Presenter: Bhavisha Desai, PharmD – Sobi
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2549: Perceived Dignity in Patients With Rheumatic Disease
Location: Hall F1
Abstract Poster Presenter: Braulio Avalos García, MS (he/him/his) – Universidad Autónoma de Nuevo Leon
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2550: Development of a ‘Training Toolkit’ to Support Advanced Practice Providers (APPs) Entry into a Rheumatology Musculoskeletal Ultrasound Subspecialty Clinic
Location: Hall F1
Abstract Poster Presenter: Christopher Estes, NP, RhMSUS – Massachusetts General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2551: Integrating Advanced Practice Providers into a Rheumatology Musculoskeletal Ultrasound Clinic: Enhancing Patient Access and Procedural Expertise
Location: Hall F1
Abstract Poster Presenter: Christopher Estes, NP, RhMSUS – Massachusetts General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2552: Effects of 360° Virtual Reality Embodiment Videos on Pain in Hand Osteoarthritis: A Within-Subject Pre-Post Study
Location: Hall F1
Abstract Poster Presenter: David Vo, OTD – Tufts University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2553: Impact of Polypharmacy on Treatment Adherence and Its Effect on The Quality of Life in Patients with Rheumatic Diseases
Location: Hall F1
Abstract Poster Presenter: Egla Sanchez-Peralta, MS (she/her/hers) – Universidad Autonoma de Nuevo Leon
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2554: Real-World Observations on Symptom Response and Tolerability of Intravenous Immunoglobulin in Patients with Inflammatory Myopathies through a Nurse-Led Outcomes Monitoring Program in a Home Infusion Setting
Location: Hall F1
Abstract Poster Presenter: Elizabeth Neal, RN – CSI Pharmacy
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2555: Ergonomic Modifications: Findings From the Making it Work^TM Systemic Sclerosis Program
Location: Hall F1
Abstract Poster Presenter: Janet Poole, PhD, OT, FAOTA – University of New Mexico
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2556: Information Needs of Patients with Vasculitis
Location: Hall F1
Abstract Poster Presenter: Jodi Hall, BA (she/her/hers) – Vasculitis Foundation
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2557: Relationship Between Sleep Quality and Psychiatric Symptoms in Autoimmune Rheumatic Diseases
Location: Hall F1
Abstract Poster Presenter: Karen Ramos-Reza, MD (she/her/hers) – Hospital Universitario "Dr. José Eluterio González"
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2558: Impact of Social Determinants of Health on Patient Perceptions of Home Infusion Therapy in the Treatment of Rheumatologic Conditions
Location: Hall F1
Abstract Poster Presenter: Leslie Myers, PharmD – CSI Pharmacy
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2559: Increasing Clinical Trial Awareness in Sample of Underrepresented Systemic Lupus Erythematosus Patients
Location: Hall F1
Abstract Poster Presenter: Leslie Ranken, MD (she/her/hers) – Atrium Health Wake Forest University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2560: Quality and Accuracy of TikTok Videos on Axial Spondyloarthritis: A Modified DISCERN Analysis
Location: Hall F1
Abstract Poster Presenter: Mahiar Rabie, MD, MS (he/him/his) – University of Tennessee- Nashville
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2561: Patient-Centricity: The Keystone to Recruitment and Retention of Research Participants for the Lupus Landmark Study and the Success of the Lupus Nexus
Location: Hall F1
Abstract Poster Presenter: Mary Jo Fekete, MS – Lupus Research Alliance
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2562: Enhancing Hand Osteoarthritis Classification with Generative AI: A CycleGAN and EfficientNetB7 Approach
Location: Hall F1
Abstract Poster Presenter: Ming Zhang, PhD – Boston University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2563: Factors Associated With Medication Use in the Preconception and Perinatal Period Among Women With Autoimmune Disorders: A Systematic Review
Location: Hall F1
Abstract Poster Presenter: Olivia Novosel, BSc – Temerty Faculty of Medicine, University of Toronto
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2564: An Illustration-based Patient-reported Outcome Measure Reveals Concealed Symptoms in Patients with Rheumatoid Arthritis and the Factor Contributing to the Discrepancy Between Patient and Evaluator Global Assessments
Location: Hall F1
Abstract Poster Presenter: Tetsuya Tomita, MD – Morinomiya University of Medical Sciences
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2565: Assessing Participation in the Lupus Sister Circle Support Group
Location: Hall F1
Abstract Poster Presenter: Wendy Rodgers, MPH – Lupus Foundation of America
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2566: Using Abdominal CT-Derived Bone Mineral Density and Psoas Volume for Opportunistic Osteoporosis Screening and Fracture Risk Assessment
Location: Hall F1
Abstract Poster Presenter: Ye Liu, MD, MPH, DrPH – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM57: Mysteries of the Brain: A case of Cognitive Impairment and Hearing Loss
Location: Hall F1
Thieves Market Poster Presenter: Aakritee Sharma Subedi, MBBS – SUNY Upstate Medical University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM58: Second Hits and Hidden Scripts: Headache Edition
Location: Hall F1
Thieves Market Poster Presenter: Londyn Robinson, MD – University of Washington
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM59: Autoimmunity By Proxy: a Case Requiring a Rheumatologic Lens
Location: Hall F1
Thieves Market Poster Presenter: Sophia Lutgen, MD – Mount Sinai Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM60: It’s More Than Skin Deep
Location: Hall F1
Thieves Market Poster Presenter: Molly Leavitt, MD – University of South Florida
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM61: Lumps, Bumps, and Diagnostic Stumps
Location: Hall F1
Thieves Market Poster Presenter: Michael Miller, MD – University of Iowa Hospitals and Clinics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM62: The Mystery of Headaches and Brain Aneurysms: a complex tale
Location: Hall F1
Thieves Market Poster Presenter: Ahmed Abuyakoub, MD – Cleveland Clinic Foundation
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM63: Something’s About to Snap…
Location: Hall F1
Thieves Market Poster Presenter: Shaurav Khanna, MD, MBBS (he/him/his) – PD Hinduja Hospital and Medical Research Centre
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM64: Still Waters Run Deep:A Storm Beneath The Smile
Location: Hall F1
Thieves Market Poster Presenter: Alex Tinianow, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM65: DIP Deformities: A Triple Threat Differential Diagnosis
Location: Hall F1
Thieves Market Poster Presenter: Griffin Reed, MD – Mayo Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM66: All That Glitters Is Not Gold – the Masquerader in the Cord
Location: Hall F1
Thieves Market Poster Presenter: Aashish Agrawal, MD, MBBS – Hinduja Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM67: A Mystifying Mass Effect
Location: Hall F1
Thieves Market Poster Presenter: Lily Sung, MD (she/her/hers) – Stanford University Hospital & Clinics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM68: A Case of Recurrent Flames
Location: Hall F1
Thieves Market Poster Presenter: Freya Shah, MD (she/her/hers) – NYMC/Landmark Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM69: A Misleading Malignant Malady
Location: Hall F1
Thieves Market Poster Presenter: Koushan Kouranloo, MBChB, MRCP – Guy's & St Thomas' NHS Foundation Trust
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM70: Echoes in the Bone: A Silent Evolution
Location: Hall F1
Thieves Market Poster Presenter: Gunasree Ediga, MD – KIMS HOSPITALS
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM71: The Skin Stiffens, the Plot Thickens
Location: Hall F1
Thieves Market Poster Presenter: Lauren He, MD – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM72: Puzzling Palpitations: A Rare Culprit Behind Arrhythmia and Heart Failure
Location: Hall F1
Thieves Market Poster Presenter: Adil Vural, MD – Cleveland Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM73: Two Nodules and The Invisible Guest
Location: Hall F1
Thieves Market Poster Presenter: Jia Li, MD, PhD (she/her/hers) – Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM74: Behind the Loss
Location: Hall F1
Thieves Market Poster Presenter: Mery Deeb, MD – Brown University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM75: A War Beneath the Skin
Location: Hall F1
Thieves Market Poster Presenter: Kuan-Tung Lin, MD – North East Medical Services
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM76: The Immunosuppression Inheritance: A Delayed Reckoning
Location: Hall F1
Thieves Market Poster Presenter: Kavita Krishna, MD (she/her/hers) – Bharati Vidyapeeth University Medical College and Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM77: When Fever Hides a Deeper Weight
Location: Hall F1
Thieves Market Poster Presenter: Hareem Farooq, MBBS (she/her/hers) – University of Alabama, Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM78: A Glimpse of Trouble
Location: Hall F1
Thieves Market Poster Presenter: Ruoning (Lemon) Ni, MD, RhMSUS (she/her/hers) – University of Iowa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM79: The Hidden Choreography: When Joints Ache, Skin Cries, and the Heart Strains
Location: Hall F1
Thieves Market Poster Presenter: Manush Sondhi, MD (he/him/his) – University of Washington
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
TM80: Mystery of the Mass
Location: Hall F1
Thieves Market Poster Presenter: Raeann Bowman, MD – University of Alabama Birmingham / UT Southwestern
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1779: Citrullinated and Malondialdehyde-Acetaldehyde Modified Fibrinogen Activates Macrophages and Induces Inflammatory Responses in Coronary Endothelium
Location: Hall F1
Abstract Poster Presenter: Wenxian Zhou, BS – University of Nebraska Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1809: Mass Spectrometry-Based N-Terminomics Uncovers Proteolytic Signatures and Pathways in Juvenile Idiopathic Arthritis Synovial Fluid
Location: Hall F1
Abstract Poster Presenter: Andrew Zeft, MD, MPH – Cleveland Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1860: GLUT and FAPα as molecular imaging markers for interstitial lung disease in systemic sclerosis
Location: Hall F1
Abstract Poster Presenter: Bo Broens, MD – Amsterdam UMC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2003: Evaluating Patient Outcomes Pre and Post Pegloticase Initiation among Uncontrolled Gout Patients: Findings from MORE² Registry and Medicare Fee-For-Service Claims Data
Location: Hall F1
Abstract Poster Presenter: Julia Buchfuhrer, DO – JB Arthritis and Rheumatology Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2200: Obstetric and Neonatal Complications in Women living with Axial Spondyloarthritis: a population-based, matched cohort study
Location: Hall F1
Abstract Poster Presenter: Sinead Maguire, PhD, MB, MRCP, BAO – Our Lady's Hospital Navan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2295: Autoantibody Profiles and Their Association with Organ Involvement in Primary Sjögren’s Syndrome: Insights from ESSDAI
Location: Hall F1
Abstract Poster Presenter: Deepak Rath, MD, MBBS, DM – John H Stroger Hospital Jr of Cook County, Chicago, Illinois 60612
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2307: Peripheral Manifestations In Axial And Peripheral Spondyloarthritis: A Systematic Literature Review On Their Assessment In Clinical Trials
Location: Hall F1
Abstract Poster Presenter: AUGUSTA ORTOLAN, MD, PhD, MSc – Policlinico Universitario Agostino Gemelli IRCSS
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2512: Contribution of the CALLY index at diagnosis to early prediction of all-cause mortality in patients with ANCA-associated vasculitis
Location: Hall F1
Abstract Poster Presenter: Jang Woo Ha, MD – Yonsei university college of medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1771: Interferon- α, Anti-Interferon-Alpha Antibodies and Disease Activity in Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Gollakota Nandita, MBBS/MD – NIMS, Hyderabad
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1822: The Circulating Immune Profile of Systemic JIA Patients with HLA-DRB1*15 alleles, Eosinophilia, and Lung Disease
Location: Hall F1
Abstract Poster Presenter: Jennifer Cheng, BA – Boston Children's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1857: Role of autoantigen-specific reactivity in the pathogenesis of murine interstitial lung disease model with anti-MDA5 antibody mouse model
Location: Hall F1
Abstract Poster Presenter: Atsubumi Ogawa, MD – Kyoto University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1992: Tolerance of Methotrexate Coadministered with Pegloticase in Patients with Uncontrolled Gout: Findings from MIRROR RCT
Location: Hall F1
Abstract Poster Presenter: Brian LaMoreaux, MD;MS – Amgen, Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1998: Reduction in Tophi Observed in Patients with Uncontrolled Gout Treated with NASP: Results from Phase 3 DISSOLVE Studies
Location: Hall F1
Abstract Poster Presenter: Herbert Baraf, MD, FACP, MACR – National Institute of Arthritis and Musculoskeletal and Skin Diseases
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2201: Adherence to Reproductive Health Guidelines in Lupus Care: Insights from Patient and Physician Surveys
Location: Hall F1
Abstract Poster Presenter: Akhil Sood, MD, MS – Washington University in St. Louis
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2229: National Multicenter study of Baricitinib in Rheumatoid Arthritis - Interstitial Lung Disease: effectiveness and progressive lung disease
Location: Hall F1
Abstract Poster Presenter: Ana Serrano-Combarro, MD – Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, Inmunopathology group, Santander
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2523: Predictors of Glucocorticoid-Free Clinical Remission at Week 48 in Newly Diagnosed Microscopic Polyangiitis and Granulomatosis with Polyangiitis: from nation-wide registry in Japan (J-CANVAS)
Location: Hall F1
Abstract Poster Presenter: Yusuke Ushio, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1819: Spatial Transcriptomic Profiling Reveals Interferon Activation and CD8⁺ T Cell Dominance in Systemic Juvenile Idiopathic Arthritis-Macrophage Activation Syndrome Liver Inflammation
Location: Hall F1
Abstract Poster Presenter: Esraa Eloseily, MD, MSc – UT Southwestern Children's Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1856: Spatial Proteomic-based Phenotyping of Fibroblast Populations and their Microenvironment in Systemic Sclerosis Primary Heart Involvement
Location: Hall F1
Abstract Poster Presenter: Andrea-Hermina Györfi, MD – Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1982: Bridging the Gap in Underserved Care: A Quality Improvement Initiative to Increase Pneumococcal Vaccination Rates in Immunocompromised Rheumatology Patients
Location: Hall F1
Abstract Poster Presenter: Kuan-Tung Lin, MD – North East Medical Services
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1993: Risk of Cardiovascular Conditions, Bone Fractures and Mortality in Patients with Uncontrolled Gout in Comparison to Those with Controlled Gout
Location: Hall F1
Abstract Poster Presenter: Brian LaMoreaux, MD;MS – Amgen, Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2223: Improving collaboration between rheumatology and OBGYN in the reproductive health care of patients with rheumatic disease
Location: Hall F1
Abstract Poster Presenter: Sara Heard, DO – University of Vermont Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2261: Palindromic Rheumatism and Predictors of Progression to Rheumatoid Arthritis: Experience from a Tertiary Care Center in Northern India
Location: Hall F1
Abstract Poster Presenter: Sryla Punjadath, MBBS, MD (she/her/hers) – All India Institute of Medical Sciences, Rishikesh
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2513: Beyond Clinical trials in Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review of effectiveness and safety data derived from real-world evidence of Mepolizumab 300 mg
Location: Hall F1
Abstract Poster Presenter: Maria Cid, MD (she/her/hers) – Hospital Clinic Barcelona. University of Barcelona
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1820: Cytokine profiling in refractory systemic juvenile idiopathic arthritis reveals distinct signatures for macrophage activation syndrome and lung disease.
Location: Hall F1
Abstract Poster Presenter: Grant Schulert, MD, PhD – Cincinnati Children's Hospital Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1867: Deciphering the Molecular Landscape of the Small Intestine in Early and Late SSc Using High-Definition Spatial Transcriptomics
Location: Hall F1
Abstract Poster Presenter: Laura Much, MSc – Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1980: Improving Vaccination Rates in the Rheumatology Clinic
Location: Hall F1
Abstract Poster Presenter: Kajal Patel, DO – Prisma Health Rheumatology Fellowship Program
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2009: Value of New PREVENT Calculator in Detecting Cardiovascular Disease in Patients with Gout
Location: Hall F1
Abstract Poster Presenter: Patrick Williamson, MD (he/him/his) – UAB Internal Medicine Residency
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2217: Improving Patient Counseling on Medication Safety During Reproductive Years
Location: Hall F1
Abstract Poster Presenter: Lauren He, MD – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2247: A Pilot Study to Identify Novel Autoantibody Biomarkers in Rheumatoid Arthritis (RA) Patients Using Immunome Protein Array
Location: Hall F1
Abstract Poster Presenter: Margaret Ma, MD,PhD – National University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2507: Reporting of infectious and hepatic adverse events with avacopan: insights from the World Health Organization pharmacovigilance database (VigiBase)
Location: Hall F1
Abstract Poster Presenter: Camille Mettler, MD – APHP, Service de Médecine Interne, Hôpital Bichat
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1823: Genome-Wide DNA Methylation Analysis in Familial Mediterranean Fever
Location: Hall F1
Abstract Poster Presenter: Kader Cetin Gedik, MD – UPMC Children's Hospital of Pittsburgh/University of Pittsburgh
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1861: Accelerated and Gene-specific Patterns of Clonal Hematopoiesis Distinguish Subtypes of Systemic Sclerosis
Location: Hall F1
Abstract Poster Presenter: Brecca Miller, n/a (she/her/hers) – Center for Human Genetics and Genomics, NYU Grossman School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1999: Characterization of Infusion Reactions Within 1 Hour of Treatment With Nanoencapsulated Sirolimus Plus Pegadricase: Pooled Results From the Phase 3 DISSOLVE I and DISSOLVE II Trials
Location: Hall F1
Abstract Poster Presenter: Herbert Baraf, MD, FACP, MACR – National Institute of Arthritis and Musculoskeletal and Skin Diseases
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2220: Human Milk Fatty Acid Profiles Among Breastfeeding Mothers With and Without Systemic Autoimmune Rheumatic Diseases
Location: Hall F1
Abstract Poster Presenter: Rashmi Dhital, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2242: Analysis of Bronchoalveolar Fluid Cytokine Profile as a Way to Understand the Lung Disease Associated with Systemic Juvenile Idiopathic Arthritis
Location: Hall F1
Abstract Poster Presenter: Ivanna Romankevych, MD, PhD – Cincinnati Children's Hospital Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2519: A Disproportionality Analysis of FDA Adverse Event Reporting System (FAERS) Events for Avacopan
Location: Hall F1
Abstract Poster Presenter: Shiamak Cooper, MD – Rochester General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1827: Transcriptomics and Machine Learning Unraveling the Molecular Drivers of PFAPA Flares
Location: Hall F1
Abstract Poster Presenter: Sivia Lapidus, MD – Hackensack University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1870: Paracrine WNT Signaling Modulates Profibrotic Macrophage Metabolic Activation in Systemic Sclerosis
Location: Hall F1
Abstract Poster Presenter: Patricia Pioli, PhD – Geisel School of Medicine at Dartmouth
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1914: Performance Comparison of Artificial Intelligence tools ChatGPT, Bing AI, and Google Bard for Clinical Rheumatology Decision Support: When AI Talks Rheumatology
Location: Hall F1
Abstract Poster Presenter: Aakanksha Pitliya, MD (she/her/hers) – Mercy Catholic Medical Center, Darby, PA
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1981: High Patient Satisfaction with a Medication Education Program: Program to Understand Rheumatology Medications with Pharmacist Led Education
Location: Hall F1
Abstract Poster Presenter: Kami Roake, PharmD (she/her/hers) – University of Utah
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2224: Failure of Steroid and Antimalarial Therapy to Normalize Placental Interferon and Angiogenic Gene Expression in SLE
Location: Hall F1
Abstract Poster Presenter: Seemal Faisal, MD, MBBS (she/her/hers) – LSU New Orleans
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2505: Avacopan is Not Associated With An Increased Risk of Infection Compared to Glucocorticoids in Patients with ANCA-Associated Vasculitis
Location: Hall F1
Abstract Poster Presenter: Beatriz Maria Franco Hondermann, MD (she/her/hers) – Loyola University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1826: Single Nuclei Multiome of JDM Muscle Biopsies Reveals Novel Upregulation of Inflammatory and Vascular Pathways
Location: Hall F1
Abstract Poster Presenter: Shannon O'Connor, MD, PhD – Cincinnati Children's Hospital Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1973: Evaluating the Impact of Clinical Pharmacist Integration on Patient Care Outcomes in a Private Rheumatology Clinic
Location: Hall F1
Abstract Poster Presenter: Brittany Panico, DO – Summit Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2007: Machine Learning-Based Prediction of Gout Onset in Individuals with Asymptomatic Hyperuricemia Using a Common Data Model
Location: Hall F1
Abstract Poster Presenter: Min Jung Kim, MD – Seoul Metropolitan Government Boramae Medical center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2222: Neonatal Myocardial Strain in Offspring born to Mothers with Systemic Lupus Erythematosus: Pilot Data from the LEGACY Cohort
Location: Hall F1
Abstract Poster Presenter: Reem Farhat, MD – McGill University, Faculty of Medicine and Health Sciences
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2249: Evaluation of a Screening Tool for Identifying Risk of Subclinical Interstitial Lung Disease in Rheumatoid Arthritis Patients Treated with Targeted Therapies
Location: Hall F1
Abstract Poster Presenter: Marina Pavía Pascual, MD – Hospital General Universitario Gregorio Marañón
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2518: Impact of psychiatric comorbidity on disease outcomes in ANCA-associated vasculitis: A multi-center retrospective cohort study
Location: Hall F1
Abstract Poster Presenter: Saloni Patel, BS (she/her/hers) – Johns Hopkins University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1824: Tissue-Resident Natural Killer Cells May Drive Monocyte Differentiation And Macrophage Accumulation In The Inflamed Joints Of Pediatric Juvenile Idiopathic Arthritis Patients
Location: Hall F1
Abstract Poster Presenter: Roselyn Fierkens, BS – University of Colorado-Anschutz Medical Campus
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1875: Fcγ-receptor activation by circulating immune complexes in autoimmunity and CD19.CAR-T cell therapy
Location: Hall F1
Abstract Poster Presenter: Wolfgang Merkt, MD – University Hospital Düsseldorf
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1984: Improving Lipid Screening Rates in Rheumatic Disease Patients: An Academic Fellowship Quality Improvement Project
Location: Hall F1
Abstract Poster Presenter: Mahnoor Javed, DO – Houston Methodist
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2010: Innate Transcriptional Response and Control of Expression of the Gout-Associated Colony Stimulating Factor-1 (CSF1) and CSF1 Receptor (CSF1R) Genes to Stimuli
Location: Hall F1
Abstract Poster Presenter: Tony Merriman, PhD – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2221: Racial Differences in Cardiovascular Events and Adverse Pregnancy Outcomes Among Pregnant Individuals With Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: Rashmi Dhital, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2236: Treatment-induced autoantibodies in Rheumatoid Arthritis patients receiving anti-TNF inhibitors or JAK inhibitors
Location: Hall F1
Abstract Poster Presenter: EVRIPIDIS KALTSONOUDIS, MD (he/him/his) – Medical School of Ioannina
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2506: Timing, Management, and Outcomes of Venous Thromboembolic Events in ANCA-Associated Vasculitis: A Retrospective Cohort Study
Location: Hall F1
Abstract Poster Presenter: Bruno Marchetti, MD – Internal Medicine, Turin
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1828: CD14+CXCL10+Monocytes Remodel the Peripheral Immune Network in sJIA via UBE2D1-Driven Inflammatory Programming
Location: Hall F1
Abstract Poster Presenter: Xuemei Tang, MD, Professor, Chief Physician – Department of Rheumatology and Immunology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1863: bag3 in Systemic Sclerosis: Possible Therapeutic Target and Biomarker for Pulmonary Fibrosis
Location: Hall F1
Abstract Poster Presenter: Claudia Iannone, MD – University of Milan, Gaetano Pini CTO
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1987: Evaluating User Engagement and Real-World Impact of a PMR-Specific Digital Symptom Assessment Tool: A 12-Month Analysis of PainSpot™
Location: Hall F1
Abstract Poster Presenter: Shilpa Venkatachalam, PhD;MPH – Global Healthy Living Foundation
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2004: Characteristics and Management of Gout Patients Under Rheumatologist Care from Low-Income and Middle-Income Asia-Pacific Countries: Data from the APLAR Gout Registry
Location: Hall F1
Abstract Poster Presenter: Kanon Jatuworapruk, MD – Thammasat University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2207: Menopause Experiences of Veterans from Minoritized Populations with Rheumatoid Arthritis
Location: Hall F1
Abstract Poster Presenter: Catherine Sims, MD – Duke University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2259: Lung Transplant Outcomes in Patients with Rheumatoid Arthritis Associated Interstitial Lung Disease Compared to Idiopathic Pulmonary Fibrosis: A Multicentric Retrospective Analysis and Meta-analysis
Location: Hall F1
Abstract Poster Presenter: Saud AlHajeri, MBChB – UBC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2508: Patient-Reported Outcomes in ANCA-Associated Vasculitis: Early Findings from a Prospective Real-World Cohort
Location: Hall F1
Abstract Poster Presenter: Colebrook Johnson, BA – Massachusetts General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1815: New-Onset Juvenile Spondyloarthritis is Characterized by Bone Metabolism Disturbances with Biomarker Potential
Location: Hall F1
Abstract Poster Presenter: Brittney Newby, MD;PhD (she/her/hers) – Children's Hospital of Philadelphia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1872: High-throughput Screening Uncovers Distinct Molecular Signatures Linked with HRCT Patterns in SARD-ILD
Location: Hall F1
Abstract Poster Presenter: Philip Stauffer, PhD – University of Zurich Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1979: Utility of ALT/AST and Fibrosis-4 Index (FIB-4) Score in Monitoring Methotrexate Hepatotoxicity in Rheumatologic Disease: A Retrospective Analysis
Location: Hall F1
Abstract Poster Presenter: Julia Wajsberg, DO – University Hospitals
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2005: Elevated Serum Uric Acid as an Independent Risk Factor for Multiple Stent Placement in Non-Hypertensive, Non-Diabetic Patients with Coronary Artery Disease: A Retrospective Cohort Analysis
Location: Hall F1
Abstract Poster Presenter: Lemei An, MD – Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2208: Contraception and Pregnancy Experiences of Veterans from Minoritized Populations with Rheumatoid Arthritis
Location: Hall F1
Abstract Poster Presenter: Catherine Sims, MD – Duke University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2258: Clinical Associations of Pulmonary Hypertension in RA Patients with and Without Interstitial Lung Disease
Location: Hall F1
Abstract Poster Presenter: Sanjita Gowda, MD (she/her/hers) – Cedars-Sinai Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2514: Comparison of Demographics and Outcomes of Inpatient Hospitalization of Severe Asthma Patients with Eosinophilic Granulomatosis with Polyangitis. A Study on the National Inpatient Sample Database
Location: Hall F1
Abstract Poster Presenter: Prakriti Subedi, MD – St. Barnabas Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1813: Frequency of Tissue-Specific Activated CD8+ T Cells is Correlated To Disease Severity in Juvenile Idiopathic Arthritis
Location: Hall F1
Abstract Poster Presenter: Abigail Thielbar, BS – Cincinnati Children's Hospital Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1864: Mitochondrial Dysfunction Drives cGAS-STING–Mediated Type I Interferon Production and Fibrosis in Systemic Sclerosis
Location: Hall F1
Abstract Poster Presenter: Giulio Forte, n/a – Università della Campania Luigi Vanvitelli
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1977: The Westergren Sedimentation Rate: To Be or Not to Be! The Westergren Sedimentation Rate is being “Killed” but has not “Died”.
Location: Hall F1
Abstract Poster Presenter: John Goldman, MD, MACR (he/him/his) – Parris and Associates
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1990: Pilot Study: Testing the Accuracy of a Capillary Point-of-Care Device Compared to Traditional Venous Analysis for Serum Urate Measurements Among Patients with Gout
Location: Hall F1
Abstract Poster Presenter: Alex Tinianow, MD – Vanderbilt University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2095: Trends in Mortality and Disability-Adjusted Life Years (DALYs) from Osteoarthritis in the United States Compared to Global Estimates: A GBD-Based Analysis (1990–2021)
Location: Hall F1
Abstract Poster Presenter: Khadija Mohib, MD – Kirk Kerkorian School of Medicine at UNLV
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2219: Transcriptomic and Immune Landscape of Recurrent Pregnancy Loss and Unexplained Infertility in Systemic Lupus Erythematosus
Location: Hall F1
Abstract Poster Presenter: noe macias-segura, PhD, MSc (he/him/his) – UANL
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2232: Risk factors for hospitalizations in a large, contemporary rheumatoid arthritis patient cohort
Location: Hall F1
Abstract Poster Presenter: Argyro Lazarini, MSc (she/her/hers) – National and Kapodistrian University of Athens
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2520: Evolution in Risk Stratification for Renal Outcomes in ANCA-Associated Vasculitides Using Established Scores and Histopathological Criteria in a Large European Cohort
Location: Hall F1
Abstract Poster Presenter: Thomas Neumann, MD – Kantonsspital St. Gallen
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1778: Towards an Earlier and Accurate Diagnosis of Connective Tissue Disease-related Interstitial Lung Disease: TGFB Isoform Genes as Upcoming Biomarkers
Location: Hall F1
Abstract Poster Presenter: Verónica Pulito Cueto, PhD – IDIVAL
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1812: Inflammasome and UPR activation in monocytes of HLA B27 positive children with Enthesitis related arthritis category of JIA
Location: Hall F1
Abstract Poster Presenter: Shivika Guleria, MSc – SGPGIMS, Lucknow
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1866: Elucidating gastric pathology in systemic sclerosis using single-cell RNA sequencing
Location: Hall F1
Abstract Poster Presenter: Kristina Clark, PhD, MBBS, MRCP – University of Oxford
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1921: Re-escalation of Treatment in Older Adults with Rheumatoid Arthritis After Anti-TNF Therapy De-escalation
Location: Hall F1
Abstract Poster Presenter: Jiha Lee, MD, MHS – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1978: Utilizing a Gap to Target Function in the Pediatric Rheumatology Care and Outcomes Improvement Network Registry Dashboard of Quality Measures
Location: Hall F1
Abstract Poster Presenter: Julia Harris, MD – Children's Mercy Kansas City
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1994: Pharmacokinetics of Ready-to-Use Pegloticase Formulation Compared to Standard Pegloticase Dosing: Data from the AGILE Study
Location: Hall F1
Abstract Poster Presenter: Brian LaMoreaux, MD;MS – Amgen, Inc.
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2198: Sociocultural Influences on Pregnancy Planning for Individuals Diagnosed with SLE in an Urban Hispanic Population: A Qualitative Study with Considerations for a Holistic Approach
Location: Hall F1
Abstract Poster Presenter: Leanna Wise, MD, MPH – LAGMC/Keck Medicine of USC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2228: COVID-19 Outcomes in Rheumatoid Arthritis Patients Prescribed Biologic vs. Conventional DMARDs: A Propensity-Matched Analysis
Location: Hall F1
Abstract Poster Presenter: Chase Verdugo, -None- (he/him/his) – University of Arizona College of Medicine Tucson
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2294: Comparative Analysis of Patients Included in Trials Utilizing Biologic Drugs in the Treatment of Primary Sjögren’s Syndrome
Location: Hall F1
Abstract Poster Presenter: Carlota Navarro Joven, -None- – Hospital Universitario de Fuenlabrada
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2521: DANGER Score as Predictor of Mortality in ANCA-Associated Vasculitis with or without Glomerulonephritis: Data from the Almenara Vasculitis Cohort
Location: Hall F1
Abstract Poster Presenter: Victor Pimentel-Quiroz, MD (he/him/his) – Universidad Científica del Sur
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1829: Multiomic Investigation of Juvenile Idiopathic Arthritis Synovium Reveals Immune Cell Heterogeneity
Location: Hall F1
Abstract Poster Presenter: Yuriy Baglaenko, PhD – Cincinnati Children's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1874: Neutrophil Extracellular Trap-Rich Systemic Sclerosis Plasma Promotes Microvascular Endothelial Cell Proliferation and Migration: Implications for Aberrant Angiogenesis
Location: Hall F1
Abstract Poster Presenter: Wenying Liang, PhD, MBBS – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1997: Bone health in patients with gout using real-world U.S. data
Location: Hall F1
Abstract Poster Presenter: Emily Holladay, MPH – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2226: Factors Associated with Contraceptive Counseling by Rheumatologists for Reproductive-Aged Female Patients Prescribed Teratogenic Medications
Location: Hall F1
Abstract Poster Presenter: Yongjay Kim, BA – Cornell University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2510: Impact of ANCA specificity on risk of severe infection occurrence in ANCA-associated vasculitis.
Location: Hall F1
Abstract Poster Presenter: Gregory Pugnet, MD,PhD (he/him/his) – CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1814: Trapped in the NET: Impaired DNase function and targeted antibodies in the pathogenesis of pediatric lupus nephritis
Location: Hall F1
Abstract Poster Presenter: Bharati Matta, PhD, MBA – The Feinstein Institutes for Medical Research
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1868: Global Downregulation of Fli1 in Mice Induces Cardiac Dysfunction via Enhanced β-fatty acid Oxidation and Collagen Deposition
Location: Hall F1
Abstract Poster Presenter: Moyo Mudhibadhi, PhD (he/him/his) – Boston University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1926: Real World Rate of Efficacy of Adalimumab Biosimilars Following a Mandated Switch in an Academic Medical Center
Location: Hall F1
Abstract Poster Presenter: Katharine McCarthy, PharmD – University of Rochester Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1974: Serial ferritin as a diagnostic surrogate marker in Hemophagocytic Lymphohistiocytosis (HLH), a retrospective single-center study
Location: Hall F1
Abstract Poster Presenter: Chen Chao, MD, MBA – Montefiore Medical Center/Albert Einstein College of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1995: The Prevalence of Multimorbidity and Polypharmacy Among US Adults with Gout: A General Population-Based Study
Location: Hall F1
Abstract Poster Presenter: Chio Yokose, MD, MSc (she/her/hers) – Massachusetts General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2209: Pregnancy outcomes in Systemic Lupus Erythematosus: Insights from a multicenter Spanish Study on the impact of antiphospholipid antibodies and APS
Location: Hall F1
Abstract Poster Presenter: Cristiana Sieiro Santos, MD – Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2335: The 14-3-3 eta AAb biomarker improves discriminative performance of CRP and HLA-B27 to differentiate people with radiographic axSpA from those with mechanical back pain.
Location: Hall F1
Abstract Poster Presenter: Walter P P. Maksymowych, MD, FRCPC, MRCP, FACP – University of Alberta
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2522: Clinical Outcomes and Prognostic Impact of Cardiac and Cerebrovascular Involvement in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Study
Location: Hall F1
Abstract Poster Presenter: Yuko Shirota, MD., PhD., – Tohoku Medical and Pharmaceutical University / Department of Hematology and Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1859: Unraveling Disparities in Systemic Lupus Erythematosus-Related Mortality Among U.S. Adults (≥25 Years) with Malignancy: A Longitudinal Analysis of Gender, Race, and Geographic Inequities Using CDC WONDER (1999–2020)"
Location: Hall F1
Abstract Poster Presenter: Ayesha Khan, n/a – Dow Medical College
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1975: Baseline QTc Screening and Monitoring Among SARD Patients with High Cardiovascular Risks on Hydroxychloroquine Based on 2021 ACR Consensus: A Quality Improvement Project
Location: Hall F1
Abstract Poster Presenter: Cristine Arcilla, MD (she/her/hers) – Lakeland Regional Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2013: Efficacy and Safety of Firsekibart in Acute Gouty Arthritis Patients with Limited Treatment Options: A Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Phase III Trial
Location: Hall F1
Abstract Poster Presenter: Yu Xue, MD – Huashan Hospital,Fudan University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2214: Hydroxychloroquine and Pregnancy Outcomes in Lupus: Results from a population-based cohort study
Location: Hall F1
Abstract Poster Presenter: Julia Simard, MSc, ScD – Stanford Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2250: Clinical and Serological Predictors of Interstitial Lung Disease in Rheumatoid Arthritis: Are Anti-Citrullinated Protein Antibodies Truly Relevant?
Location: Hall F1
Abstract Poster Presenter: Martí Aguilar Coll, MD – Hospital Universitari de Bellvitge
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1873: TGF-β-Driven Mitochondrial Stress Activates cGAS-STING Signalling via Impaired Mitophagy in Systemic Sclerosis Endothelial Cells
Location: Hall F1
Abstract Poster Presenter: Stefano Di Donato, MD – University of Leeds
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1988: Advancing Vascular Assessment: Combining NIRS-VOT and Ultrasound-based Brachial Artery Diameter for Improved Diagnostics in Healthy Controls and APS
Location: Hall F1
Abstract Poster Presenter: Soongho Park, PhD – NIH
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1996: Hospital Burden of Crystal-related Arthritis in Spain: a nationwide dataset of 183,001 inpatients.
Location: Hall F1
Abstract Poster Presenter: Cristina Rodríguez Alvear, III, -None- – Hospital Doctor José Molina Orosa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2202: Epidemiologic Evaluation of Postpartum Mental Health for Women Living with Systemic Lupus Erythematosus: A Population-Based Cohort Study Among Medicaid Enrollees
Location: Hall F1
Abstract Poster Presenter: Alyssa Howren, PhD, MSc – Stanford University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2252: Association Between Frailty and Survival Among Older Adults with Rheumatoid Arthritis and Lung Cancer
Location: Hall F1
Abstract Poster Presenter: Michelle Nguyen, MD – University of Washington
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2014: Efficacy and Safety of Firsekibart in Acute Gouty Arthritis Patients with eGFR < 60ml/min/1.73m²:A Post-Hoc Analysis of 24-Week Data
Location: Hall F1
Abstract Poster Presenter: Yu Xue, MD – Huashan Hospital,Fudan University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2014: Efficacy and Safety of Firsekibart in Acute Gouty Arthritis Patients with eGFR < 60ml/min/1.73m²:A Post-Hoc Analysis of 24-Week Data
Location: Hall F1
Abstract Poster Presenter: Yu Xue, MD – Huashan Hospital,Fudan University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2205: Effectiveness of Reproductive Health Counseling for Rheumatology Patients
Location: Hall F1
Abstract Poster Presenter: Caroline Maretz, MD – University of Colorado
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2000: Can Uric Acid Protect Joints? Lower Incidence of Large Joint Replacements Among Individuals with Higher SUA
Location: Hall F1
Abstract Poster Presenter: Janis Timsans, MD – Päijät-Häme Central Hospital, Department of Rheumatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2099: Incidence and Prevalence of Osteoarthritis in the United States Compared to Global Trends: Insights from the Global Burden of Disease Study (1990–2021)
Location: Hall F1
Abstract Poster Presenter: Nicolas Barnechea Alvarado, MD (he/him/his) – Kirk Kerkorian School of Medicine at UNLV
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2211: Maternal Adverse Pregnancy Outcomes and Risk Factors in Patients with Systemic Lupus Erythematosus in the United States
Location: Hall F1
Abstract Poster Presenter: Grace Haeun Lee, BA – Massachusetts General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2243: Differences In GDF-15 Levels In Rheumatoid Arthritis Patients With Remission Or Mild Disease Activity Are Associated With Fewer Depressive Symptoms: Clinical Data And Bioinformatic Analysis
Location: Hall F1
Abstract Poster Presenter: Jessica Roldan Ortega, MD – INSTITUTO NACIONAL DE CARDIOLOGIA
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2090: Don’t Throw Out X-Rays! Radiographic Osteoarthritis Severity is Prognostic for Onset of Frequent Knee Pain
Location: Hall F1
Abstract Poster Presenter: Grace Lo, MD, MSc – Baylor College of Medicine / MEDVAMC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2218: Pregnancy Outcomes and Placental Findings in Women with IgA Vasculitis: A Case-Control Study
Location: Hall F1
Abstract Poster Presenter: Maria del Carmen Zamora Medina, MD – National Institute of Perinatology
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2245: Add-on of Coronary Artery Calcium Score Significantly Improves the Risk Prediction of Cardiovascular Diseases in Patients with Rheumatoid Arthritis: From a Real-world Cohort Study
Location: Hall F1
Abstract Poster Presenter: Lie Dai, PhD – Department of Rheumatology and Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2215: Placenta Abnormalities in Systemic Lupus Erythematosus: Novel Marker of Adverse Pregnancy Outcomes
Location: Hall F1
Abstract Poster Presenter: Kaitlin Nuechterlein, MD – McGill University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2235: Proportion of Early Rheumatoid Arthritis Patients with Improved, Stable, or Worsened Lung Function Over 1-Year: Results from a Multicenter, Prospective Cohort Study
Location: Hall F1
Abstract Poster Presenter: Erica Mulcaire-Jones, MD – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2212: Impact of the 2020 ACR Reproductive Health Guidelines on Treatment Strategies and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Single-Center Retrospective Study
Location: Hall F1
Abstract Poster Presenter: Hiromi Shimada, MD, PhD – Kagawa University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2237: Safety of DMARD therapy in veterans with rheumatoid arthritis following melanoma diagnosis: a survival analysis
Location: Hall F1
Abstract Poster Presenter: Gabriella Girolami, MS-4 – University of Washington
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2204: A Novel Framework for Teratogenicity Counseling for Adolescents and Young Adults (AYAs) with Rheumatic Disease on Teratogenic Medications
Location: Hall F1
Abstract Poster Presenter: Brittany Huynh, MD; MPH (she/her/hers) – Indiana University School of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2254: Association of Disease Activity with Insomnia, Depression, and Fatigue in Patients with Rheumatoid Arthritis: A Multicenter Prospective Observational Study
Location: Hall F1
Abstract Poster Presenter: Misako Higashida-Konishi, MD – NHO Tokyo Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1772: Correlation between Soluble Checkpoint Molecules and Disease Activity in Autoimmune Diseases
Location: Hall F1
Abstract Poster Presenter: Kosaku Murakami, MD, PhD (he/him/his) – Kyoto University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1811: Pharmacogenomic analysis of prediction of IL-1 Inhibitor treatment response in the CARRA First-line Options for Systemic Juvenile Idiopathic Arthritis Treatment (FROST) Study
Location: Hall F1
Abstract Poster Presenter: Mariana Correia Marques, MD – National Institutes of Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1871: Examining the Impact of ETV2 on altered endothelial phenotype in systemic sclerosis
Location: Hall F1
Abstract Poster Presenter: Eliza Pei-Suen Tsou, PhD (she/her/hers) – University of Michigan
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1991: Co-Use of Mycophenolate Mofetil with Pegloticase Yielded Similar Clinical Outcomes as the Co-Use of Methotrexate
Location: Hall F1
Abstract Poster Presenter: Bradley Marder, MD – AMGEN, Inc
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2199: Disparities in Reproductive Health Counseling Among Hispanic Women with Autoimmune Rheumatic Diseases: Insights from a Patient-Reported Survey in an Urban Safety-Net Setting
Location: Hall F1
Abstract Poster Presenter: Leanna Wise, MD, MPH – LAGMC/Keck Medicine of USC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2262: Assessment of Small Airway Disease in Rheumatoid Arthritis
Location: Hall F1
Abstract Poster Presenter: Stéphane HILLIQUIN, n/a – Département de Rhumatologie, Hôpital Cochin, Assistance publique des Hôpitaux de Paris, Université Paris-Cité, Paris, France
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2301: Use of lived experiences in childhood Sjogren Disease to develop outcome measures for an N-of-1 treatment trial.
Location: Hall F1
Abstract Poster Presenter: Sara Stern, MD – University of Utah
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2504: Variables Associated with In-Hospital Mortality in Adult Eosinophilic Granulomatosis with Polyangiitis from the National Inpatient Sample Database 2017-2021
Location: Hall F1
Abstract Poster Presenter: Anuya Natu, MBBS – John H Stroger, Jr. Hospital of Cook County
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2213: Awareness Regarding Contraceptive Measures, Drug Usage And Factors Affecting Pregnancy Among Patients With Autoimmune Rheumatic Diseases
Location: Hall F1
Abstract Poster Presenter: Juhi Dixit, MD, DM (she/her/hers) – Shri Balaji Institute of Medical Sciences, Mowa Raipur
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2308: Physical Function Mediates Most—but Not All—of the Effect of Disease Activity on Health-Related Quality of Life in Axial Spondyloarthritis: A 10-Year Longitudinal Analysis
Location: Hall F1
Abstract Poster Presenter: AUGUSTA ORTOLAN, MD, PhD, MSc – Policlinico Universitario Agostino Gemelli IRCSS
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2216: Expanding Reproductive Health Assessments in Rheumatic Diseases: A Comparative Analysis of Demographic and Disease-Specific Factors
Location: Hall F1
Abstract Poster Presenter: Krista Topalsky, DO – University Hospitals
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2234: Early Sustained Remission Resulted in Superior Long-term Patient-Reported Outcomes in Rheumatoid Arthritis
Location: Hall F1
Abstract Poster Presenter: Cheuk Yin Tam, n/a – Department of Medicine and Therapeutics, The Chinese University of Hong Kong
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2203: Maternal and Fetal Outcomes Associated with IL-17 Inhibitor Exposure During Pregnancy in Patients with Seronegative Arthritis: A Case Series of Nine
Location: Hall F1
Abstract Poster Presenter: Arshdeep Waring, -None- – University of British Columbia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2256: Improved Outcomes of Acute Myocardial Infarction Among Patients with Rheumatoid Arthritis: A Propensity Matched National Study
Location: Hall F1
Abstract Poster Presenter: Qurat Ul Ain, MD (she/her/hers) – Medstar Georgetown University hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2233: Spatial Multi-omics Demonstrates Shared Immune States Across Autoimmune Diseases and Target Tissues in the Accelerating Medicines Partnership: Autoimmune and Immune-Mediated Diseases Network (AMP AIM)
Location: Hall F1
Abstract Poster Presenter: Caleb Marlin, PhD – Oklahoma Medical Research Foundation
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2241: RADAR: A Deep Learning Pipeline for Automated Scoring of Joint Damage in Rheumatoid Arthritis Radiographs
Location: Hall F1
Abstract Poster Presenter: Hugo PENSEC, MSc – CHRU Brest
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2231: Inverse Correlation Between Neutrophil Activation and Rheumatoid Factor Concentrations in Rheumatoid Arthritis (RA)
Location: Hall F1
Abstract Poster Presenter: Anne-Christine Bay-Jensen, PhD, MSc – Nordic Bioscience
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2263: Comparison of a Patient-Reported Disease Activity Measure with Physician-Based Indices in Rheumatoid Arthritis Patients in Nigeria
Location: Hall F1
Abstract Poster Presenter: Uchechukwu Tralagba, MBBS (she/her/hers) – University of Port Harcourt Teaching Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2260: Generative AI model identifies patients with Rheumatoid Arthritis (RA) months prior the diagnosis date: results from a large real-world RA cohort
Location: Hall F1
Abstract Poster Presenter: Shant Ayanian, MD, MS – Mayo Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2230: Racial and Ethnic Disparities in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Their Impact on Antifibrotic Therapy
Location: Hall F1
Abstract Poster Presenter: Andrea Galecio Chao, MD (she/her/hers) – Baylor College of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2238: Impact of Type 2 Diabetes on Cardiovascular and Renal Outcomes in Rheumatoid Arthritis: Insights from a Large-Scale Multi-Center Analysis
Location: Hall F1
Abstract Poster Presenter: Gurjot Singh, MD – Trihealth Good Samaritan Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1774: Citrullinated and Malondialdehyde-Acetaldehyde Co-Modified Fibrinogen Activates Macrophages and Induces Pro-Fibrotic shift in Coronary Endothelium Phenotype
Location: Hall F1
Abstract Poster Presenter: Nozima Aripova, PhD – University of Nebraska Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1810: Destabilized Treg Cells Predominant in Severe Forms of Juvenile Idiopathic Arthritis
Location: Hall F1
Abstract Poster Presenter: Ki Pui Lam, PhD – Division of Immunology, Boston Childrens Hospital, Harvard Medical School
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1876: Targeting the NK cell checkpoint NKG2A promotes lung fibrosis resolution by enhancing immune clearance of senescent myofibroblasts
Location: Hall F1
Abstract Poster Presenter: Wolfgang Merkt, MD – University Hospital Düsseldorf
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1989: Moving Out of the Kid’s Rheum: Transitioning Young Adult Patients from Pediatric to Adult Rheumatology Practices
Location: Hall F1
Abstract Poster Presenter: Victoria Koenigsberger, BA (she/her/hers) – The Warren Alpert Medical School of Brown University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2006: Storytelling and Navigation to Improve Gout Follow-up: A Multicenter, Randomized Controlled Trial
Location: Hall F1
Abstract Poster Presenter: Lesley Jackson, MD, MSPH – University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2196: Recognition and Treatment of Idiopathic Granulomatous Mastitis: A Case Series
Location: Hall F1
Abstract Poster Presenter: Jenny Solomon, MD – NYU Langone Long Island
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2246: Different Populations, Different SDAI Cut-Off? A Proposal for a New Remission Threshold in Brazilian RA Patients from a National Multicenter Study
Location: Hall F1
Abstract Poster Presenter: Lucas Pires, MD – State University of Campinas (UNICAMP) - Brazil
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2297: Clinically Relevant Anti-Vaccine and Virus Antibodies in Patients with Sjogren’s Disease Treated with Nipocalimab: Post-Hoc Analysis of the DAHLIAS Study
Location: Hall F1
Abstract Poster Presenter: Faye Yu, BSc – Johnson & Johnson Innovative Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2332: Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints: DAPSA44
Location: Hall F1
Abstract Poster Presenter: Sofia Ramiro, MD, PhD – Leiden University Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2517: Predictors for Mortality in Patients Who Received Plasmapheresis for Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis
Location: Hall F1
Abstract Poster Presenter: Sai Shanmukha Sreeram Pannala, MD (he/him/his) – Northwell Health/Staten Island University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1773: Redefining disease activity assessment in IgG4-Related Disease: The role of classical and novel biomarkers
Location: Hall F1
Abstract Poster Presenter: Marta López, MD – Complex Hospitalari Universitari Moisès Broggi
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1818: Epigenetic Profiling of Childhood-onset Lupus Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Drivers of Disease Activity
Location: Hall F1
Abstract Poster Presenter: Desire Casares Marfil, PhD – School of Medicine, University of Pittsburgh
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1865: Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multi-omics analysis
Location: Hall F1
Abstract Poster Presenter: Hanlin Yin, MD, PhD – Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1983: Documenting Transition: A Review and Intervention to Increase the Receipt of Transition Summary Letters
Location: Hall F1
Abstract Poster Presenter: Kyla Blasingame, MD, BA (she/her/hers) – Baylor College of Medicine
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2001: Characteristics of Gout Flares Over Time with Treat-to-Target Urate-Lowering Therapy Use
Location: Hall F1
Abstract Poster Presenter: Jason Yang, MD, PhD (he/him/his) – Boston Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2197: Mechanisms of Fetal Growth Restriction in Rheumatologic Autoimmune Diseases: Insights into Placental Pathology and Immune Dysregulation
Location: Hall F1
Abstract Poster Presenter: Larabe Farrukh, MD – University of California San Diego
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2257: Impact of Family History of RA in Patients Evaluated for Arthralgia: A Comprehensive Analysis of the Reuma-check Cohort
Location: Hall F1
Abstract Poster Presenter: Rodrigo Garcia Salinas, MD – Hospital Italiano La Plata
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2303: Metabolic impact of low dose IL‐2 therapy for primary Sjögren’s Disease in a double‐blind, randomized clinical trial
Location: Hall F1
Abstract Poster Presenter: Yuebo Jin, MD – Peking University People's Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2312: Sociodemographic Characteristics and Healthcare Utilization in Patients with IBD-Associated Arthritis vs. IBD Alone: A Nationwide Inpatient Analysis
Location: Hall F1
Abstract Poster Presenter: Faria Sami, MD – The University of Alabama at Birmingham
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2315: Alterations in the Gut Microbiome in Ankylosing Spondylitis and Their Correlation with Disease Activity
Location: Hall F1
Abstract Poster Presenter: Hyemin Jeong, MD – Soonchunhyang University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2516: Mortality Trends in Primary Systemic Vasculitis in the United States (1999–2023)
Location: Hall F1
Abstract Poster Presenter: Sabah Mohib, MBBS – Dow Medical College
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1770: Brepocitinib Inhibits Key Pathogenic Cytokine Signaling in Dermatomyositis Patients
Location: Hall F1
Abstract Poster Presenter: Christina Charles-Schoeman, MD;MS – UCLA Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1817: Sex-specific mechanisms associated with female childhood-onset systemic lupus erythematosus revealed by transcriptomic analysis of transgender adolescents undergoing gender-affirming sex hormone therapy.
Location: Hall F1
Abstract Poster Presenter: Coziana Ciurtin, MD, PhD, FRCP – University College London
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1858: Antinuclear Antibodies from Systemic Sclerosis Patients Enter Cells via a Clathrin Endocytosis Mechanism and Interact with Their Intracellular Antigen
Location: Hall F1
Abstract Poster Presenter: Aurélien Chepy, -None- (he/him/his) – INFINTE U186 inserm, univeristy of Lille
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1976: Implementing a Change Package for Depression Screening and Appropriate Response for Children with Rheumatic Disease
Location: Hall F1
Abstract Poster Presenter: Emily Vara, DO (she/her/hers) – Medical University of South Carolina
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2008: Exposure to Anaerobic Antibiotics and Risk of Gout Flares: Target Trial Emulation for the Potential Role of the Gut Microbiome in Gout and Chronic Kidney Disease (CKD)
Location: Hall F1
Abstract Poster Presenter: Natalie McCormick, PhD – Massachusetts General Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2195: Enhancing MTX and LEF Safety for Immunosuppressed Women of Childbearing Age with Rheumatic Diseases
Location: Hall F1
Abstract Poster Presenter: Angela Bobak, DO (she/her/hers) – Geisinger Medical Center Rheumatology Fellowship
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2244: Bone Mineral Density Trajectories and Fracture Risk in Rheumatoid Arthritis: A 7-Year Longitudinal Analysis Using Group-Based Trajectory Modeling
Location: Hall F1
Abstract Poster Presenter: Kei Hirose, MD – Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2298: When Imaging and Biopsy Disagree: Diagnostic Value of Doppler Ultrasound and Histologic Features beyond the Focus Score
Location: Hall F1
Abstract Poster Presenter: Kyung Ann Lee, MD, PhD (she/her/hers) – Soonchunhyang University Hospital Seoul: Soonchunhyang University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2511: The SHIPE index: A tertile-based approach to predict end-stage kidney disease in ANCA-associated vasculitis
Location: Hall F1
Abstract Poster Presenter: HYUNSUE DO, MD – Kangwon national university hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1777: Granzyme B as a regulator of interferon alpha production in cutaneous lupus erythematosus
Location: Hall F1
Abstract Poster Presenter: Touraj Khosravi, MD, FRCPC, FAAD – University of British Columbia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1825: Serum proteomic and single cell RNA sequencing analysis reveals macrophage activation syndrome physiology and widespread complement dysregulation are associated with severe dengue infection in a pediatric cohort
Location: Hall F1
Abstract Poster Presenter: Sarah McCuaig, MD, PhD (she/her/hers) – Children's Hospital of Philadelphia
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1862: Comprehensive analysis of the major histocompatibility complex in systemic sclerosis-associated interstitial lung disease identifies novel associated loci and potential progression biomarkers
Location: Hall F1
Abstract Poster Presenter: Carlos de la Rosa Báez, MSc – Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, CSIC
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1985: Identifying Gaps in Documented Contraception Counseling and Gynecology Referrals for Women on Teratogenic DMARDs: A Foundation for EMR-Based Quality Improvement
Location: Hall F1
Abstract Poster Presenter: Rachel Galvao, MD – University of Pennsylvania Health System
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2011: A Phase 1 Placebo Controlled, Single (SAD) and Multiple Dose Escalation (MAD) Safety and Pharmacokinetic (PK) Study of a Novel Colchicine Analogue ABP-745 in Healthy Volunteers (HV)
Location: Hall F1
Abstract Poster Presenter: Ullrich Schwertschlag, MD, PhD (he/him/his) – Atom Therapeutics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2225: The Impact of Pregnancy Planning on the Prevalence of Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Retrospective Study from Three Japanese Tertiary Referral Centers
Location: Hall F1
Abstract Poster Presenter: Takehiro Nakai, MD – St. Luke's International Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2255: Diagnostic Accuracy of Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis: A Systematic Review and Meta-analysis
Location: Hall F1
Abstract Poster Presenter: Pannathorn Nakaphan, MD (he/him/his) – Weiss Memorial Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2299: Real-world clinical effectiveness of rituximab rescue therapy in patients with progressive interstitial lung disease associated with primary sjögren’s syndrome
Location: Hall F1
Abstract Poster Presenter: Paula Valentina Estrada Alarcón, MD, PhD – H Moisès Broggi
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2515: The Association Between Neurologic Involvement and Cumulative Damage in ANCA-Associated Vasculitis
Location: Hall F1
Abstract Poster Presenter: Ruoning (Lemon) Ni, MD, RhMSUS (she/her/hers) – University of Iowa
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1776: Preclinical Development of a Novel TL1A-Targeting Antibody with Extended Half-life and Low Immunogenicity Risk for the Treatment of Inflammatory Diseases
Location: Hall F1
Abstract Poster Presenter: Quan Yu, PhD – Ailux
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1816: Single-Cell RNA-Transcriptomics of JDM Skin Identifies JDM-Associated Immune Cell Populations and Dysregulated Interferon Signaling in Immune and Endothelial Cells
Location: Hall F1
Abstract Poster Presenter: Chioma Madubata, MD, PhD – UCSF
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1855: Small Bowel Microbial Dysbiosis and Impaired Intestinal Absorptive Function in Systemic Sclerosis- A Single Center Prospective Study
Location: Hall F1
Abstract Poster Presenter: Adam Edwinson, PhD – Mayo Clinic
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2012: A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ABP-671 in Subjects with Hyperuricemia or Gout in China
Location: Hall F1
Abstract Poster Presenter: Ullrich Schwertschlag, MD, PhD (he/him/his) – Atom Therapeutics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2210: Changes in Treatment Pathways Over Time in Pregnancies with Active Lupus Nephritis
Location: Hall F1
Abstract Poster Presenter: Dahima Cintron, MD;MSc – Duke Health
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2248: Elevated Anti-PAD Autoantibodies in a Singaporean Chinese Rheumatoid Arthritis (RA) Cohort with Rheumatoid Factor (RF) and Anti-Citrullinated Protein Antibodies (ACPA) Positivity: A Case-control Exploratory Study
Location: Hall F1
Abstract Poster Presenter: Margaret Ma, MD,PhD – National University Hospital
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2293: CLN-978, a CD19 x CD3-Directed T Cell Engager, Leads to Rapid and Deep B Cell Depletion In Vitro and In Vivo, Supporting Clinical Development Across Multiple Autoimmune Diseases
Location: Hall F1
Abstract Poster Presenter: Antoine Sreih, MD – Cullinan Therapeutics
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1775: Study Of Type -1 Interferon Gene Signature Markers In Muscle Biopsy Samples Of Patients With IIM
Location: Hall F1
Abstract Poster Presenter: pradeep sosigowda, MBBS/MD/DM – NIMS
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1821: Transcriptiomics of tear RNA from children with active and inactive chronic anterior uveitis
Location: Hall F1
Abstract Poster Presenter: Grant Schulert, MD, PhD – Cincinnati Children's Hospital Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1869: A Mirna Signature Consisting of High let7i-5p, High mir-483-5p, Low mir-223- 3p Characterizes Connective Tissue Diseases with Interstitial Lung Disease
Location: Hall F1
Abstract Poster Presenter: Olga Sanchez Pernaute, MD,PhD (she/her/hers) – Clinica Universidad de Navarra
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
1972: Enhancing Patient Safety: Improving Contraceptive Counseling for Patients on Teratogenic Medications in the Rheumatology Clinic
Location: Hall F1
Abstract Poster Presenter: Abi Fadairo Azinge, MD, MPH – University of California San Francisco
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2002: Methods to Address Survival Bias and Competing Risks in Estimating the Causal Risks of Gout on Dementia Risk
Location: Hall F1
Abstract Poster Presenter: Joshua Baker, MD, MS – University of Pennsylvania
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2206: Adolescents with Systemic Lupus Erythematosus at Highest Risk of Adverse Pregnancy Outcomes
Location: Hall F1
Abstract Poster Presenter: Catherine Deffendall, MD – Vanderbilt University
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2264: Male Sex and Obesity Are Risk Factors for Sarcopenia in RA: Korea National Health and Nutrition Survey 2008–2011
Location: Hall F1
Abstract Poster Presenter: Yoon-Jeong Oh, MD – Uijeongbu Eulji Medical Center
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2304: Updates in the local treatments in Primary Sjögren's Syndrome “Efficacy and Safety”
Location: Hall F1
Abstract Poster Presenter: Marta Ramírez Martín, MD (she/her/hers) – Hospital University Principe de Asturias
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time
2509: Predicting future relapse with proteomics in ANCA-Associated Vasculitis
Location: Hall F1
Abstract Poster Presenter: Evan Barnes, MD, MS – Massachusetts General Hospital